Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 651.0;Proximal tubular cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 51.9;SK-BR-3: 82.5"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.1	8.9	3.0	9.5	13.1	7.7	10.6	7.5	10.9	8.6	8.2	11.9	9.2	4.8	5.4	12.0	4.2	5.4	8.2	12.7	4.7	7.0	8.5	6.2	7.9	33.7	8.5	14.3	14.0	14.2	9.1	7.4	5.3	5.4	11.6	11.8	5.8	5.7	9.5	10.6	13.8	10.2	3.2	51.9	10.8	3.1	5.8	8.1	24.2	24.2	2.6	4.1	7.3	82.5	5.2	4.4	8.5	11.5	8.4	5.2	5.0	10.4	10.3	7.6	4.8	3.8	8.5	12.5	8.3	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9	38.7	31.4	45.5	55.9	29.7	37.5	2.4	109.5	17.4	19.4	62.8	13.7	77.1	140.9	89.4	3.0	25.4	292.3	23.3	69.3	52.5	32.7	64.1	18.5	651.0	74.1	7.9	52.9	34.4	86.5	6.4	33.1	68.8	55.6	86.6	63.2	33.0	78.8	122.8	31.1	601.4	14.2	32.3	25.8	17.5	11.7	31.0	83.1	42.0	60.0	69.8
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 686.3;Proximal tubular cells: 536.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3200000	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.8	14.1	23.6	21.6	31.3	16.6	12.0	7.2	11.8	12.2	9.5	30.0	12.3	12.6	15.5	26.6	12.6	0.9	39.3	4.6	12.1	38.6	9.2	8.9	18.5	35.6	14.8	0.1	16.9	21.9	1.5	19.7	6.2	9.9	20.0	18.3	7.7	11.9	33.9	16.3	0.5	19.5	21.4	5.3	5.7	31.0	50.5	46.2	41.3	0.6	33.9	26.9	0.5	16.6	1.1	19.5	9.4	13.1	9.5	10.4	13.1	15.7	7.9	24.2	27.9	32.2	7.4	18.2	9.5	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5	35.7	38.9	45.7	10.9	3.2	5.9	161.7	229.3	29.4	30.7	52.4	3.9	30.0	250.4	111.1	56.2	32.3	191.9	0.0	40.7	49.6	32.6	10.2	44.9	686.3	101.9	1.6	38.5	46.6	63.1	122.0	44.5	46.6	18.6	61.3	59.2	53.2	84.8	76.3	35.0	536.1	27.2	19.4	17.6	27.7	39.6	4.3	22.5	68.2	98.9	4.5
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537114-73543794	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.6"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.2;T-47d: 25.1"									HPA043705	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	8.5	7.2	5.1	3.7	3.9	1.0	13.7	2.0	7.7	3.0	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9.0	0.9	3.2	6.0	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13.0	1.9	1.0	3.4	2.7	2.4	0.9	1.8	5.0	1.9	5.6	1.7	3.8	5.7	1.0	1.7	4.2	6.3	3.1	4.2	5.0	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0.0	0.0	3.6	0.0	2.5	0.0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3.0	7.9	0.4	3.6	0.0	0.1	2.0	0.0	0.0	0.0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0.0	0.0	0.0	1.3	3.6	0.0	4.0	0.1	1.3	1.0	6.0	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2.0	7.7	4.3	3.6	3.2	6.0	5.6	2.4	0.0	2.7	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.0	0.0	0.0	7.2	0.2	0.3	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.4	0.8	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.2	11.0	2.3	9.7	10.3	4.0	0.4	6.0	14.0	9.8	13.0	7.8	7.5	0.0	4.4	3.2	5.1	6.2	0.0	0.6	5.2	14.2	13.9	6.8	4.5	26.8	6.7	0.0	19.3	9.1	0.0	3.7	0.0	9.6	4.2	0.0	0.0	0.0	8.4	4.7	1.0	7.7	3.3	1.3	16.7	16.1	9.8	0.1	3.6	4.7	10.1	12.2	14.8	11.5	12.0	1.1	27.6	5.4	7.6	8.6	21.6	5.5	5.7	0.0	0.0	4.0	7.2	0.0	8.1	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7	0.0	5.4	1.7	1.0	1.4	0.9	43.0	7.6	4.0	1.2	7.0	9.8	4.6	11.6	18.3	1.0	3.6	16.2	0.0	29.2	2.3	3.9	0.3	13.8	25.8	13.9	1.6	15.1	3.7	4.0	0.4	5.5	2.0	5.0	30.7	15.1	3.3	19.0	5.8	7.8	16.5	4.5	6.5	4.2	0.4	4.3	0.4	6.9	5.7	19.7	0.4
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591706-73596496	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.6"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 22.2;Proximal tubular cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.3;MCF7: 5.6;SK-BR-3: 11.7;T-47d: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA					"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	6.3	2.2	2.9	1.4	3.6	0.6	4.4	1.6	5.7	3.6	2.6	1.0	1.5	3.9	1.0	2.4	2.0	0.9	3.3	2.9	2.1	2.0	13.0	15.6	3.9	1.1	1.6	2.8	0.9	2.2	1.1	0.7	4.9	2.7	1.4	3.1	1.8	3.1	3.4	0.7	0.9	7.4	2.5	0.8	1.4	1.9	2.8	0.9	0.3	1.2	0.8	1.2	1.1	1.3	1.7	0.6	5.0	0.4	4.6	10.6	3.2	4.3	1.2	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.3	0.5	0.1	7.3	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	1.6	0.0	0.8	0.0	4.1	0.3	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	5.6	0.1	0.8	0.4	1.5	1.2	0.0	0.0	0.0	0.1	2.1	0.6	0.2	2.8	11.7	0.8	0.0	29.2	4.4	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	1.0	10.6	0.4	5.5	1.6	5.2	6.0	0.2	1.7	3.2	6.5	0.3	4.6	0.2	0.6	4.8	3.2	2.9	3.6	1.6	5.7	2.1	2.0	1.6	2.8	2.7	0.9	0.0	2.4	2.2	1.0	0.2	0.2	1.2	2.5	2.7	1.2	10.4	0.0	11.8	13.3	3.6	1.6	0.3	10.3	0.0	8.3	11.5	1.1	0.5	5.7	22.2	10.2	1.6	0.0	0.0	2.7	3.8	0.3	1.7	0.0	1.8	2.7	0.5	4.8	2.9	0.4	51.8	0.5	0.0	0.9	2.7	14.3	0.3	3.8	4.4	2.8	1.1
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 6.8;liver: 6.1;skeletal muscle: 6.5"	"Cell type enhanced"	"Detected in some"	21	"Hepatocytes: 2.4;Proximal tubular cells: 2.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"T-47d: 15.3"									HPA058258	Uncertain					NA	NA					"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	2.6	1.0	1.5	0.0	2.0	0.0	0.1	0.8	1.2	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.8	0.6	6.8	6.1	0.0	0.0	0.8		0.7	0.4	0.0	0.0	0.0		0.0	0.0		0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.0	0.9			1.4		0.0	0.0	0.0	0.1	1.8	0.0	0.6	0.0	1.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.0	2.8	0.1	0.0	15.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.1	0.8	1.8	0.1	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6394391	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 20.5;plasmacytoid DC: 19.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		29000	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	4.7	13.3	25.8	10.8	29.8	7.7	3.9	23.9	50.0	4.4	18.3	11.3	0.5	33.2	5.1	3.8	14.3	4.4	5.3	6.3	27.8	43.9	29.4	9.1	8.6	12.3	36.0	20.7	5.3	4.0	1.9	18.5	7.4	49.9	5.6	13.5	6.6	4.1	4.9	1.5	9.4	33.2	14.3	14.2	8.9	6.2	13.1	6.9	9.0	2.3	6.5	11.6	9.1	6.6	1.0	19.4	0.4	0.6	20.5	4.4	2.8	23.7	20.7	20.4	22.0	4.7	7.8	7.7	20.5	10.6	30.4	18.2	71.4	7.7	29.1	15.1	16.6	23.5	23.5	32.9	54.7	11.4	25.5	28.7	15.3	16.4	25.3	19.3	17.9	12.7	6.9	10.5	25.1	29.8	8.1	17.0	36.5	12.4	6.3	16.0	27.7	37.3	19.0	10.2	23.9	48.0	44.6	23.5	19.7	17.1	9.1	11.2	31.7	18.4	28.3	65.2	10.5	10.1	8.4	27.5	27.7	16.2	27.4	32.3	5.3	21.6	40.9	17.5	31.3	16.8	0.0	0.1	0.1	4.1	0.6	1.0	1.0	3.4	3.6	2.9	0.4	1.2	2.3	0.4	20.5	0.5	19.4	4.4	2.8	25.8	29.8	23.9	50.0	27.8	43.9	36.0	20.7	49.9	6.9	6.0	25.5	13.7	13.3	28.2	33.6	8.1	12.7	1.4	7.9	8.7	9.8	15.1	13.3	19.1	73.6	15.6	70.9	0.0	6.2	23.1	14.2	7.0	137.0	13.4	26.8	44.5	4.6	5.5	4.0	118.5	3.4	16.9	37.1	25.2	88.8	10.6	16.5	29.1	6.7	214.2	15.6	0.0	6.2	38.2	26.7	25.7	14.4	21.4	48.7	19.5
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.7	9.3	3.2	6.4	9.0	5.5	5.6	5.3	4.3	7.4	6.9	13.6	10.8	9.7	23.9	7.2	17.1	15.2	6.1	13.1	2.5	7.2	10.7	9.7	12.5	13.0	8.1	9.3	9.1	6.4	10.1	7.1	5.1	11.0	4.5	11.4	8.6	12.1	5.2	21.8	13.2	12.1	5.6	15.2	24.9	6.4	5.9	17.4	7.8	8.8	11.0	5.2	11.6	29.8	18.1	5.2	16.4	22.8	5.2	18.3	4.1	9.4	8.7	10.3	15.2	6.1	22.7	9.8	9.7	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1	32.8	13.1	13.4	10.4	5.5	17.5	9.4	10.2	17.4	9.1	12.2	15.7	27.1	54.7	19.6	30.4	8.2	74.4	0.0	18.1	16.7	7.2	11.9	13.9	22.2	24.7	7.9	18.5	11.6	16.5	58.7	9.2	13.0	10.1	26.2	34.3	15.2	19.9	59.6	8.1	57.5	19.5	12.9	8.5	25.9	8.7	6.9	16.2	14.6	27.0	11.6
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 185.5;Hepatocytes: 244.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 35.3;RT4: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.4	7.7	2.5	3.8	13.3	5.6	35.3	4.0	4.0	4.8	5.5	5.4	9.0	3.1	4.3	6.8	4.5	3.3	10.7	4.2	7.6	2.8	3.2	4.0	4.4	17.7	7.2	3.4	2.6	9.3	3.3	5.4	3.6	5.1	12.0	4.3	4.1	3.1	5.3	16.1	7.6	2.5	1.9	13.5	6.7	4.2	7.7	3.6	8.1	47.5	3.1	4.6	11.4	17.8	3.8	8.7	10.9	3.9	7.9	6.7	4.9	5.4	3.8	5.1	3.5	1.2	3.9	3.2	3.9	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3	26.8	20.6	3.0	13.1	11.9	23.8	38.6	48.4	14.7	18.2	22.7	21.6	32.5	18.3	19.8	8.4	14.6	185.5	23.3	35.6	39.3	17.0	27.2	16.2	244.8	23.1	17.5	33.1	22.1	31.8	6.5	27.6	19.9	13.5	25.2	35.0	64.2	31.5	87.7	44.2	74.6	28.4	0.0	16.4	5.6	10.7	26.5	36.2	10.2	32.4	22.6
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 75.4;Proximal tubular cells: 33.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 20.7;fHDF/TERT166: 6.7;Hep G2: 8.0;HSkMC: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		190000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	20.7	3.6	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	1.8	0.0	0.0	13.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0	3.0	4.3	0.5	7.2	0.6	0.2	14.4	0.0	0.0	1.2	3.5	0.0	0.6	13.3	0.3	0.1	1.1	5.4	0.0	1.7	0.2	5.0	0.8	1.1	75.4	5.3	1.6	2.9	4.3	2.2	1.4	10.0	0.8	0.0	0.0	4.7	10.0	0.5	0.0	8.1	33.8	0.8	6.5	3.4	0.2	0.5	0.3	0.7	0.0	3.6	0.8
ACOX3		ENSG00000087008	"Acyl-CoA oxidase 3, pristanoyl"	O15254	4	8366282-8440723	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Syncytiotrophoblasts: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035840, HPA035841"	Uncertain		Approved	Peroxisomes		NA	NA			Peroxisomes		"HPA035840: AB_10696514, HPA035841: AB_10671940"	"unprognostic (3.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	9.6	12.0	9.9	7.4	10.9	5.0	15.5	11.7	12.8	12.2	9.9	11.5	11.2	10.8	10.7	12.3	32.0	9.2	7.4	20.6	9.0	6.7	8.3	18.0	8.9	7.4	10.3	8.4	9.8	15.4	10.0	14.8	28.9	10.2	13.4	8.0	12.0	19.1	11.2	8.2	14.8	10.5	18.6	7.2	7.6	12.7	5.0	11.6	9.0	11.5	7.4	14.2	14.8	16.0	4.6	16.8	2.6	12.0	7.3	8.0	6.9	6.3	6.9	7.8	10.3	8.4	14.3	12.7	8.0	11.1	13.8	12.0	3.4	8.5	8.5	8.7	16.4	18.6	3.9	3.3	10.4	10.7	2.9	3.3	3.7	5.8	10.5	13.9	7.4	7.0	14.3	9.0	12.3	4.8	9.9	16.2	9.5	4.9	7.8	11.8	5.8	7.9	11.0	4.3	8.1	12.0	8.4	12.8	10.1	8.4	8.9	3.8	8.7	10.3	5.3	5.3	6.7	5.3	10.7	15.6	13.6	4.4	5.5	8.4	5.9	3.9	3.8	17.3	9.4	8.6	0.0	10.6	2.6	5.2	12.0	5.4	4.6	6.1	6.6	14.0	4.5	5.6	5.8	2.5	7.3	10.6	16.8	8.0	6.9	9.9	10.9	11.7	12.8	9.0	6.7	10.3	8.4	10.2	11.6	6.0	5.1	6.4	6.8	3.9	8.6	8.5	7.6	4.0	4.5	10.4	31.4	19.8	3.3	13.9	2.2	3.9	11.8	0.0	11.9	8.2	5.8	7.8	0.0	9.9	8.9	1.6	1.7	5.5	3.2	2.1	6.4	4.2	5.0	8.2	4.9	4.1	15.1	9.9	10.6	5.1	15.8	0.0	6.2	1.2	1.9	5.1	62.4	5.0	6.7	10.0
ACSBG1	"BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352"	ENSG00000103740	"Acyl-CoA synthetase bubblegum family member 1"	Q96GR2	15	78167468-78245688	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.4;brain: 40.5;skin 1: 19.9"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 26.8;Spermatogonia: 7.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.1;SK-MEL-30: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041642, CAB045955, HPA058869"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.42e-2)"	1.1	11.4	16.9	1.5	26.9	4.5	3.8	6.6	27.0	1.1	1.2	10.5	0.0	1.6	1.2	2.3	1.3	5.9	1.3	1.1	16.4	8.5	1.0	1.0	1.7	1.6	21.1	13.9	1.2	1.0	0.9	0.3	1.1	32.9	2.0	1.1	0.0	1.5	1.4	1.2	19.9	1.5	1.2	40.5	1.3	1.2	5.4	19.0	0.0	1.2	0.0	1.1	1.5	0.2	0.4	3.9	1.2	0.2	0.6	0.2	1.5	0.8	0.1	1.6	2.4	0.0	0.0	0.6	0.5	0.0	0.5	0.1	0.5	0.6	0.8	0.2	0.1	0.6	0.9	0.1	0.3	0.2	0.4	1.4	0.7	1.4	0.7	0.0	0.7	1.6	0.6	0.0	0.4	0.2	0.5	0.2	1.0	0.5	1.1	0.1	0.4	0.6	1.4	8.1	0.7	0.3	0.3	1.0	0.5	0.0	1.0	0.6	0.9	0.4	1.0	3.8	1.0	0.5	0.5	1.0	0.6	0.6	0.5	0.3	0.9	0.3	0.9	0.3	0.6	1.6	0.4	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.4	0.2	0.1	1.2	0.6	0.2	3.9	0.0	1.5	16.9	26.9	6.6	17.9	16.4	8.5	21.1	13.9	32.9	19.0	0.0	1.3	0.0	0.3	1.0	2.1	2.0	0.0	26.8	4.5	0.0	3.9	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.9	0.9	7.7	0.5	0.3	0.0	0.0	0.3
ACSBG2	"BGR, DKFZp434K1635, PRTD-NY3"	ENSG00000130377	"Acyl-CoA synthetase bubblegum family member 2"	Q5FVE4	19	6135247-6193094	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 71.3"	"Group enriched"	"Detected in some"	68	"Early spermatids: 443.1;Late spermatids: 1482.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0"	"Not detected"	"Not detected"							"HPA043421, HPA051013"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA043421: AB_10794182, HPA051013: AB_2681311"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.96e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.70e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	2.6	0.0	1.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.5	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	443.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1482.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.0	0.0	6.5	0.0	14.2	5.7	0.0	1.1	0.0	0.0	0.0
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860934-222944639	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 206.1"	"Cell type enhanced"	"Detected in all"	9	"Horizontal cells: 494.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 94.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Nucleoli rim,Lipid droplets"		NA	NA			"Nucleoli, Nucleoli rim"	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: AB_2686335"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (2.75e-4)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	14.7	17.0	22.8	9.9	26.0	16.3	51.5	19.4	45.9	15.3	16.5	16.1	11.6	12.7	10.9	18.4	28.3	9.0	11.8	22.7	20.9	22.8	17.9	22.3	15.6	10.5	19.6	21.2	11.7	10.3	206.1	8.8	19.1	24.4	44.4	16.7	14.4	34.2	15.5	19.1	11.4	12.7	12.2	22.2	9.7	28.3	13.7	14.2	13.5	17.3	11.2	8.7	14.6	15.4	15.0	22.5	21.8	16.8	16.6	20.1	16.5	10.1	17.9	27.4	29.8	12.0	29.8	7.6	12.9	33.6	15.5	32.7	16.1	26.1	4.8	7.5	12.3	33.5	29.9	5.9	28.7	20.1	8.7	11.2	11.4	14.5	17.9	26.5	7.5	5.6	15.3	40.8	25.6	44.7	11.9	16.8	8.5	21.5	18.6	21.8	21.5	14.6	8.8	13.9	23.0	9.3	8.0	23.2	8.2	22.3	41.6	14.5	10.7	7.6	20.6	94.2	22.1	10.3	18.4	11.6	10.4	16.6	8.9	9.4	6.6	3.2	16.8	11.1	7.1	31.4	16.6	14.6	21.8	20.1	16.8	19.3	11.6	12.8	14.6	15.7	15.0	18.7	16.7	21.8	16.6	15.9	22.5	9.5	16.5	22.8	26.0	19.4	45.9	20.9	22.8	19.6	21.2	24.4	14.2	32.8	58.5	16.4	65.8	41.3	91.7	51.2	40.8	37.5	44.3	34.9	72.6	32.9	6.6	28.6	31.0	38.3	33.1	23.3	27.3	8.4	36.3	113.5	26.5	47.9	33.5	494.2	20.1	36.2	50.2	18.9	24.2	42.9	45.5	32.5	32.3	205.8	32.5	38.6	33.6	12.5	51.8	45.3	51.8	50.2	49.9	42.7	50.7	27.7	46.5	102.1
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Alveolar cells type 2: 210.9;granulocytes: 598.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		NA	NA		100000	"Golgi apparatus"	Mitochondria	"HPA000286: AB_2665966, HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favorable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.9	4.5	5.6	6.0	21.1	13.2	4.4	20.5	22.7	20.0	20.9	4.4	9.7	10.0	8.0	14.8	24.6	4.0	4.8	19.7	31.6	3.5	5.0	39.4	6.4	46.6	9.7	9.3	81.7	11.4	7.7	22.8	16.7	11.6	15.0	6.4	1.1	12.3	22.9	0.9	8.1	12.3	7.0	3.1	8.2	5.9	10.3	8.2	28.7	4.5	3.7	2.8	24.5	0.0	12.6	11.5	0.3	10.0	27.7	18.3	5.2	28.9	18.8	6.1	7.0	9.4	32.3	20.9	11.6	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7	71.5	210.9	20.6	16.2	19.8	34.7	32.3	10.2	17.4	64.8	69.8	2.0	5.7	43.1	24.1	1.2	28.6	0.7	23.3	22.2	29.6	17.9	10.6	598.2	1.7	22.2	6.4	7.5	17.8	68.3	2.0	5.2	45.1	15.1	64.9	2.9	11.7	26.4	1.4	9.6	10.0	14.5	0.0	22.3	3.9	3.8	7.0	26.4	13.8	1.7	12.4
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 266.6;Paneth cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.6	0.3	0.2	0.0	0.8	0.1	1.0	0.3	2.3	0.0	0.2	10.6	43.3	14.2	2.6	0.6	2.1	0.1	0.0	0.0	0.2	11.9	0.0	11.1	0.4	18.5	2.8	17.2	18.8	1.9	0.0	0.2	0.0	0.8	0.8	0.0	0.0	6.5	0.0	0.0	0.0	7.9	0.0	9.8	0.4	3.9	0.0	8.7	1.2	44.2	0.0	0.3	17.3	6.6	0.0	0.0	0.0	9.7	12.5	0.1	0.1	0.7	0.7	4.7	0.0	6.9	0.4	21.6	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5	11.9	43.5	21.6	7.4	3.4	0.0	1.4	12.7	5.3	33.0	0.0	3.9	1.6	0.0	12.0	65.8	24.5	266.6	0.0	5.6	1.9	1.7	5.7	17.3	79.9	16.7	0.0	39.2	16.0	19.2	29.7	14.7	23.5	3.3	4.6	84.3	0.0	29.0	93.1	11.3	0.0	1.2	0.0	1.4	1.7	1.4	1.5	0.6	14.9	90.6	41.4
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 216.0;Erythroid cells: 116.8;Rod photoreceptor cells: 126.2"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 14.9;U-937: 8.7"									HPA040470	Enhanced					NA	NA					"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.6	4.8	16.5	1.5	15.7	21.3	0.7	22.8	34.0	0.5	0.7	5.3	30.1	5.4	0.5	1.0	0.9	0.7	0.9	2.0	12.4	9.7	2.3	2.6	0.8	2.5	9.6	12.1	0.5	1.9	13.0	2.7	1.1	12.1	0.8	0.8	3.3	0.8	35.8	3.6	0.6	3.3	0.5	4.2	1.2	1.2	23.0	4.7	0.0	0.9	0.0	1.5	0.7	0.3	0.1	0.0	0.6	0.1	1.2	4.2	1.1	0.0	0.0	0.3	0.1	0.6	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.5	0.1	1.6	0.2	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	0.0	2.1	1.0	0.2	0.0	0.0	0.0	1.5	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	14.9	0.7	0.2	0.2	1.2	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	8.7	0.5	0.6	0.1	0.1	1.5	0.0	3.5	0.1	2.1	4.2	0.0	0.1	3.9	1.8	0.2	1.2	0.0	0.0	0.1	1.1	16.5	15.7	22.8	18.8	12.4	9.7	9.6	12.1	12.1	4.7	23.8	33.5	0.5	1.0	1.6	55.8	0.0	2.5	14.7	29.6	1.8	216.0	0.3	6.6	0.4	22.7	0.4	0.7	116.8	0.2	0.2	1.1	1.0	9.3	5.7	0.1	20.6	2.4	2.5	1.2	3.6	0.3	7.9	0.0	0.0	0.6	20.4	0.2	0.9	1.8	0.3	126.2	0.0	0.8	16.1	1.3	1.1	0.2	10.7	0.2	0.9
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.5	0.2	0.0	0.6	0.5	1.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.3	0.1	0.1	0.2	10.8	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	3.2	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.2	0.0	0.1	0.1	0.3	0.0	0.1	0.7	0.4	0.0	0.2	0.2	0.2	6.6	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.5	0.1	25.7	185.8	22.4	0.0	0.8	5.7	0.3	0.2	0.4	0.0	0.0	0.3	5.7	4.4	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.1	315.1	1.8	0.1	0.0	11.4	1.6	2.6	1.6	0.0	0.6	0.1	5.4	0.0	4.4	0.1	0.0	0.0	0.0	134.5	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2	62.5	27.2	1.5	11.8	18.8	2.5	2.4	239.5	96.4	128.5	59.3	0.0	0.0	11.6	33.9	14.9	17.8	9.3	70.0	290.3	0.0	13.4	11.4	4.6	511.8	0.3	0.0	1.7	26.4	14.5	8.0	140.4	3.8	101.3	8.2	1.7	47.9	184.6	0.9	138.6	40.8	4.3	0.0	14.4	1.7	0.7	17.9	0.1	0.9	2.6	140.8
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 437.4"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 11.6;OE19: 5.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	45.9	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	437.4	0.0	0.0	0.0	14.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	6	"Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 17.5;HEL: 28.0"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		5800000	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.5	2.9	1.3	1.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	2.6	0.6	0.9	0.6	0.0	1.0	2.2	0.0	0.1	0.0	1.9	2.3	28.0	3.9	1.9	0.1	0.2	4.6	0.0	0.0	0.0	0.0	1.7	0.0	1.9	1.8	1.0	0.0	0.2	0.3	0.6	0.9	0.1	0.6	1.0	0.6	0.4	0.0	2.2	0.1	0.6	0.5	0.6	0.2	1.8	1.0	0.7	3.2	1.5	0.9	1.5	0.7	0.5	0.2	0.5	0.9	2.1	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8"	"Cell type enhanced"	"Detected in many"	13	"granulocytes: 194.3;Hofbauer cells: 78.7;Kupffer cells: 81.6;Macrophages: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CAPAN-2: 6.1;Daudi: 22.3;HMC-1: 16.0;Karpas-707: 7.0;RT4: 10.5;U-266/70: 10.5;U-698: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	7.4	3.9	2.9	18.3	7.4	39.9	5.8	13.2	3.2	3.4	6.5	6.4	1.0	4.5	3.2	4.7	4.9	5.4	8.0	6.1	3.9	2.6	4.8	2.6	34.7	36.9	9.0	1.7	2.6	10.0	1.3	1.7	11.2	6.1	7.8	3.4	3.2	6.6	3.4	1.1	2.9	14.4	7.8	8.4	41.8	4.5	2.0	6.2	2.4	3.0	1.4	16.7	27.2	10.5	14.8	11.1	45.2	21.3	0.0	0.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	6.1	22.3	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.2	4.3	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.8	0.3	10.5	0.5	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.0	1.2	0.0	0.0	10.5	1.9	7.4	0.0	0.1	0.0	36.7	21.3	27.0	0.0	20.0	0.1	14.8	0.5	0.2	11.1	10.4	0.0	0.0	45.2	0.0	19.6	0.3	0.1	9.5	2.9	7.4	13.2	3.2	3.9	2.6	9.0	1.7	6.1	6.2	14.9	58.3	34.9	5.4	1.0	0.8	2.0	15.3	4.0	12.5	8.7	2.0	0.5	0.0	19.2	0.4	0.7	2.1	0.0	18.9	1.4	0.6	3.3	194.3	0.6	78.7	0.0	6.8	2.5	81.6	1.1	0.3	81.2	0.0	18.0	0.7	0.3	17.8	0.0	0.0	0.0	0.2	12.9	0.7	0.4	0.8	1.3	3.4	1.3	0.4	35.5
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 745.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		470000	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.1	0.0	0.8	0.7	0.4	0.5	0.1	0.2	0.3	1.0	2.6	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.2	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.8	0.4	89.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	745.7	0.0	0.0	0.0	11.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell type enhanced"	"Detected in many"	16	"Distal tubular cells: 179.1;Proximal tubular cells: 617.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.3	10.7	10.9	9.5	2.4	1.2	13.4	10.0	6.8	6.3	8.1	2.0	6.6	11.8	17.4	6.2	3.1	24.0	9.4	10.1	2.3	27.0	19.9	17.7	6.5	3.4	22.7	1.4	27.8	6.1	7.8	2.4	2.1	20.1	25.0	6.3	41.3	5.0	3.5	12.5	11.0	5.8	7.0	11.4	5.2	5.1	12.2	7.0	3.7	4.4	2.4	6.5	6.5	11.0	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4	29.8	52.6	3.4	39.4	27.0	1.3	8.5	38.2	22.7	33.0	102.9	0.0	6.7	179.1	38.9	1.1	24.3	37.4	0.0	19.3	13.9	51.4	21.0	18.5	63.8	17.7	3.2	22.0	28.3	13.2	2.1	64.7	10.3	21.9	19.8	19.9	45.8	21.4	14.1	73.2	617.5	2.2	12.9	24.2	0.7	1.7	23.3	2.9	17.3	23.0	33.1
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 641.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018433, CAB034291"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		12000000	Nucleoplasm	Cytosol	"CAB034291: AB_2070856, HPA018433: AB_1846109"	"prognostic favorable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favorable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.3	39.1	4.8	12.3	25.1	25.4	0.2	28.5	20.5	15.6	18.7	14.4	14.9	6.4	18.8	26.5	30.1	18.7	9.8	27.9	12.0	31.5	23.1	19.1	22.8	9.8	14.4	10.6	17.6	12.4	35.2	15.1	6.6	17.9	16.6	0.0	0.0	4.7	14.3	25.1	5.3	11.1	0.0	0.0	28.6	0.0	0.1	17.7	41.4	12.7	14.0	12.5	27.5	40.0	32.4	3.9	18.9	14.8	16.7	17.5	7.4	44.3	20.6	32.0	57.9	0.1	32.1	10.6	25.3	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9	113.2	54.7	13.0	59.4	113.9	11.9	19.9	81.5	111.1	96.7	90.7	2.0	102.1	641.6	73.2	5.9	17.8	131.2	46.7	60.9	77.8	54.3	48.6	34.6	203.8	78.0	3.2	37.1	54.6	65.5	2.9	113.6	47.2	86.0	102.8	58.6	65.5	81.3	71.8	124.5	200.8	7.4	25.8	60.8	4.2	11.3	108.0	74.6	30.9	77.6	42.0
CBR3	SDR21C2	ENSG00000159231	"Carbonyl reductase 3"	O75828	21	36134912-36146566	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 68.2"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 43.6"	"Low region specificity"	"Detected in all"			HPA018434	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA			"Nucleoplasm, Cytosol"		"HPA018434: AB_1846110"	"unprognostic (3.64e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.75e-1)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (3.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.94e-1)"	9.2	1.5	5.4	3.0	13.9	0.9	12.2	3.1	4.7	8.6	3.8	1.4	4.1	2.4	5.5	8.8	27.6	4.1	4.9	4.9	3.6	2.9	1.6	0.4	3.5	3.4	3.8	6.1	9.3	1.2	0.3	1.2	2.2	2.5	7.2	2.9	3.3	21.8	4.2	2.4	16.3	2.6	10.5	2.3	1.5	2.7	4.3	2.7	0.9	2.3	68.2	14.1	7.1	8.0	11.9	1.2	0.4	0.5	4.9	17.9	6.2	12.2	3.5	1.5	3.1	12.0	18.6	2.4	13.4	15.9	15.4	12.3	0.1	2.6	0.0	3.9	13.7	5.4	5.7	2.0	2.7	6.2	16.7	6.4	0.5	3.7	0.1	1.0	0.0	0.0	2.6	0.3	10.7	1.4	7.4	9.3	1.4	0.0	0.1	4.5	9.2	1.1	5.4	1.2	3.8	15.5	2.6	2.9	23.9	5.1	5.2	0.8	1.1	10.2	12.5	19.5	0.8	3.7	1.4	6.4	10.0	0.8	11.2	12.9	0.6	0.2	0.0	10.4	0.3	17.9	0.0	0.3	0.0	1.2	0.2	1.5	11.9	13.0	4.0	1.2	10.6	17.9	12.3	0.4	4.9	0.5	0.3	5.1	6.2	5.4	13.9	3.1	4.7	3.6	2.9	3.8	6.1	2.5	2.7	0.0	2.7	0.0	23.4	63.1	0.2	0.2	5.1	5.3	11.4	0.0	0.0	0.9	8.3	3.3	0.5	11.3	1.1	0.0	0.6	0.2	7.7	36.1	5.7	0.0	7.4	0.0	0.0	8.6	3.7	1.1	62.7	5.6	62.4	36.1	8.9	1.4	2.1	1.1	71.1	0.0	0.4	0.0	20.3	0.4	0.2	40.8	0.2	1.3	2.9	11.5
CBR4	"FLJ14431, SDR45C1"	ENSG00000145439	"Carbonyl reductase 4"	Q8N4T8	4	168863770-169010275	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037499	Supported					NA	NA		33000			"HPA037499: AB_10672386"	"unprognostic (1.60e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.64e-14)"	"unprognostic (1.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.38e-3)"	9.9	15.0	13.8	8.8	13.7	6.2	14.7	18.1	18.7	10.5	12.3	14.0	14.2	12.8	10.8	21.4	11.9	10.0	8.6	17.3	13.8	14.7	27.6	48.1	7.7	10.3	15.9	18.0	13.9	13.4	12.7	27.1	8.5	16.6	12.6	14.6	13.6	13.3	17.1	15.8	15.7	11.8	12.4	16.7	10.6	10.9	14.4	13.6	9.7	16.1	10.6	11.5	12.0	10.1	11.6	7.0	9.0	7.3	8.3	10.3	3.1	6.0	4.6	14.2	8.9	12.4	14.8	2.9	4.4	6.0	5.3	4.9	5.4	6.5	12.5	2.4	3.3	5.0	6.6	13.1	13.9	5.8	4.7	6.5	21.9	10.8	7.2	7.5	8.6	7.8	9.6	12.1	3.8	6.5	12.7	15.6	10.6	11.8	10.1	8.4	3.1	8.9	14.1	5.1	4.2	7.0	7.8	5.0	5.3	18.7	6.4	12.6	9.5	5.3	7.6	11.3	12.4	8.2	5.6	9.2	5.6	3.0	6.2	4.4	10.1	6.7	6.0	9.7	10.6	3.4	8.6	6.1	9.0	10.3	5.3	6.2	8.5	7.1	10.0	5.2	11.6	8.0	10.2	4.6	8.3	7.3	7.0	5.9	3.1	13.8	13.7	18.1	18.7	13.8	14.7	15.9	18.0	16.6	13.6	0.0	6.5	22.4	28.5	20.5	34.4	26.0	28.1	10.7	9.1	47.1	37.3	35.3	43.1	51.8	12.8	15.2	25.9	46.7	36.9	21.5	17.7	26.4	2.3	66.8	22.0	58.8	28.2	18.4	25.1	19.4	41.1	19.0	33.7	21.6	21.3	37.5	33.5	28.5	29.4	68.1	45.4	58.2	15.1	50.2	34.3	17.7	16.9	25.5	23.4	19.4
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211448-1249953	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	32.3	35.8	42.4	39.8	44.4	31.3	54.6	70.7	56.1	27.6	29.4	29.2	29.0	44.9	35.8	30.8	31.9	38.2	37.6	41.2	41.5	45.7	29.3	36.0	28.5	48.4	38.0	41.2	35.4	62.2	28.4	48.1	27.2	30.2	32.6	21.6	28.2	44.9	27.9	74.2	33.9	43.6	29.7	29.3	47.0	33.5	16.7	27.2	44.9	29.4	30.5	30.2	32.2	38.6	15.6	25.0	11.6	16.2	16.1	24.5	10.3	22.8	33.9	26.2	32.1	18.4	13.3	22.5	18.1	16.9	22.5	23.0	29.0	55.6	28.1	21.0	21.0	34.9	18.4	15.8	23.8	6.8	21.3	19.1	25.4	38.3	37.0	30.7	22.8	36.3	22.9	18.3	19.1	11.1	21.9	16.8	32.1	28.8	48.3	12.4	37.8	73.3	71.9	31.0	18.7	32.8	51.9	15.8	36.6	14.4	29.2	49.3	30.9	17.3	18.7	23.9	16.5	40.9	35.2	21.4	37.7	21.3	21.6	38.7	35.2	33.5	32.5	29.8	35.6	29.5	8.6	11.9	11.6	24.5	16.2	18.4	15.3	17.2	20.8	14.7	15.6	13.5	19.5	9.3	16.1	15.8	25.0	14.6	10.3	42.4	44.4	70.7	56.1	41.5	45.7	38.0	41.2	30.2	27.2	38.7	35.8	50.6	18.9	30.3	28.2	46.2	45.9	24.1	19.4	34.9	3.9	21.5	10.0	27.3	2.7	34.3	46.6	46.7	35.0	26.5	27.8	33.2	23.1	79.0	37.1	38.1	44.3	48.5	64.1	3.6	41.7	35.1	43.9	24.4	42.4	41.9	38.2	31.6	33.6	29.3	15.7	6.5	27.0	6.0	15.1	33.1	16.6	39.6	51.0	23.8
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338610	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"placenta: 440.1"	"Cell type enriched"	"Detected in some"	36	"Syncytiotrophoblasts: 1678.9"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.9"	"Cell type enriched"	"Detected in single"	17	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	9.0	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3.0	0.2	0.3	3.0	0.2	0.2	1.2	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	45.7	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.3	0.1	3.7	0.3	0.0	0.0	15.3	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	8.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.4	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.0	0.0	13.4	0.0	0.0	0.0	1.6	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.3	7.7	0.2	0.0	1678.9	0.0	0.0	0.0
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell type enhanced"	"Detected in some"	21	"Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA					"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.3	0.1	0.0	0.3	0.0	7.2	0.0	0.0	0.4	0.2	22.0	0.9	0.2	5.9	0.0	5.4	6.9	0.4	4.4	0.2	0.0	0.6	0.3	1.5	3.2	0.1	0.2	7.1	0.0	12.0	0.1	0.9	0.2	11.5	0.2	1.3	0.2	0.0	0.4	0.0	0.2	0.1	7.2	1.8	0.7	0.0	0.2	0.0	1.4	0.3	0.1	1.0	9.0	2.3	23.3	0.3	0.1	0.6	1.0	0.3	3.2	0.0	0.4	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	3.2
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748844-74756202	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 143.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 44.0"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA					"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	1.1	4.5	1.2	1.1	0.7	0.3	1.1	0.9	2.7	2.1	0.2	0.0	1.6	0.7	0.0	0.0	0.2	0.6	1.3	2.2	0.5	0.0	1.8	1.2	0.1	0.2	0.1	0.5	1.2	2.8	1.6	0.8	0.1	1.9	1.1	0.4	0.3	0.1	0.0	0.7	0.2	3.9	1.9	4.0	0.0	0.8	2.5	1.3	1.7	0.9	0.6	2.6	2.4	0.9	0.0	2.2	2.2	1.1	2.1	6.0	0.4	2.3	1.6	1.0	0.4	1.1	1.4	1.1	1.2	1.0	0.7	1.6	1.1	2.4	1.2	3.2	1.2	1.2	0.6	0.6	0.5	0.8	0.7	0.5	0.4	1.7	0.7	0.7	4.5	1.1	0.8	1.1	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease mutation, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.0;lung: 39.2"	"Cell type enhanced"	"Detected in many"	11	"Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"classical monocyte: 45.0"	"Lineage enriched"	"Detected in many"	22	"monocytes: 45.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	9.1	3.1	0.5	9.4	1.2	0.0	11.4	1.0	1.2	11.4	2.1	0.7	4.5	0.0	12.8	5.9	3.5	15.0	6.9	17.5	1.2		8.8	3.5	39.2	26.3	3.1	1.0	6.1	3.6	0.0	1.3	0.8	3.3	10.7	0.0	19.3	0.0	13.0	4.8	0.5	1.4	10.6	5.1	15.7	0.3	3.9	0.5	5.1	2.5	1.1	4.2	6.9	2.1	0.0	0.4	2.0	45.0	0.0	0.0	16.2	1.2	13.2	0.4	0.0	24.6	26.4	0.0	0.1	0.8	0.2	2.3	0.0	5.5	0.0	3.6	3.2	0.5	10.8	0.0	0.7	0.4	1.0	0.7	0.0	4.0	0.0	6.8	0.0	0.0	105.7	10.3	5.7	0.2	24.4	0.0	0.0	0.1	0.0	0.1	5.2	0.0	4.0	1.4	1.8	2.5	0.0	0.0	0.0	2.5	0.1	0.1	0.4	49.2	7.2	0.0	1.4	9.1	1.9	0.0	0.2	0.0	20.2	0.0	0.0	0.0	0.0	26.8	0.0	2.2	0.4	45.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	5.5	0.2	0.0	16.2											17.9	50.6	0.5	98.2	15.8	0.9	2.7	0.0	12.0	35.2	43.6	0.0	0.4	13.3	5.0	11.7	36.8	0.0	0.0	0.5	0.7	41.1	345.6	3.5	9.7	12.6	0.0	1.7	5.5	116.2	8.6	147.9	28.1	16.9	39.7	0.3	0.5	0.4	0.0	160.5	0.8	0.3	19.4	20.8	1.0	1.8	12.4	0.2	0.0	0.8	295.9
CYP2A13	"CPAD, CYP2A"	ENSG00000197838	"Cytochrome P450 family 2 subfamily A member 13"	Q16696	19	41088472-41096195	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 30.7"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 3.0"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.1;NTERA-2: 1.6"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (9.79e-2)"						"unprognostic (1.00e-1)"	"unprognostic (4.51e-3)"		"unprognostic (4.92e-2)"				"unprognostic (1.99e-1)"	"unprognostic (1.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	30.7	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843538-40850447	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	165	"liver: 199.5"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 161.7"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	199.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.1	5.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	161.7	0.0	0.0	0.0	12.9	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"liver: 53.7"	"Cell type enhanced"	"Detected in some"	29	"Hepatocytes: 29.0;Ito cells: 12.3;Kupffer cells: 5.7"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 2.0"									"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	29.0	0.0	0.0	0.0	12.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991250-41018398	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 137.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 326.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.0;OE19: 4.9"					"Not detected"	"Not detected"			"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	3.0	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0.0	0.4	0.2	0.3	0.0	0.1	1.5	0.0	0.3	0.3	0.2	0.1	7.0	0.4	0.1	0.1	0.3	0.6	0.4	0.7	0.4	0.4	0.4	0.4	0.0	0.4	0.3	0.1	0.3	0.5	0.7	0.4	0.1	0.2	0.1	0.8	1.8	0.6	4.9	0.4	0.2	0.5	0.4	1.7	0.1	0.9	0.2	0.3	0.1	0.5	0.3	0.7	1.1	0.8	0.6	0.3	0.7	0.5	0.3	0.7	0.9	0.2	1.1	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.2	2.5	1.4	1.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.9	46.7	0.2	0.0	0.0	0.1	0.0	326.3	0.0	0.0	0.0	10.4	11.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	7.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.2	0.6
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683621-94736190	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 62.9;liver: 56.1"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 113.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4"														"Intracellular and membrane"	NA	NA						"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0.0	6.7	0.2	0.2	0.0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19.0	0.2	0.2	0.3	0.2	5.0	3.8	0.2	3.7	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	4.4	0.0	0.0	0.0	0.9	0.5	0.2	0.3	0.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	3.5	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	14.7	0.0	6.4	0.1	0.0	0.0	0.0	113.1	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.3	0.0	1.5	0.0
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94853205	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 47.7;liver: 76.4"	"Cell type enriched"	"Detected in single"	31	"Hepatocytes: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;RPMI-8226: 1.6"									HPA015066	Supported				"Intracellular and membrane"	NA	NA					"HPA015066: AB_1847433"			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	30.0	0.0	0.0	14.7	0.0	0.0	1.0	0.0	3.7	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"liver: 247.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 1616.5"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3"									"HPA013547, HPA013970, HPA015066"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433"	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	1.1	0.2	0.0	0.2	0.0	0.7	1.0	0.0	1.0	0.5	2.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.3	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	2.3	1.2	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	21.0	0.0	0.0	0.9	0.2	155.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	70.0	0.2	0.0	0.0	0.1	0.0	1616.5	0.0	4.8	1.7	61.4	65.7	5.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.1
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94989391	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 233.0"	"Cell type enriched"	"Detected in some"	48	"Hepatocytes: 1765.4"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6"									"HPA015066, CAB016123"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB016123: AB_629363, HPA015066: AB_1847433"	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	45.8	0.0	0.0	13.6	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.5	233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	43.8	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.4	0.9	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.1	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	0.0	4.2	23.3	0.6	0.0	0.0	0.0	0.0	1765.4	0.0	0.0	0.0	36.8	31.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 78.0"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 435.9"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3"									HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	78.0	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.3	0.2	0.0	0.6	0.0	0.2	3.6	0.0	1.1	0.0	0.0	0.1	0.3	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.3	4.3	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.5	0.5	6.5	0.3	2.5	1.4	0.0	1.8	2.0	0.1	1.7	0.6	2.9	0.3	3.9	0.0	0.5	0.1	0.2	0.5	0.0	435.9	0.1	11.1	1.2	6.7	6.2	11.4	0.0	0.0	0.0	0.0	1.0	0.9	0.5	2.9	1.4	0.5	2.0	0.0	0.2	0.7	0.3	1.0	0.3	0.5	0.8	0.2
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128366	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	3.1	6.1	0.0	2.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.7	48.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	4.8	0.0	0.0	0.0	0.0	0.0
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926790	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.9;intestine: 46.6;liver: 74.6"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 84.7;Cytotrophoblasts: 107.4;Syncytiotrophoblasts: 201.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"OE19: 9.9;RT4: 36.0;SK-BR-3: 9.7"					"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	0.8	0.9	8.8	1.2	12.0	0.7	5.8	7.9	8.5	1.2	13.1	22.1	0.0	17.9	1.2	1.1	7.2	1.1	1.7	44.9	9.1	6.9	2.2	74.6	1.4	0.8	13.2	6.3	0.7	1.8	0.6	0.7	11.9	12.3	2.4	12.0	0.5	7.2	1.0	12.2	5.3	46.6	1.6	10.1	0.7	3.0	0.9	15.5	0.0	0.7	0.5	2.3	5.8	1.8	1.8	1.2	0.0	0.0	0.7	6.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.7	0.2	1.6	0.0	0.5	0.0	2.1	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	1.8	0.0	0.0	0.9	9.9	1.6	0.0	3.8	0.0	2.0	36.0	0.5	2.3	0.0	9.7	0.3	0.1	2.4	0.0	0.0	1.2	1.5	0.0	0.5	1.1	0.1	0.0	0.4	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.2	1.8	0.7	0.4	0.1	0.9	6.0	5.2	0.0	0.7	0.0	1.2	0.0	1.0	8.8	12.0	7.9	8.5	9.1	6.9	13.2	6.3	12.3	15.5	3.0	2.6	0.5	1.2	0.3	0.0	84.7	12.7	29.4	35.2	0.0	0.0	107.4	0.0	9.1	16.8	0.0	23.8	0.0	0.8	7.3	1.0	0.8	0.0	44.3	6.1	0.0	8.6	0.0	0.6	19.0	0.0	0.0	0.0	1.0	21.4	11.9	1.8	21.0	0.0	2.9	1.0	0.0	0.0	0.3	0.1	1.9	201.5	0.0	23.6	0.9
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193049-41207539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.5;myeloid DC: 33.1"	"Group enriched"	"Detected in many"	121	"dendritic cells: 33.1;monocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.2	0.8	0.8	2.3	1.0	0.5	0.6	0.1	1.0	1.7	18.3	1.2	0.5	37.6	0.3	0.9	10.1	2.4	29.1	1.0	1.4	1.6	0.9	2.1	3.8	3.3	5.6	0.4	0.8	0.6	0.0	0.9	1.6	4.5	0.9	7.2	1.1	3.8	0.3	0.1	2.0	62.7	0.6	1.1	4.0	45.9	0.5	1.2	2.6	0.4	15.8	21.0	3.2	2.7	0.0	33.1	0.0	9.5	0.0	0.1	3.9	1.2	31.3	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.3	0.0	16.1	4.5	0.0	3.7	0.2	0.0	16.8	5.5	8.5	0.1	0.0	0.1	4.2	1.7	5.8	6.6	0.0	0.1	0.2	0.4	0.4	0.2	0.0	0.2	1.4	1.9	0.1	0.0	0.6	0.1	0.0	23.7	51.4	4.1	0.0	0.0	0.3	0.5	6.7	0.0	0.2	3.1	0.0	0.0	9.7	4.1	1.6	3.6	0.0	1.3	0.6	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	9.5	0.0	0.0	2.3	0.1	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	3.9	0.8	1.0	0.1	1.0	1.4	1.6	5.6	0.4	4.5	1.2	0.0	8.6	0.0	1.6	2.3	0.0	0.8	0.0	8.1	7.9	1.8	0.0	16.5	0.0	0.8	0.3	0.0	23.2	0.0	0.9	0.6	1.3	0.4	1.1	0.0	12.8	0.0	0.0	0.6	4.7	0.0	0.0	11.5	0.0	8.2	29.0	0.0	13.8	14.8	0.0	0.0	0.0	0.0	0.3	0.1	0.4	2.5	8.6	0.0	13.9	0.1
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 18.6;Peritubular cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	5.2	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	13.5	2.5	7.8	0.1	3.3	5.5	1.8	7.4	0.0	3.5	0.2	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	3.0	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4	3.0	3.8	3.2	3.2	1.0	4.3	3.4	2.5	13.4	3.4	8.7	3.9	0.4	0.0	0.9	9.6	5.8	2.6	0.0	1.7	0.3	5.1	1.7	4.6	6.8	1.9	1.6	2.9	6.7	6.1	6.1	16.4	4.6	18.6	3.6	1.1	9.9	0.4	0.0	16.6	2.4	3.3	0.0	5.2	0.9	4.3	1.3	0.2	1.3	1.6	0.7
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell type enriched"	"Detected in some"	45	"Hepatocytes: 2276.5"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0"									"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.1	4.5	0.3	0.0	0.0	0.0	2.2	6.7	0.0	0.5	2.6	5.0	0.5	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.4	0.0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.3	1.0	0.3	0.0	0.3	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.6	46.7	0.8	0.0	0.0	0.5	0.0	2276.5	0.0	0.0	0.0	39.3	50.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.4	0.9
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.2	0.2	0.2	1.2	0.7	1.5	0.3	0.3	0.1	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.5	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.6	0.5	0.1	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.3	0.0	0.9	0.0	0.2	0.8	1.6	0.5	0.4	0.6	1.7	0.0	0.7	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.3	6.8	0.1	1.6	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.2	0.3	0.0	0.0	0.0	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	2.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	8.3	5.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.3	0.2	23.6	0.0	0.1	0.0	0.6	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4	11.9	11.3	11.2	107.3	41.0	13.1	1.0	346.5	14.7	12.5	3.5	11.8	1.3	0.0	58.0	1.7	2.5	640.5	46.7	44.6	1.0	3.8	166.5	9.3	330.1	0.6	7.9	52.5	9.8	8.3	0.0	2.3	4.6	3.3	7.2	117.1	6.0	69.5	210.5	2.5	4.2	20.2	0.0	3.5	6.8	4.2	51.6	1.3	12.9	85.2	352.8
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99684957-99735196	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 82.6"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 135.0"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.4	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.2	0.0	3.9	0.0	0.1	0.0	2.8	82.6	0.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.4	3.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	135.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	18.4	0.1	0.0	0.0	4.9	3.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"	P24462	7	99685226-99735093	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 73.9"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 7.6"									"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.3;U-87 MG: 2.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "																		0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0		1.1	73.9	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.0	0.0	0.5	0.0	0.3	0.5	1.6	0.5	0.2	4.3	0.0	0.6	0.2	0.0	0.0	0.0	1.3	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.9	1.4	1.9	0.0	0.0	0.5	0.3	0.4	0.4	0.0	0.4	0.5	0.0	0.8	0.5	1.1	0.1	0.2	1.2	0.5	0.2	0.5	0.2	0.1	0.4	1.5	0.0	0.0	0.4	0.2	0.0	0.5	0.6	0.6	0.0	0.1	0.4	0.3	0.5	0.5	0.6	0.9	0.7	0.1	2.6	0.7	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enriched"	"Detected in some"	8	"RT4: 81.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1	1140.4	70.0	0.0	114.6	0.5	0.0	4.8	0.0	602.3	304.8	0.0	0.0	0.9	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.2	4.7	3.9	5.8	0.0	0.6	0.0	0.0	2.5	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.6	0.7	0.0	0.0	142.5
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 88.6"	"Cell type enhanced"	"Detected in many"	17	"Ductal cells: 13.3;Hepatocytes: 48.8;Urothelial cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 7.6;CAPAN-2: 30.3;EFO-21: 11.4;Hep G2: 14.7;RPMI-8226: 7.9;RT4: 9.1"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.4	2.2	3.6	0.5	4.4	0.5	1.7	1.8	5.4	1.1	2.5	4.4	0.0	7.5	0.5	11.8	7.9	2.2	12.9	0.4	3.9	1.4	4.9	88.6	2.4	0.4	2.1	3.8	0.3	3.5	0.2	0.6	0.2	8.3	2.4	1.9	0.6	2.6	3.4	0.5	0.8	15.7	0.2	9.7	0.9	2.7	1.0	3.0	0.0	2.2	2.8	1.8	4.8	2.0	0.1	0.1	0.8	1.2	0.0	0.2	0.1	7.6	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.1	11.4	0.0	6.5	0.9	0.0	3.9	0.0	0.0	0.0	0.0	2.3	14.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	1.1	0.0	0.1	0.0	6.7	0.0	0.0	0.1	7.9	2.1	9.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.0	0.8	0.5	0.0	0.1	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.1	3.6	4.4	1.8	5.4	3.9	1.4	2.1	3.8	8.3	3.0	0.0	0.0	0.0	7.8	0.1	0.0	0.3	0.0	4.0	1.2	8.7	0.0	0.0	1.7	13.3	0.0	0.0	5.3	0.0	9.9	0.0	0.0	7.8	0.0	48.8	0.0	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.0	2.5	7.5	2.9	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.7	13.3
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"		19	15672757-15697174	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 53.0;liver: 24.2"	"Cell type enhanced"	"Detected in many"	16	"Enterocytes: 95.3;Paneth cells: 35.4;Undifferentiated cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	39	"basophil: 5.3;eosinophil: 13.2"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;HaCaT: 18.7;Hep G2: 5.2;Karpas-707: 12.6;OE19: 27.1"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (2.33e-4)"	1.9	0.7	1.6	6.1	0.9	0.6	3.5	0.0	1.9	3.9	24.6	5.6	1.4	24.6	1.4	1.8	11.5	2.1	10.8	1.7	1.9	0.3	1.1	24.2	0.9	0.3	3.0	3.5	1.9	0.2	0.1	0.3	0.4	2.7	4.4	5.1	1.4	3.0	1.5	0.4	12.9	53.0	5.1	0.8	0.7	8.0	0.4	4.8	0.2	0.6	8.9	6.3	10.1	6.5	0.0	0.0	13.2	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.1	18.7	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	13.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	1.9	1.9	0.3	3.0	3.5	2.7	4.8	0.0	2.6	0.8	10.1	12.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.1	0.0	0.3	1.1	1.5	95.3	0.0	0.0	0.1	3.0	2.8	0.0	24.2	0.4	0.0	7.5	0.6	0.3	2.2	3.7	0.0	1.7	0.0	24.4	2.7	1.1	35.4	1.1	2.1	0.0	0.0	0.8	0.1	0.0	18.4	0.2	0.7	26.0	18.3
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 69.1;liver: 102.9"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 132.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 8.5"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 9.0"									"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	1.9	0.0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.7	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.2	9.0	0.0	1.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	1.6	0.1	0.0	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	6.2	0.0	16.2	0.0	0.3	0.0	0.0	0.6	0.0	132.0	0.0	0.0	1.7	0.6	3.9	11.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	5.8	0.0	14.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.0	0.1
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508493-15552317	"Disease related genes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	Ichthyosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 44.6;skin 1: 29.0"	"Cell type enhanced"	"Detected in some"	21	"Glandular cells: 1.9;granulocytes: 6.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 2.6"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2"	"Group enriched"	"Detected in many"	9	"monocytes: 13.2;T-cells: 4.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;JURKAT: 2.8;MCF7: 5.1;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain					NA	NA					"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	0.5	0.0	0.0	0.1	0.0	0.1	3.6	0.0	0.0	5.4	0.1	0.0	10.3	0.2	0.6	0.2	12.1	0.1	0.6	0.0	0.0	0.0	0.0	19.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.2	0.0	0.0	1.6	44.6	1.2	29.0	0.1	1.0	0.0	0.3	0.5	0.7	0.0	0.4	0.0	14.7	6.7	5.5	10.3	0.0	0.2	0.0	13.2	1.0	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.8	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.8	6.1	4.6	0.0	0.6	1.5	0.2	0.0	0.0	0.4	0.0	1.0	13.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.9	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	0.0	0.9	0.0	0.2
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 159.2"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 506.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	68	"neutrophil: 33.1"	"Lineage enriched"	"Detected in single"	166	"granulocytes: 33.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	0.4	0.1	0.3	0.3	1.5	24.8	0.1	0.1	2.2	2.1	3.4	6.5	0.0	3.1	0.1	0.4	8.6	0.3	19.8	0.2	0.8	0.2	23.7	159.2	0.7	0.0	0.4	1.9	0.1	0.2	0.0	0.2	0.0	1.6	0.3	0.5	0.0	1.3	0.1	0.1	1.2	13.4	0.1	1.0	2.6	1.7	0.2	1.8	0.0	0.1	1.1	0.8	1.8	2.7	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.0	0.0	0.1	0.0	0.0	9.1	0.0	0.1	0.0	0.3	0.0	0.1	1.9	10.9	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	2.2	0.8	0.2	0.4	1.9	1.6	1.8	8.9	5.9	5.1	2.3	0.9	0.0	0.8	91.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	13.5	23.3	0.2	0.1	0.3	1.7	1.1	506.3	0.0	0.0	50.9	6.2	10.2	0.4	0.0	0.4	0.0	0.0	5.6	0.0	2.5	7.0	0.0	31.2	0.0	0.0	0.2	0.0	0.1	5.6	0.0	0.8	8.3	10.8
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	155	"ductus deferens: 265.6;seminal vesicle: 360.6"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4"	"Group enriched"	"Detected in some"	31	"breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.4
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023568-47050751	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 38.1"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 156.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5"	"Low region specificity"	"Detected in all"							HPA017661	Approved					NA	NA					"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	7.9	3.6	9.0	1.1	14.9	0.5	16.0	7.1	16.9	38.1	2.0	1.6	2.5	2.1	3.6	3.2	12.0	9.7	2.0	6.7	4.8	10.6	6.3	10.0	8.9	2.0	3.3	13.5	1.7	2.0	2.0	4.1	1.5	7.8	8.0	2.3	17.6	23.7	3.4	4.5	5.0	1.8	2.4	2.0	1.0	14.3	4.2	0.9	0.0	4.0	6.9	8.8	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.9	1.0	0.0	0.0	0.5	0.0	0.6	0.2	3.8	0.0	0.0	0.3	0.0	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9	20.8	10.5	0.0	23.5	2.3	0.9	1.0	0.0	156.6	27.3	0.0	0.0	0.0	0.0	0.3	6.0	2.3	0.0	0.0	0.6	0.0	1.9	10.7	0.0	2.5	2.9	0.0	0.0	0.6	0.3	5.6	9.8	0.6	5.0	0.0	0.0	0.0	0.2	0.0	19.4	1.3	0.7	0.0	14.5	0.0	1.5	1.3	0.1	0.0	0.6	26.2
CYP4Z1	CYP4A20	ENSG00000186160	"Cytochrome P450 family 4 subfamily Z member 1"	Q86W10	1	47067488-47118319	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"breast: 23.1"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9"	"Cancer enriched"	"Detected in some"	50	"breast cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	39	"HDLM-2: 13.7;SK-BR-3: 5.9"															NA	NA						"unprognostic (4.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-3)"		"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (5.09e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.46e-2)"	"unprognostic (3.49e-3)"	2.5	0.2	0.4	0.4	0.9	0.0	23.1	0.4	2.0	1.0	0.4	0.4	0.4	0.0	0.4	0.8	0.8	0.7	0.4	0.4	0.4	1.8	0.4	1.5	2.1	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.7	1.3	0.0	0.4	1.5	0.8	0.5	2.2	0.4	0.4	0.4	0.4	0.2	1.0	0.4	0.6	0.4	0.4	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	2.0	0.4	1.8	0.4	0.4	0.7	0.4	8.9	0.6	0.0	0.4	0.1	0.0	0.2	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 338.2;Proximal tubular cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		No	No		740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavorable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.5	6.0	17.8	20.1	12.5	20.3	3.8	9.3	16.1	6.1	9.5	2.4	10.5	8.1	7.4	11.1	5.5	8.0	6.6	9.4	10.2	12.2	0.7	19.3	5.4	9.6	15.6	4.2	4.0	16.0	7.3	4.8	8.1	15.1	18.0	12.9	20.1	16.0	29.0	12.1	12.0	6.2	1.1	22.4	18.2	10.2	4.7	14.4	29.8	26.6	0.8	6.7	14.0	132.5	11.1	0.5	17.0	10.9	16.3	10.3	4.9	13.5	5.5	8.1	6.1	9.5	9.8	9.6	13.1	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5	71.5	50.7	52.5	52.8	36.7	12.7	229.8	79.0	71.0	51.2	68.0	2.0	44.0	338.2	106.7	118.9	49.7	161.9	0.0	82.2	42.9	47.8	37.6	48.5	196.2	104.2	30.2	100.6	52.2	85.9	33.7	79.1	96.9	81.0	80.2	84.9	41.0	80.5	101.7	48.4	333.3	6.5	71.1	40.1	118.4	23.4	35.9	34.3	71.9	118.0	55.4
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401826-412487	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 68.2"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 103.3;Proximal tubular cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes,Microtubules		NA	NA			Peroxisomes	Microtubules	"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	5.7	10.8	3.2	4.3	4.0	3.5	4.0	3.8	5.0	2.9	10.2	2.7	5.0	14.2	4.0	7.3	4.1	2.5	7.8	4.4	2.8	2.3	16.9	68.2	4.3	3.9	2.0	3.0	2.6	9.7	1.8	2.6	2.3	2.0	4.1	2.4	3.0	6.2	5.6	15.9	2.9	14.4	5.1	1.9	1.9	5.9	4.1	1.8	1.2	1.7	4.3	2.9	2.7	2.2	3.3	9.5	0.4	6.1	2.7	5.1	3.9	1.1	11.1	1.4	6.6	1.3	3.0	4.2	3.4	2.5	2.9	3.0	7.0	7.6	3.8	7.3	4.2	1.7	2.5	1.1	2.8	0.4	8.4	3.6	0.9	5.4	16.6	8.7	3.4	5.4	4.3	2.1	1.9	2.4	3.3	3.6	4.4	2.3	3.5	2.4	11.6	1.9	4.7	4.1	4.2	5.8	4.5	0.5	6.9	2.9	2.9	2.9	4.5	6.4	7.2	3.7	0.5	10.3	4.2	7.5	2.5	2.7	3.5	2.6	5.0	3.9	1.6	3.4	5.1	8.1	0.0	6.1	0.4	3.6	5.6	2.5	2.8	2.2	2.4	6.5	3.3	5.1	3.0	0.3	2.7	4.5	9.5	1.7	3.9	3.2	4.0	3.8	5.0	2.8	2.3	2.0	3.0	2.0	1.8	11.9	14.4	4.2	8.0	3.4	2.0	7.0	17.8	12.0	9.1	19.2	0.0	28.2	33.2	28.8	1.8	5.8	56.4	46.7	34.2	4.7	8.9	4.3	12.7	103.3	11.0	3.2	12.0	6.7	6.7	5.5	6.1	5.3	5.0	15.4	26.4	5.8	28.8	35.1	6.3	98.2	2.7	0.0	6.2	1.8	5.7	5.3	10.5	2.2	34.3	2.7
DGAT2L6	"DC3, FLJ25989"	ENSG00000184210	"Diacylglycerol O-acyltransferase 2 like 6"	Q6ZPD8	X	70177483-70205545	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"breast: 6.9;skin 1: 10.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NB-4: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.90e-2)"				"unprognostic (3.08e-1)"							"unprognostic (1.43e-3)"	"unprognostic (3.47e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	20.1	1.5	0.1	0.0	49.9	0.0	0.2	1.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.4	2.2	0.1	0.4	0.1	0.0	59.8	0.2	0.3	0.4	292.6	0.3	0.0	0.2	0.0	0.0	0.1	95.8	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	5.9	6.6	0.0	3.4	0.0	0.0	0.0	0.2	10.3	0.3	0.2	0.0	0.8	1.6	0.0	3.4	0.0	0.8	3.0	0.0	0.0	0.0	1.0	0.0	0.0	6.7	0.0	1.1	0.1	1.0	6.5	0.0	0.0	8.5	0.1	20.7	0.0	0.5	11.9
DHRS4	"FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2"	ENSG00000157326	"Dehydrogenase/reductase 4"	Q9BTZ2	14	23953586-23969279	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.21e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.55e-6)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.68e-2)"	15.8	18.5	8.3	10.3	13.7	5.9	15.4	4.4	9.6	11.0	22.2	10.2	12.1	30.3	13.7	11.7	17.2	8.3	16.3	16.3	9.0	6.6	65.8	40.3	12.6	13.6	14.0	7.7	12.6	20.6	7.3	9.7	8.9	9.3	17.0	12.4	12.0	17.5	14.4	25.3	16.6	35.2	14.4	9.6	12.4	12.9	13.5	12.6	6.9	17.1	16.1	11.1	10.0	14.8	9.7	22.0	2.6	25.5	7.9	10.6	14.9	7.7	15.7	5.4	8.8	8.6	9.6	0.1	14.6	7.7	5.8	4.6	3.3	8.3	6.6	7.8	7.2	4.0	9.2	4.3	6.0	5.2	17.8	8.9	4.0	13.2	18.3	5.2	5.7	24.6	9.5	7.5	4.8	10.6	6.6	7.2	9.9	5.9	15.8	7.9	26.3	10.4	5.4	5.3	9.0	15.8	16.9	9.5	21.8	6.0	9.0	10.5	8.8	14.0	9.1	6.9	3.6	8.4	7.7	13.4	7.2	7.6	7.4	4.7	12.1	11.2	1.8	6.3	6.5	7.2	2.4	25.5	2.6	8.9	21.0	10.6	9.7	10.1	8.9	22.0	8.3	10.3	9.9	1.1	7.9	11.1	18.5	8.6	14.9	8.3	13.7	4.4	9.6	9.0	6.6	14.0	7.7	9.3	12.6	14.9	26.2	4.7	9.5	11.1	4.7	30.1	7.6	32.1	31.8	14.0	0.0	8.3	66.3	5.2	39.4	10.8	35.9	0.0	8.6	4.2	11.6	9.3	12.8	64.8	26.6	6.4	18.5	16.0	34.4	43.6	10.3	34.4	5.0	3.6	41.8	12.8	6.6	7.0	16.3	63.7	1.6	6.5	11.3	27.0	2.0	11.7	3.2	14.1	63.5	9.0
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	26	"Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		270000	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.2	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	20.3	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	3.0	2.6	14.9	0.0	0.5	3.3	0.3	0.0	0.0	1.2	22.7	0.0	0.1	48.0	0.3	10.3	0.1	4.2	0.0	171.7	0.3	4.5	0.0	1.1	0.0	0.5	0.0	8.5	1.8	0.0	29.1	268.4	1.7	5.0	1.8	1.9	0.0	43.8	11.5	1144.5	391.6	0.1	6.5	0.3	15.6	2.9	0.3	0.3	0.5	1.2	0.0
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 105.1"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 29.3;Kupffer cells: 40.0;Macrophages: 33.7;Syncytiotrophoblasts: 45.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 105.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.4;HMC-1: 19.9;NB-4: 4.3;U-937: 6.6"					"Low region specificity"	"Detected in many"			HPA035644	Approved					NA	NA		260000000			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	7.8	0.9	1.3	7.1	2.4	13.0	3.5	0.7	2.5	1.5	2.6	2.4	1.1	1.7	4.1	4.1	1.8	2.0	6.8	2.4	1.6	1.3	2.0	2.0	11.4	10.4	2.1	2.0	0.7	0.9	0.1	0.9	19.4	2.7	2.4	2.4	5.1	2.8	0.4	1.6	1.2	10.1	2.3	3.3	26.4	1.6	2.5	1.6	3.5	2.5	3.8	11.1	6.3	1.5	5.0	4.3	105.1	15.3	5.6	4.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.4	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	4.4	0.0	0.1	0.0	0.1	19.9	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.3	0.1	0.0	0.0	0.1	4.3	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	6.6	0.0	43.5	10.7	105.1	2.3	13.0	2.7	4.1	4.0	1.9	4.3	5.0	4.9	2.5	47.3	5.6	15.3	0.6	4.0	5.7	1.3	2.4	0.7	2.5	1.6	1.3	2.1	2.0	2.7	1.6	0.0	12.2	15.6	0.0	1.8	0.0	1.1	0.0	2.7	2.3	0.0	0.0	7.7	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.6	1.6	0.0	2.3	0.0	29.3	0.0	0.0	17.2	40.0	0.9	0.0	33.7	3.3	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	6.5	6.1	1.1	45.2	13.8	0.0	0.1
DPEP3		ENSG00000141096	"Dipeptidase 3"	Q9H4B8	16	67975663-67980829	"Enzymes, Predicted intracellular proteins"		"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 56.7"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 154.2;Spermatogonia: 290.0"	"Group enriched"	"Detected in many"	10	"melanoma: 3.7;ovarian cancer: 16.9;testis cancer: 5.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 9.2;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.2;NK-cells: 2.3"	"Cell line enriched"	"Detected in single"	11	"U-266/70: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031870, HPA058607"	Enhanced				"Intracellular and membrane"	NA	NA		16000000			"HPA031870: AB_2674079, HPA058607: AB_2683775"	"unprognostic (9.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.49e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.51e-1)"	0.2	0.0	0.1	0.4	0.4	1.0	0.6	0.1	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.6	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.5	0.0	0.4	1.4	0.2	56.7	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.1	9.2	0.5	2.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.5	0.3	0.4	0.0	0.0	0.1	0.8	0.8	0.3	9.2	2.3	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.3	0.3	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	30.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	25.8	0.0	154.2	290.0	0.0	0.2	0.0	0.0	0.0
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 1338.6;Proximal tubular cells: 2021.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.9	36.3	19.8	49.3	28.7	18.6	18.1	21.3	28.2	29.8	25.2	79.7	28.1	21.8	18.5	23.9	15.6	27.2	25.7	21.6	21.6	16.7	45.0	21.8	22.0	56.6	24.2	28.1	15.5	20.7	18.7	19.7	25.2	26.5	26.3	15.9	19.6	19.2	28.9	68.6	14.0	55.0	13.8	45.9	43.6	24.2	24.0	11.6	36.8	37.1	12.8	20.3	22.0	36.6	27.7	11.9	28.5	27.2	21.1	13.4	19.5	27.9	28.0	14.4	8.8	24.8	31.9	15.4	11.1	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2	41.7	72.4	78.2	79.8	60.7	58.8	224.4	180.9	62.9	56.9	165.7	5.9	406.8	479.1	144.4	24.0	65.0	374.4	46.7	88.5	126.6	74.8	83.9	89.0	1338.6	193.8	42.9	126.4	78.5	88.6	29.7	71.9	72.7	128.2	149.7	152.5	112.9	99.9	252.6	86.3	2021.6	42.1	84.1	76.9	50.6	40.1	66.7	250.1	49.0	276.7	103.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.7	6.8	27.8	2.6	3.7	25.5	7.4	5.2	6.2	9.1	31.1	22.7	10.7	18.7	4.6	4.4	18.3	7.9	7.1	0.8	18.5	40.7	3.3	16.5	38.4	23.8	9.6	1.5	6.8	16.8	5.1	11.1	4.4	6.1	0.2	17.7	22.7	2.1	30.4	0.9	14.4	15.7	11.9	17.9	33.6	7.3	51.4	11.7	8.4	23.4	14.8	18.1	34.1	22.5	3.5	22.0	17.1	5.0	4.8	18.1	5.2	8.3	25.2	14.8	17.4	6.3	8.9	6.8	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6	3.0	23.3	31.8	94.0	18.9	51.2	90.1	94.3	9.4	14.8	73.3	41.2	151.4	255.4	28.6	6.2	23.5	150.2	0.0	31.7	67.6	25.6	72.7	5.7	199.4	41.4	20.6	43.7	26.4	26.7	4.2	22.7	23.7	37.1	14.4	73.5	52.4	28.1	70.2	22.6	187.7	57.7	0.0	30.2	2.5	15.8	19.4	91.9	17.5	89.4	98.4
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 363.1;Proximal tubular cells: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.3	20.5	30.5	2.0	25.3	25.9	27.6	24.7	7.3	2.7	0.7	31.9	27.5	25.1	9.4	18.4	14.7	40.2	6.7	21.1	9.4	13.7	39.3	11.9	8.5	4.7	20.9	9.0	23.5	13.2	37.6	57.5	30.4	30.8	6.9	26.1	7.1	24.0	21.2	11.0	1.7	34.8	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.3	30.8	24.5	4.0	58.0	20.8	11.4	18.4	15.0	10.5	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3	26.8	25.1	23.1	44.0	16.3	13.3	158.2	86.6	121.8	59.1	34.9	11.8	242.5	363.1	46.4	49.2	44.3	33.7	46.7	154.5	15.1	57.4	23.5	22.0	167.8	55.4	17.5	50.1	41.7	22.4	39.8	58.7	24.7	33.7	36.1	38.2	54.7	71.1	41.2	47.7	504.9	43.8	25.8	23.7	25.7	33.2	11.2	85.2	49.0	60.0	20.4
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
ESCO1	"EFO1, ESO1, KIAA1911"	ENSG00000141446	"Establishment of sister chromatid cohesion N-acetyltransferase 1"	Q5FWF5	18	21529281-21600884	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 108.2;Spermatogonia: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042497	Approved					NA	NA					"HPA042497: AB_10794278"	"unprognostic (8.12e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.80e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.72e-2)"	8.7	7.8	10.2	15.1	9.7	18.1	14.0	22.2	13.3	11.5	13.1	4.7	11.5	7.7	10.0	13.7	11.9	7.9	6.8	7.7	10.4	8.2	9.4	11.0	8.8	11.9	9.4	9.1	10.7	9.0	16.4	29.0	14.6	10.8	9.6	7.9	5.7	11.9	13.8	15.1	10.1	17.2	8.0	12.9	14.1	8.7	24.3	9.9	16.6	11.7	8.4	12.6	11.7	9.5	4.6	2.7	8.8	2.0	4.2	7.4	2.2	6.3	3.1	6.8	3.3	6.5	7.1	7.0	3.9	8.1	5.9	8.0	6.2	4.3	11.6	9.2	5.3	6.4	9.3	8.5	5.6	8.1	11.8	5.6	8.6	4.6	10.4	10.1	14.4	8.9	5.9	12.0	4.4	11.7	7.8	7.7	9.1	12.1	11.7	8.0	7.4	10.8	15.2	13.8	12.9	7.5	7.2	8.3	12.7	11.3	10.2	10.3	7.6	7.8	9.8	16.3	10.9	6.8	10.2	4.0	7.3	7.3	5.4	5.0	29.0	16.4	13.3	7.2	8.5	7.1	6.6	1.2	7.9	6.9	2.0	6.0	4.1	6.0	6.2	2.4	4.6	7.3	7.4	8.8	4.2	1.7	2.7	5.9	2.2	10.2	9.7	22.2	13.3	10.4	8.2	9.4	9.1	10.8	9.9	11.9	22.7	15.4	20.2	9.5	38.9	32.1	5.1	14.7	21.6	10.4	19.6	20.7	16.6	20.2	6.5	12.7	14.0	0.0	11.9	13.6	10.1	17.5	28.8	6.8	11.8	28.6	10.9	12.9	6.3	6.4	19.5	15.0	15.1	18.0	12.7	15.2	16.8	17.3	21.2	14.2	34.9	25.8	9.2	108.2	95.6	10.9	31.5	27.4	10.8	27.1
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Group enriched"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	25.1	19.1	8.6	10.4	1.1	1.8	4.8	15.1	6.4	14.1	16.1	6.7	5.0	9.3	8.0	3.9	11.8	13.9	10.4	4.1	21.4	7.2	4.4	11.0	8.6	7.1	0.1	5.6	10.3	0.3	0.4	8.2	2.1	1.4	5.2	7.2	8.8	14.2	8.1	4.9	22.6	2.5	5.8	13.8	6.4	10.0	25.7	6.8	4.6	15.2	3.7	5.5	7.6	9.2	3.8	3.3	6.3	6.2	2.3	8.7	18.0	17.5	11.8	1.9	5.0	11.5	4.8	9.4	12.0	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2	0.0	6.6	2.2	0.7	2.1	1.5	1.1	0.0	2.7	5.7	0.0	3.9	1.0	0.0	0.3	3.9	0.1	5.3	70.0	0.0	5.5	0.9	0.2	1.1	1.1	4.5	0.0	1.2	0.6	4.1	0.4	1.7	3.5	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	1.8	6.5	0.3	30.1	77.3	0.5	0.8	2.9	4.0	0.9
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		4600000	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.3	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.2	0.2	4.3	0.0	3.8	2.8	1.4	0.2	0.1	35.6	2.9	0.1	8.6	14.0	1.5	0.3	11.9	0.4	0.2	0.6	0.4	0.3	0.1	5.3	2.0	52.5	0.2	0.4	0.3	14.6	1.4	37.9	0.2	0.2	2.2	51.6	48.0	0.6	0.2	0.3	0.1	9.3	0.2	5.5	9.3	11.1	2.2	3.5	2.3	10.8	0.3	15.8	5.9	0.2	7.4	15.0	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1	74.5	21.4	3.4	0.1	0.7	0.4	0.4	40.8	2.7	7.9	1.8	0.0	0.9	1.7	54.8	1.1	0.1	80.7	0.0	7.2	0.3	1.3	3.0	5.7	34.1	4.7	0.0	1.2	2.5	3.0	4.1	0.0	2.9	1.7	5.4	2.5	2.0	33.5	23.0	0.4	32.7	0.0	0.0	0.2	0.6	0.7	0.4	0.7	3.2	4.2	0.0
GGT2	GGT	ENSG00000133475	"Gamma-glutamyltransferase 2"	P36268	22	21207973-21227637	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (4.27e-1)"	"unprognostic (6.91e-2)"		"unprognostic (7.03e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.38e-5)"	"unprognostic (1.05e-3)"		"unprognostic (5.85e-4)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.46e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.2	0.0			1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	2.2	0.0	0.0		0.0	0.1	0.0	0.2	0.0		0.0	0.0		5.5	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.3	1.0			8.4		0.0	0.0	0.0	0.1	0.2	0.4	0.4	0.4	0.5	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.1	0.5	0.6	13.9	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.5	0.3											3.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245142	"Enzymes, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Ito cells: 44.2;Sertoli cells: 181.1;Smooth muscle cells: 82.1"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"basophil: 4.0;eosinophil: 7.5;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.5"	"Group enriched"	"Detected in some"	4	"ASC diff: 39.5;ASC TERT1: 30.1;HHSteC: 56.4;HSkMC: 65.0;TIME: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		18000000	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	20.2	14.8	2.0	5.2	3.5	0.0	13.2	0.5	4.2	10.7	4.0			5.7	7.9	3.6	2.1	10.2	12.1	14.0	2.4	3.4	13.1	13.7	5.1	12.4	4.7		3.9	5.0	2.2	6.0	3.2		6.5	3.4		5.4	6.8	2.5	5.3	7.2	10.1	2.7	4.8	5.6	1.2			17.2		5.2	6.3	9.3	0.1	0.4	7.5	0.9	0.8	0.1	0.4	0.0	0.3	0.0	0.0	39.5	30.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.1	5.2	56.4	0.6	1.4	65.0	0.0	0.7	0.7	0.0	10.6	0.1	0.1	0.1	10.1	0.1	0.0	4.9	0.6	0.1	0.0	0.0	0.9	0.1	1.1	0.0	0.0	1.4	0.0	1.7	0.0	5.6	0.2	0.3	25.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.1	0.0	4.0	0.9	7.5	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.8	0.0	0.1	0.0	0.4											3.0	16.5	0.5	3.1	6.3	0.0	4.8	0.0	2.7	11.4	0.0	0.0	0.2	0.0	0.1	0.5	37.5	0.0	0.0	0.2	0.1	8.7	1.3	1.1	0.0	1.6	0.0	0.0	44.2	1.2	2.6	33.6	2.9	3.3	5.4	0.0	0.2	0.3	0.0	22.3	0.0	0.4	181.1	82.1	0.3	0.4	3.9	0.2	0.0	0.0	0.9
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 136.8;Mucus-secreting cells: 63.3;Paneth cells: 98.2;Undifferentiated cells: 77.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Group enriched"	"Detected in some"	8	"RT4: 30.5;SK-BR-3: 10.4;T-47d: 32.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	30.5	0.1	0.1	0.0	10.4	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3	32.8	5.8	2.2	16.1	3.7	0.0	0.2	17.8	33.5	29.6	22.7	2.0	0.0	18.3	16.4	0.0	0.0	136.8	0.0	33.4	0.0	0.3	3.4	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.6	1.3	0.0	3.6	63.3	0.2	14.4	98.2	0.0	32.1	0.2	0.0	1.0	0.0	0.1	18.2	0.0	0.5	77.9	19.7
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872860	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 38.6;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1500000	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	6.8	6.7	21.6	6.7	23.7	2.9	8.5	42.6	29.1	9.5	11.5	9.7	14.3	9.8	12.3	19.5	6.4	10.5	11.4	13.8	19.7	17.0	9.9	7.2	9.0	10.3	11.2	32.1	13.4	19.5	20.8	18.3	8.5	19.2	11.4	9.6	6.9	18.8	15.3	31.6	11.1	9.0	9.6	11.0	8.3	12.9	5.0	15.6	4.9	16.3	4.3	8.2	9.3	8.5	6.1	2.6	1.5	3.0	3.2	12.8	1.8	2.2	3.3	17.0	17.4	13.4	12.0	15.1	9.4	9.6	7.8	11.6	17.4	11.1	0.0	11.2	7.3	7.9	1.5	7.3	4.1	5.1	0.7	13.1	6.7	5.9	9.1	12.0	0.3	11.1	17.4	4.7	8.7	4.0	23.3	0.6	8.9	5.0	1.2	5.3	3.8	1.7	3.4	3.9	3.8	1.7	0.0	11.6	10.7	11.3	3.3	9.9	11.6	4.8	7.7	12.1	6.7	5.9	6.1	0.2	26.8	10.7	2.5	5.3	13.1	1.7	0.8	31.5	0.6	9.8	1.5	3.0	1.4	7.4	2.0	2.1	5.6	6.3	2.8	2.6	6.1	12.8	8.9	0.3	3.2	0.7	1.4	4.8	1.8	21.6	23.7	42.6	29.1	19.7	17.0	11.2	32.1	19.2	15.6	3.0	2.4	0.9	17.1	6.5	38.6	1.6	22.9	1.4	3.4	17.4	11.8	18.6	0.0	13.9	2.1	2.1	10.5	0.0	4.9	9.8	11.9	9.2	2.3	10.2	4.0	38.1	10.4	0.6	1.9	0.5	11.5	2.4	10.1	3.6	16.0	9.4	6.7	14.0	7.4	5.1	16.9	6.5	8.6	11.1	10.6	3.8	14.1	4.1	17.8	12.0
GGTLC1	"dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4"	ENSG00000149435	"Gamma-glutamyltransferase light chain 1"	Q9BX51	20	23985050-23988779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	13	"lung: 24.2;testis: 11.1"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 128.1;Early spermatids: 37.6;Late spermatids: 92.1"	"Cancer enriched"	"Detected in some"	8	"lung cancer: 7.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.3;SK-BR-3: 1.7;T-47d: 1.2;U-2197: 4.5"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (3.14e-1)"			"unprognostic (1.62e-1)"	"unprognostic (1.94e-2)"			"unprognostic (5.32e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1			1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.1	0.0	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.1	4.5	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2											128.1	14.9	0.0	0.0	0.0	0.0	0.0	5.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.0	0.0
GGTLC2	GGTL4	ENSG00000100121	"Gamma-glutamyltransferase light chain 2"	Q14390	22	22644475-22647903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 11.1"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 22.5;Late spermatids: 5.2;Spermatocytes: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;RPMI-8226: 4.6;THP-1: 2.8;U-2 OS: 2.4"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"				"unprognostic (2.58e-2)"			"unprognostic (2.35e-2)"	"unprognostic (7.17e-2)"		"unprognostic (2.96e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.48e-2)"		"unprognostic (1.55e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	11.1			0.2		0.0	0.0	0.0	0.3	0.9	1.4	1.3	0.8	0.7	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	4.6	1.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.3	2.8	0.0	0.0	2.4	0.0	0.0	0.7	0.5	0.1	0.0	0.2	0.0	0.5	1.3	0.0	0.0	0.5	0.2	0.3	0.7	0.4	0.9	0.0	0.0	0.3	1.4	0.8	0.7	0.0	0.7	0.6											20.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	10.9	0.1	0.0	0.0	0.0	0.0	0.0
GGTLC3		ENSG00000274252	"Gamma-glutamyltransferase light chain family member 3"	B5MD39	22	18516344-18518161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"lung: 4.2;salivary gland: 3.0"	"Group enriched"	"Detected in some"	21	"Alveolar cells type 1: 3.0;Early spermatids: 4.1;Late spermatids: 10.4;Spermatocytes: 6.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.9;SuSa: 5.3;U-2197: 3.6"									"HPA045635, HPA047534"	Uncertain					NA	NA					"HPA045635: AB_2679400, HPA047534: AB_2680079"													"unprognostic (1.37e-1)"			"unprognostic (2.06e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.0	0.0	0.0	0.0	0.0	0.0			0.9	0.0	4.2	0.0			0.0	0.9	0.0		0.0		0.0	0.0		3.0	0.0	0.0	0.0	1.2	0.0		0.0	0.7	1.5			0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.5	1.2	0.0	0.0	1.2	0.3	0.0	0.7	0.6	1.1	0.3	0.0	0.0	5.3	0.0	0.0	0.0	0.3	1.4	3.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0											3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499958-49527047	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 2.0;liver: 5.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	73	"T-47d: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain					NA	NA					"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 89.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000		Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	89.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6	6.0	7.7	0.0	2.8	0.0	0.0	0.0	614.0	837.9	106.9	69.8	0.0	0.1	454.3	72.7	8.0	0.0	11.8	46.7	1419.6	0.0	0.0	51.4	2.3	628.5	0.1	0.0	2.9	23.4	22.6	21.8	60.7	4.4	0.0	22.6	33.3	0.0	1010.1	6.0	4.2	2005.4	0.0	0.0	0.0	5.6	3.4	0.0	0.5	4.3	29.3	42.0
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Cell type enhanced"	"Detected in many"	15	"Cholangiocytes: 338.8;Ciliated cells: 780.3;Pancreatic endocrine cells: 549.6;Proximal tubular cells: 368.8"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 20.7;Hep G2: 15.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.5	0.3	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	5.9	0.5	0.1	0.0	0.0	0.0	338.8	780.3	46.6	15.7	0.0	0.0	180.8	6.3	4.5	0.0	0.0	0.0	201.6	0.1	0.0	5.3	0.0	50.4	0.1	0.0	0.0	1.3	1.6	6.5	1.1	1.3	0.0	9.0	0.4	0.0	549.6	0.0	0.4	368.8	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.1	1.0
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	33.5	10.3	0.0	0.0	121.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.4	0.2	0.0	1.1	0.2	13.5	0.0	0.0	0.0	0.0	1.3	1.4	0.0	23.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	8.5	430.9	0.0	0.0	0.0
GSTA4		ENSG00000170899	"Glutathione S-transferase alpha 4"	O15217	6	52977948-52995378	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 105.4"	"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 233.2;Syncytiotrophoblasts: 376.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 17.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 17.4"	"Cell line enhanced"	"Detected in many"		"AF22: 32.5;ASC TERT1: 32.2"					"Low region specificity"	"Detected in all"			HPA048934	Approved					NA	NA					"HPA048934: AB_2680563"	"unprognostic (5.13e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	6.3	105.4	15.0	3.4	27.0	0.8	12.2	23.8	29.6	11.2	6.7	13.2	4.3	7.2	12.2	21.0	18.6	8.8	7.8	6.7	16.7	17.8	10.7	11.3	15.1	2.8	11.7	19.2	18.4	10.2	29.1	27.3	16.2	21.6	14.0	8.5	15.5	13.9	10.1	10.6	45.2	6.6	8.9	11.3	5.1	12.1	12.7	6.8	0.9	8.5	18.4	9.4	5.9	13.6	2.8	1.9	0.0	17.4	3.1	3.1	0.9	0.4	3.4	32.5	26.5	18.7	32.2	2.9	4.8	11.2	3.1	5.2	4.9	0.1	0.3	3.2	8.7	3.5	1.4	22.9	4.4	4.0	0.8	10.4	1.1	2.8	17.3	13.8	0.0	0.7	27.4	6.7	4.1	3.3	10.0	19.0	5.7	4.1	5.1	10.4	0.0	0.4	0.1	12.2	19.4	5.9	0.9	13.7	5.8	11.1	0.5	14.5	21.0	0.1	3.4	8.3	17.0	0.8	1.0	10.0	3.4	8.0	3.3	3.6	7.1	0.8	0.1	5.2	0.6	3.6	0.0	0.0	0.0	3.1	1.0	2.0	0.9	0.8	1.5	0.8	2.8	0.6	0.9	0.0	3.1	17.4	1.9	0.9	0.9	15.0	27.0	23.8	29.6	16.7	17.8	11.7	19.2	21.6	6.8	47.6	58.1	0.0	20.6	40.0	37.9	8.4	12.7	20.1	23.9	26.2	0.0	233.2	46.4	9.4	1.1	16.8	6.3	23.3	7.7	97.4	41.6	38.0	5.7	19.0	55.1	35.0	23.0	25.8	2.7	6.5	38.6	3.5	91.1	3.6	29.1	70.2	16.8	7.0	36.7	36.1	10.2	19.4	25.4	5.4	9.1	118.4	376.6	5.0	17.0	11.1
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52846095	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Cell type enriched"	"Detected in single"	5	"Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes		NA	NA		1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favorable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.3	19.7	2.8	24.6	43.6	62.7	13.1	16.2	27.8	14.5	29.0	11.9	70.3	15.6	23.1	23.4	21.9	41.6	10.8	25.3	12.7	30.0	11.7	12.7	14.8	18.6	30.1	15.3	20.8	56.5	31.2	16.7	11.9	21.7	38.5	20.5	17.8	19.1	38.8	21.1	15.6	27.8	6.5	53.4	29.9	13.5	0.4	30.8	50.2	15.1	11.4	15.6	29.7	48.4	24.6	17.7	23.3	21.5	22.7	7.9	7.3	20.6	13.7	32.7	15.3	3.5	28.6	61.8	16.2	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8	65.5	100.3	104.0	135.2	101.4	10.8	146.0	216.6	120.5	84.2	115.1	11.8	257.6	247.1	119.7	471.4	96.3	424.2	23.3	105.8	108.4	95.9	76.6	140.9	263.3	268.7	7.9	147.4	136.2	267.9	923.0	67.3	177.0	143.4	164.1	202.4	80.8	97.6	394.4	47.7	486.1	13.7	84.1	117.9	6.2	8.8	101.8	153.7	238.2	288.1	173.8
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 8.9;Ciliated cells: 9.4;Club cells: 11.4;Ito cells: 8.0;Kupffer cells: 10.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 26.9;HeLa: 32.1;HHSteC: 25.7;hTEC/SVTERT24-B: 23.2;HUVEC TERT2: 19.7;MOLT-4: 34.6"									"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.9	0.0	0.4	0.0	0.1	0.2	0.0	0.1	26.9	32.1	0.5	25.7	0.0	0.2	0.0	0.0	23.2	0.1	15.4	19.7	15.8	0.0	18.0	0.8	0.0	34.6	0.2	17.3	0.0	0.0	0.1	0.1	3.4	2.8	0.0	1.7	0.2	0.0	0.1	0.1	0.8	0.3	14.2	0.0	11.5	0.6	0.2	0.0	14.4	19.0	1.1	9.9	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2	8.9	5.0	0.0	1.0	1.5	0.0	5.6	5.1	9.4	11.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.6	0.1	0.0	0.0	8.0	10.1	0.0	3.4	0.8	0.0	1.0	0.0	2.3	0.8	0.0	2.1	0.0	0.0	0.0	0.6	0.2	0.2	1.4	0.0	5.3	0.0	0.1
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 56.8;Ciliated cells: 17.4;Club cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 41.4;HSkMC: 41.0"									"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		930000	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	23.8	27.3	30.7	14.7	48.3	5.7	31.7	13.7	25.0	36.4	20.9	19.9	54.3	14.5	24.0	37.1	15.4	31.4	15.7	35.2	32.5	21.7	15.9	6.0	11.1	7.5	17.0	21.1	90.1	17.8	20.4	40.2	5.8	22.4	30.7	10.7	36.0	26.6	87.5	88.5	39.2	13.6	22.0	24.9	10.7	16.4	9.2	28.9	6.7	20.4	25.6	8.7	20.2	31.0	5.2	16.5	16.0	3.5	8.9	20.9	5.8	0.0	1.2	13.0	13.3	15.5	41.4	2.5	8.2	14.5	7.6	9.7	2.3	0.0	0.3	8.8	20.6	6.2	0.0	1.0	0.0	9.9	0.5	0.3	4.7	0.1	3.1	10.5	0.4	8.7	41.0	0.3	11.3	0.0	20.5	5.4	3.9	1.3	0.2	16.5	0.1	6.3	8.1	2.4	0.2	11.1	7.9	0.0	0.0	2.3	0.2	2.8	6.4	0.0	0.3	4.2	8.1	13.2	2.3	0.1	8.4	0.4	12.1	0.6	4.1	6.0	0.5	12.7	0.1	0.1	1.0	2.2	16.0	1.9	3.5	1.8	5.2	5.3	2.0	12.7	3.7	20.9	8.9	1.3	8.9	2.1	16.5	4.5	5.8	30.7	48.3	13.7	25.0	32.5	21.7	17.0	21.1	22.4	28.9	0.0	3.7	1.5	1.9	4.2	1.5	56.8	2.5	17.4	20.5	3.5	0.0	0.3	0.0	0.1	1.2	2.4	0.3	0.0	0.0	0.2	3.3	0.6	2.3	0.6	1.2	3.2	0.0	1.3	1.5	6.8	14.4	1.0	5.0	0.0	0.8	11.0	0.1	0.0	9.9	0.8	0.2	6.5	3.1	0.4	0.4	2.5	0.5	4.3	0.4	0.7
GSTM3	GST5	ENSG00000134202	"Glutathione S-transferase mu 3"	P21266	1	109733932-109741038	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 115.3;testis: 96.0"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 1724.2;Late spermatids: 2908.0;Spermatocytes: 818.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.1;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.7;T-47d: 96.9;WM-115: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017130, HPA035190, CAB040583, HPA055972"	Enhanced		Approved	Cytosol		NA	NA		560000	Cytosol		"CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992"	"unprognostic (2.13e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (3.45e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.48e-2)"	7.5	11.3	21.4	2.9	27.8	0.9	23.1	8.5	18.4	15.4	11.7	9.9	51.0	12.6	9.0	67.2	11.1	8.8	12.3	27.6	14.0	14.4	54.0	5.3	5.2	2.4	9.6	22.0	32.3	26.5	7.3	9.4	5.8	30.7	13.6	5.6	13.4	4.5	115.3	15.5	15.0	7.5	15.9	13.3	3.3	14.2	96.0	6.4	0.1	15.8	15.6	3.3	17.4	12.0	0.6	0.8	4.1	0.3	1.0	11.1	1.4	0.0	1.3	9.9	0.0	13.5	8.3	1.7	10.7	1.8	11.8	11.5	4.3	0.3	0.0	6.2	5.4	8.2	0.5	2.0	4.4	16.4	0.0	2.9	10.0	32.5	6.4	14.4	0.0	23.3	8.3	5.4	17.7	0.0	13.1	14.5	12.4	0.9	0.1	5.3	5.8	2.7	0.2	1.1	0.0	18.6	0.0	6.4	0.4	3.3	23.0	17.5	9.4	22.4	45.7	2.1	3.0	96.9	14.6	11.4	0.1	4.3	12.0	7.0	1.5	2.4	0.0	0.1	0.0	37.6	0.8	0.3	4.1	4.2	0.1	1.2	0.6	5.3	3.1	0.1	0.6	11.1	5.5	2.0	1.0	0.2	0.8	2.3	1.4	21.4	27.8	8.5	18.4	14.0	14.4	9.6	22.0	30.7	6.4	6.0	11.5	8.1	96.3	127.5	19.3	82.7	40.8	1.4	17.0	211.1	5.9	13.4	679.8	74.2	1724.2	31.5	27.6	0.0	131.2	7.7	152.1	47.5	9.2	2.5	8.6	14.3	48.5	54.0	6.6	2908.0	356.9	16.6	57.3	5.4	23.4	255.3	110.8	25.9	259.6	35.7	14.3	187.5	89.7	818.6	48.1	93.8	8.6	7.9	40.9	29.8
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656081-109674836	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 69.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		660000	Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favorable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	12.5	17.6	14.0	12.3	20.2	3.6	10.9	12.9	24.7	12.6	33.2	18.0	9.4	85.3	12.1	15.3	15.9	11.0	14.5	14.7	13.7	12.3	27.2	22.0	7.4	10.1	14.8	16.9	31.4	12.2	23.1	9.9	5.1	15.8	14.7	23.2	20.5	15.4	26.3	47.4	10.6	77.2	19.0	16.1	16.2	14.7	11.8	14.0	4.0	14.9	14.5	12.8	22.2	14.2	3.6	7.8	69.8	3.0	2.5	3.1	2.3	5.3	2.4	4.3	32.5	9.7	15.0	5.5	1.7	14.0	4.1	5.4	17.1	0.6	5.0	6.7	7.7	8.0	5.5	11.1	5.8	2.6	7.4	0.0	10.9	10.1	15.3	15.8	3.7	13.2	9.5	5.8	5.2	0.0	11.5	3.3	12.9	5.0	7.5	2.8	5.0	3.1	16.4	3.3	22.5	13.0	6.7	2.4	7.3	16.0	3.8	3.1	7.2	0.0	28.2	21.8	3.4	7.6	8.0	1.4	4.7	18.7	5.2	2.5	11.2	19.6	0.4	15.6	5.5	13.3	2.0	2.9	69.8	2.7	3.0	1.6	3.6	2.0	3.1	7.8	2.8	2.0	2.3	0.4	2.5	0.7	2.7	2.8	2.3	14.0	20.2	12.9	24.7	13.7	12.3	14.8	16.9	15.8	14.0	8.9	2.4	13.5	21.7	16.1	5.5	25.8	25.5	10.7	7.9	29.6	0.0	18.5	86.2	40.9	2.6	9.0	85.7	0.0	50.8	15.9	20.4	8.2	20.7	21.9	30.0	4.8	6.9	16.0	14.6	4.7	27.9	17.0	38.8	15.4	33.9	22.1	36.3	28.8	23.3	64.5	4.7	32.3	32.0	5.7	6.9	13.4	7.3	17.8	57.6	10.4
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in many"	6	"Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3"									"HPA048652, HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.6	1.6	0.3	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9	0.0	0.3	0.0	0.5	6.0	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.2	0.8	0.0	0.0	0.0	0.1	12.3	0.1	0.0	0.0	0.2	0.0	0.0	7.4	1.2	9.9	132.9	0.6	10.1	0.0	0.0	217.3	0.0	0.0	119.5	0.0	5.8	25.8	7.6	1.9	1.1	5.6	0.0	0.0	0.0	0.1
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 123.8"	"Low region specificity"	"Detected in all"							"HPA037603, HPA037604"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		200000000	Cytosol	Nucleoplasm	"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favorable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	29.6	31.9	19.9	21.8	24.4	35.8	20.0	15.0	24.3	17.8	29.7	16.8	17.8	36.3	16.5	21.4	22.6	15.2	24.7	67.9	19.7	21.5	32.7	137.3	32.0	35.7	23.2	23.1	19.7	21.2	18.6	23.2	26.3	17.0	18.2	20.8	18.0	25.3	21.2	42.7	13.3	41.0	21.4	18.9	26.8	19.8	7.0	14.2	30.8	32.9	24.0	16.8	28.0	18.8	18.7	55.4	85.5	68.3	21.8	25.5	68.0	31.7	21.8	16.9	28.8	23.7	45.3	7.3	41.5	73.7	27.6	30.0	27.3	34.0	28.3	18.0	27.5	35.2	18.3	11.0	36.8	29.1	14.1	26.4	20.9	15.5	59.6	42.5	26.7	35.1	34.3	15.7	40.0	48.3	39.3	52.7	26.5	42.9	17.7	57.7	17.3	20.7	37.6	15.6	34.4	15.2	15.3	11.1	11.9	40.9	20.4	8.4	10.5	13.4	9.6	123.8	29.8	10.5	21.5	48.6	32.7	17.1	50.8	36.9	0.3	0.4	0.2	61.3	46.5	12.9	85.5	68.3	19.2	18.3	57.2	22.0	18.7	22.6	23.4	55.4	15.0	19.7	19.8	19.5	21.8	43.9	25.7	25.5	68.0	19.9	24.4	15.0	24.3	19.7	21.5	23.2	23.1	17.0	14.2	71.5	58.2	98.7	286.1	83.2	26.3	290.4	244.5	58.9	78.5	96.0	19.6	399.2	281.8	289.2	13.5	118.6	130.2	70.0	215.9	135.5	154.5	94.2	142.1	611.8	643.1	22.3	99.4	338.8	323.0	12.0	106.2	397.5	119.8	265.1	129.8	50.2	258.3	117.9	106.1	410.6	24.7	148.8	123.7	5.4	2.6	68.8	92.8	101.2	167.3	176.7
GSTO2		ENSG00000065621	"Glutathione S-transferase omega 2"	Q9H4Y5	10	104268873-104304945	"Enzymes, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Distal tubular cells: 112.7;Early spermatids: 313.3;Late spermatids: 338.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.0;hTCEpi: 20.9;hTERT-HME1: 22.7;MCF7: 13.7;OE19: 24.7;T-47d: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048141	Approved					NA	NA					"HPA048141: AB_2680281"	"unprognostic (5.77e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (7.10e-7)"	"unprognostic (4.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.47e-1)"	0.9	3.8	7.5	2.2	15.7	2.1	13.1	2.1	9.8	6.7	6.8	6.9	15.5	6.2	4.3	16.7	11.0	10.6	6.7	1.0	4.6	4.8	10.6	3.3	3.7	0.6	3.5	7.6	7.1	37.3	18.1	24.0	1.3	3.2	10.6	8.8	9.4	13.2	18.0	1.8	12.3	6.0	2.8	3.2	1.0	9.8	30.3	5.4	1.7	10.7	9.6	4.5	5.9	6.7	1.3	1.0	5.1	0.7	2.9	3.7	0.8	9.2	0.8	0.2	0.4	0.3	0.8	1.1	4.4	8.1	2.2	2.4	0.2	24.0	1.2	4.2	0.5	0.3	12.7	0.3	5.4	0.6	0.5	1.7	0.2	2.1	1.3	2.1	0.3	0.3	1.7	20.9	0.1	22.7	0.8	0.4	0.9	0.7	1.9	0.6	13.7	0.1	0.2	0.8	24.7	0.8	0.3	0.3	0.3	5.8	6.9	0.4	0.5	3.1	2.3	1.3	0.6	17.9	0.1	1.1	0.7	3.6	0.4	0.2	1.6	3.3	0.2	0.7	0.4	0.2	0.5	0.5	2.4	1.3	0.7	1.3	1.0	1.9	0.8	0.2	1.3	2.1	1.3	5.1	2.9	0.3	1.0	3.7	0.8	7.5	15.7	2.1	9.8	4.6	4.8	3.5	7.6	3.2	5.4	3.0	18.9	0.8	44.7	30.3	18.2	2.1	22.9	26.8	33.0	38.4	15.7	12.3	112.7	24.0	313.3	3.5	17.0	0.0	55.1	8.2	2.3	28.3	2.3	2.8	1.6	0.0	52.1	14.7	3.4	338.1	2.6	2.3	16.9	3.6	32.1	9.4	27.8	35.1	9.2	22.7	22.3	6.5	1.0	9.6	7.5	41.4	5.6	4.4	42.1	33.3
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583595-67586656	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 252.4;OE19: 379.4"					"Low region specificity"	"Detected in all"			"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol		No	No		120000000	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	24.2	25.3	20.2	23.8	21.7	46.2	39.5	15.5	19.8	51.8	51.9	23.5	125.4	35.2	43.5	41.9	181.6	60.8	51.1	45.3	18.3	23.5	44.2	5.9	61.0	39.4	25.5	19.9	33.4	60.7	44.1	33.8	57.9	46.0	37.0	17.9	59.9	50.2	110.8	33.7	58.5	34.0	30.1	22.8	25.1	48.5	15.4	15.4	29.8	91.6	131.5	75.6	40.8	79.5	25.3	191.4	12.4	168.2	70.1	40.7	167.2	57.6	78.7	38.4	59.6	29.7	33.5	35.4	25.2	33.9	38.5	30.0	144.5	60.6	0.1	57.9	39.9	34.5	84.4	103.5	111.0	10.9	40.2	37.6	2.8	57.2	0.0	44.0	18.9	33.7	41.5	252.4	30.7	29.7	28.5	57.8	41.6	62.5	16.1	30.1	0.2	43.4	52.9	73.4	379.4	33.8	40.5	6.4	0.1	61.4	0.1	13.0	37.2	35.3	11.5	114.2	31.7	0.1	31.9	31.1	17.8	45.2	37.2	18.2	10.0	62.4	21.1	20.2	31.4	36.9	2.3	168.2	12.4	40.7	125.7	15.0	25.3	18.4	33.3	191.4	24.3	15.3	27.3	7.0	70.1	79.4	76.2	18.3	167.2	20.2	21.7	15.5	19.8	18.3	23.5	25.5	19.9	46.0	15.4	1072.0	720.7	317.1	1402.4	769.0	173.6	263.2	1108.3	2518.8	1170.4	1167.2	31.4	2000.9	1530.2	1548.4	3.0	432.0	610.1	46.7	1274.3	1522.1	711.2	802.7	262.2	7.2	793.1	66.7	353.7	365.8	595.7	9.3	529.8	867.5	1452.6	2663.7	867.8	370.2	1415.0	772.2	376.2	1617.9	188.6	355.7	676.5	3.2	63.0	928.1	1376.1	396.6	983.6	3031.0
GSTT2B	GSTT2P	ENSG00000133433	"Glutathione S-transferase theta 2B (gene/pseudogene)"	P0CG30	22	23957414-23961186	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"breast: 83.4"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 27.7;Muller glia cells: 19.5;Peritubular cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.6;HHSteC: 33.3;SK-MEL-30: 23.0;T-47d: 25.5"									HPA000750	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA000750: AB_1849804"	"prognostic favorable (5.06e-4)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.19e-3)"	1.6	11.7	2.7	0.7	1.9	0.0	83.4	0.0	4.2	2.6	1.5			0.1	1.7	2.9	2.6	1.4	1.1	2.4	1.7	2.9	1.3	6.1	2.0	0.1	2.5		3.1	3.2	0.9	3.6	0.8		6.1	0.2		1.2	2.5	1.3	11.4	0.7	2.7	1.4	0.9	2.6	0.5			2.5		0.1	0.7	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.3	0.0	22.6	0.5	0.6	0.9	3.2	1.8	4.6	4.8	9.7	0.0	0.0	5.1	7.9	12.0	9.5	0.0	10.0	2.1	0.0	0.8	0.3	12.7	1.5	33.3	0.0	3.6	13.7	1.6	13.2	2.7	13.3	3.7	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.3	4.8	0.0	16.8	0.0	10.2	0.0	0.4	9.5	3.1	0.0	23.0	0.0	25.5	0.3	12.3	3.8	2.6	0.5	2.4	0.0	0.0	0.0	2.4	0.0	9.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											3.0	2.2	0.0	8.7	0.0	3.5	0.1	2.5	0.0	2.3	0.0	0.0	1.2	24.9	7.2	0.4	1.6	0.0	23.3	7.9	3.6	0.1	7.9	1.1	27.7	8.3	0.0	1.2	15.4	4.0	1.3	9.2	0.2	0.0	5.4	0.4	19.5	4.7	0.0	26.9	3.8	2.6	6.5	0.3	0.5	0.4	0.0	1.5	0.0	0.0	2.3
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 348.1;Late spermatids: 326.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favorable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.5	12.5	9.9	7.0	6.3	8.7	16.8	4.1	4.2	7.7	10.9	4.2	16.5	14.6	5.9	4.8	4.8	8.4	6.7	7.9	7.4	7.7	6.7	7.1	4.8	8.9	9.9	2.6	5.9	8.1	8.6	4.4	7.5	4.3	6.6	8.7	5.9	13.5	5.1	60.8	4.0	5.5	2.9	22.6	10.0	7.0	10.4	11.3	11.7	8.0	10.9	9.9	9.1	18.2	12.9	5.8	29.7	3.9	4.5	6.0	20.4	6.8	3.0	10.1	10.8	12.8	15.6	4.0	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2	6.0	8.1	12.7	18.0	11.8	6.8	12.0	50.9	10.7	5.7	8.7	3.9	76.5	39.7	34.9	105.1	8.7	47.2	23.3	59.7	57.9	10.6	19.8	3.5	348.1	39.6	15.9	27.6	9.8	28.3	326.5	10.9	14.4	16.9	35.1	36.9	20.9	39.0	38.6	5.6	58.4	11.2	0.0	10.3	33.5	24.7	12.3	63.7	7.7	45.9	17.7
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Cell type enhanced"	"Detected in all"	4	"Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria		No	No		8700000	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.7	8.2	17.7	12.9	42.7	13.8	8.6	12.9	19.2	14.0	13.8	5.9	16.5	49.8	6.9	10.5	9.1	11.8	23.6	17.8	15.5	15.2	12.3	11.6	15.6	13.0	6.8	24.4	5.4	14.3	9.5	9.9	9.1	11.5	9.4	35.0	14.3	26.5	15.8	15.9	41.4	9.7	8.4	38.7	10.9	31.6	24.9	24.9	15.1	35.6	21.5	12.3	12.4	44.5	12.7	10.8	21.2	19.3	5.2	9.9	5.6	13.9	7.0	15.0	17.3	21.6	13.5	16.6	7.6	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2	26.8	26.0	29.0	45.8	13.9	7.3	194.2	61.1	81.7	36.4	33.2	3.9	27.5	135.9	37.9	159.1	14.3	244.0	46.7	28.1	33.2	15.5	29.6	10.4	229.1	96.2	6.4	31.2	19.0	32.4	78.4	42.8	17.2	20.3	6.4	71.1	24.6	30.7	84.2	33.2	241.4	5.7	38.8	30.8	25.1	20.1	15.8	14.2	16.2	172.2	38.7
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 922.0;Distal tubular cells: 441.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	23.1	18.3	12.8	22.9	79.0	43.7	13.0	19.5	29.9	20.1	19.7	21.8	22.6	11.6	13.7	31.9	22.6	18.3	21.2	27.6	24.7	26.1	18.5	26.6	10.9	42.7	33.9	21.5	20.4	42.3	45.5	20.9	34.0	34.3	37.2	18.0	22.3	18.8	41.9	17.0	12.0	41.5	8.9	34.8	19.9	13.3	42.2	22.0	41.3	32.9	6.1	21.1	33.4	38.1	51.2	16.0	23.6	38.4	25.7	19.0	19.9	17.8	14.0	14.1	21.2	20.4	21.8	34.3	18.8	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8	44.7	32.2	48.9	103.6	55.2	29.0	922.0	127.4	46.8	42.1	92.5	53.0	177.3	441.0	96.4	60.4	68.1	196.9	116.8	50.2	61.8	59.6	61.5	62.2	218.5	127.1	12.7	71.9	67.5	100.7	74.5	52.3	80.0	84.4	77.5	85.7	52.4	56.5	91.7	59.1	244.7	72.5	71.1	92.4	75.6	46.1	47.8	156.1	48.0	100.9	85.2
HHAT	"FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn"	ENSG00000054392	"Hedgehog acyltransferase"	Q5VTY9	1	210328252-210676296	"Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 17.4;Muller glia cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 7.1;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.4;LHCN-M2: 11.2;RH-30: 12.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA016462	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA016462: AB_2669360"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.89e-3)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-3)"	"prognostic favorable (8.47e-7)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.67e-2)"	3.8	11.7	5.1	5.4	5.3	1.3	7.5	0.9	5.0	10.4	4.9	3.9	9.7	3.3	12.8	10.6	4.7	8.1	8.5	4.1	3.1	2.6	6.3	4.3	4.1	2.3	2.7	3.8	4.9	5.2	4.2	15.1	3.8	3.3	11.6	4.0	11.5	10.4	6.6	2.8	5.3	4.2	5.1	2.3	3.8	3.9	6.2	2.5	7.1	12.8	3.1	5.7	6.7	4.9	3.0	7.1	0.0	0.7	0.2	2.6	0.7	0.7	0.9	2.3	1.4	1.0	1.3	4.7	1.1	1.0	1.8	3.1	0.2	0.9	0.0	1.2	0.9	3.0	0.6	0.5	0.5	2.2	1.6	1.1	0.0	0.1	1.0	0.2	0.3	13.4	1.2	2.7	1.6	1.2	3.1	0.3	1.1	0.0	0.0	11.2	1.1	0.6	0.0	0.6	0.6	0.1	1.2	12.2	0.0	7.3	2.5	1.9	7.7	2.0	0.0	5.6	6.1	3.9	0.7	1.7	2.8	8.5	1.6	4.3	3.8	0.1	0.0	1.2	0.8	2.3	0.0	0.6	0.0	1.5	0.7	2.6	3.0	1.8	1.7	0.7	2.7	0.1	0.6	0.0	0.2	0.2	7.1	0.4	0.7	5.1	5.3	0.9	5.0	3.1	2.6	2.7	3.8	3.3	2.5	0.0	3.7	1.4	4.9	1.9	0.4	2.2	2.5	17.4	0.0	8.7	0.0	4.0	3.3	2.6	0.7	2.1	1.3	0.0	0.6	2.6	1.1	5.2	0.0	2.1	1.8	0.0	0.0	2.5	2.4	0.0	1.1	0.9	0.0	0.0	3.1	21.1	1.2	2.5	0.4	0.8	0.5	0.0	1.0	0.3	0.9	2.3	1.8	0.8	1.9	4.6
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.7	0.0	0.0	17.2	1.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	60.6	2.1	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	15.8	1.4	2.8	0.0	0.2	5.7	94.3	0.1	0.1	0.0	0.2	0.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5	14.9	46.1	5.2	57.7	15.3	3.1	0.4	43.3	5.3	20.5	21.0	0.0	25.6	18.3	2.4	1.1	0.5	273.6	0.0	86.5	488.8	12.1	51.1	816.1	165.7	20.7	0.0	8.1	18.4	16.1	0.2	18.4	10.6	72.6	1.0	48.2	0.0	26.0	217.5	0.0	68.8	0.6	0.0	6.6	0.4	0.4	19.6	47.4	50.3	31.0	266.0
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 1000.1;Hofbauer cells: 476.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 15.8"	"Group enriched"	"Detected in some"	8	"HEL: 32.4;HMC-1: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		170000	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	14.3	2.9	8.0	1.6	12.1	1.6	5.8	2.0	7.7	5.4	6.9	4.4	0.2	7.5	4.7	3.3	4.1	2.5	9.3	3.0	8.4	3.6	2.5	1.3	12.7	0.9	9.6	2.4	1.5	1.8	1.7	1.5	24.8	9.0	6.4	7.5	2.9	3.8	2.2	1.4	5.8	8.6	5.8	14.6	1.4	4.4	1.8	12.1	1.5	1.2	2.8	1.5	4.5	3.5	0.0	0.1	15.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	2.5	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	8.0	12.1	2.0	7.7	8.4	3.6	9.6	2.4	9.0	12.1	11.9	75.3	0.0	0.8	3.7	0.0	0.0	0.0	2.7	6.8	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	4.1	4.0	1000.1	0.0	476.4	0.0	6.8	0.0	3.9	0.0	0.3	14.5	3.3	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	4.6	4.6	0.0	0.0	0.1
HRASLS2	FLJ20556	ENSG00000133328	"HRAS like suppressor 2"	Q9NWW9	11	63552770-63563383	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 16.1;intestine: 42.5"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 19.5;Ciliated cells: 45.5;Enterocytes: 59.0;Proximal tubular cells: 75.2;Urothelial cells: 43.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 16.1;naive B-cell: 5.3"	"Lineage enriched"	"Detected in many"	12	"B-cells: 16.1"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 54.4"									HPA058997	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.4	0.0	0.4	1.5	0.4	0.0	4.7	0.4	0.4	0.6	20.6	0.5	0.4	33.4	0.6	1.1	0.5	2.1	0.4	1.0	0.4	0.2	5.5	1.9	3.3	1.1	0.4	0.4	0.4	0.4	0.0	0.4	1.4	0.4	0.4	6.5	0.4	0.7	0.4	0.4	0.2	42.5	0.4	0.4	0.7	8.8	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	16.1	0.8	0.1	0.1	1.2	0.9	3.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.4	0.0	0.4	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	3.5	0.8	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	54.4	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.9	16.1	0.2	0.9	0.0	5.3	0.2	0.6	0.1	1.2	0.0	0.8	0.0	3.6	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	0.4	0.4	3.0	0.6	3.0	19.5	0.1	0.0	0.3	5.1	45.5	5.7	0.0	0.0	0.1	8.3	0.4	0.3	0.0	59.0	0.0	0.4	0.3	0.0	6.2	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.7	7.0	0.0	75.2	0.0	0.0	0.0	0.7	0.1	0.0	0.7	1.0	0.9	43.6
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.2"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	2.9	2.8	10.4	1.9	4.9	5.3	2.1	2.2	4.5	1.0	4.5	1.3	2.9	0.7	4.9	1.9	0.8	1.5	1.2	1.6	1.0	2.4	3.1	1.9	2.5	1.8	3.4	0.7	7.1	5.2	3.5	1.6	1.5	9.6	1.6	4.4	1.9	2.8	4.2	0.4	1.8	2.0	2.8	12.5	3.3	3.3	0.4	2.5	8.7	0.7	2.8	17.2	0.5	1.5	11.0	3.8	2.4	0.6	2.8	2.6	4.6	4.4	1.8	6.9	2.3	0.8	7.2	1.1	2.0	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5	0.0	1.6	0.8	7.6	7.2	11.2	2.0	5.1	13.4	4.5	22.7	13.7	4.0	13.3	8.9	6.8	3.8	3.8	0.0	4.1	3.9	8.9	8.0	10.3	3.2	4.2	7.9	24.6	8.0	2.8	9.6	6.6	3.6	5.0	2.8	4.3	17.0	4.8	2.8	12.0	23.7	11.7	0.0	9.9	10.3	10.6	8.9	2.4	3.3	3.5	7.5
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.8	0.3	1.1	0.1	1.3	2.8	0.0	0.0	0.1	0.1	4.5	1.0	0.0	2.1	0.0	0.1	5.8	3.9	0.4	0.0	0.0	1.3	0.0	0.5	4.8	0.4	0.5	0.0	1.3	2.3	0.2	0.0	0.0	0.0	3.5	0.3	0.0	0.0	2.8	0.1	0.1	8.7	21.3	0.7	0.0	0.1	10.2	0.4	10.3	11.4	0.7	0.6	10.2	0.4	1.0	4.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3	0.0	0.3	0.0	8.0	1.3	0.0	0.5	33.1	0.0	1.2	181.5	0.0	0.8	38.1	1.7	0.1	0.0	273.5	0.0	2.7	0.7	3.1	15.6	9.2	1.3	1.3	0.0	25.8	1.3	0.0	0.0	23.6	0.0	1.7	0.0	229.5	0.0	0.8	137.2	6.3	14.6	0.0	12.9	0.4	0.2	1.0	3.0	95.8	0.0	114.3	5.7
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434373	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 343.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					NA	NA		1800000			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	20.9	29.8	13.2	19.1	14.5	16.4	15.9	7.9	14.0	16.9	20.6	16.2	20.2	17.2	17.1	19.0	31.3	14.8	19.6	42.6	11.9	14.0	33.9	96.7	12.7	21.6	16.1	9.7	21.0	32.7	12.5	18.4	25.0	14.9	15.3	19.4	13.0	23.2	17.8	35.4	22.9	17.4	18.6	14.8	19.7	17.4	8.6	14.0	25.6	28.4	39.0	26.0	16.1	17.9	30.4	53.2	12.8	38.2	27.7	33.3	32.9	22.3	38.3	18.7	34.7	18.4	8.1	28.3	13.9	13.9	37.1	24.4	39.3	19.3	38.2	12.7	15.9	24.1	23.5	60.2	28.1	20.4	30.2	33.8	18.0	54.9	32.5	30.9	33.9	28.2	17.3	26.7	28.7	16.1	8.1	27.1	34.4	25.7	30.3	17.2	78.9	30.0	51.0	51.8	30.3	49.5	30.7	34.6	67.6	28.5	24.8	33.1	43.6	40.0	47.9	25.3	24.9	50.4	31.6	12.1	15.9	25.3	33.1	21.0	24.8	34.5	47.2	22.1	71.4	23.4	12.8	38.2	11.4	27.0	36.7	27.8	30.0	25.1	26.7	53.2	30.4	21.1	22.2	3.2	27.7	26.8	29.0	33.3	32.9	13.2	14.5	7.9	14.0	11.9	14.0	16.1	9.7	14.9	14.0	44.7	34.1	58.8	68.9	76.7	11.0	53.6	96.8	29.4	30.7	96.0	3.9	152.6	240.4	110.3	1.3	54.5	72.5	116.8	117.5	226.1	88.0	68.7	56.4	343.1	121.0	12.7	100.4	52.8	71.2	4.5	72.5	86.0	91.1	131.7	59.9	45.2	90.4	42.1	89.1	333.9	11.4	77.6	85.6	15.1	62.3	101.6	126.8	78.8	78.6	62.3
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 489.8;Paneth cells: 501.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.5"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.7	5.2	13.1	16.1	22.2	7.4	5.8	9.1	3.8	7.0	8.9	68.5	0.0	11.2	5.9	3.6	0.2	15.2	1.2	4.2	16.9	3.2	14.7	5.9	30.0	9.1	26.2	27.5	15.7	0.4	5.2	1.8	12.1	7.3	6.4	15.3	7.6	7.0	0.4	5.3	32.1	8.9	33.3	1.8	14.7	4.8	17.3	10.5	16.4	1.7	16.7	11.4	0.3	19.5	7.0	0.0	25.6	6.1	2.6	11.8	10.5	3.0	3.7	1.5	1.6	4.9	18.6	17.8	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6	291.8	133.2	72.8	64.6	24.8	1.2	4.4	310.8	75.0	111.5	41.8	2.0	27.4	21.6	38.6	0.9	71.4	489.8	0.0	51.8	45.8	75.4	36.7	98.1	303.2	118.3	17.5	90.0	101.9	213.8	0.9	96.4	169.0	64.1	36.1	155.1	34.2	52.9	501.0	55.9	148.1	3.9	71.1	54.2	2.6	13.1	18.7	12.5	110.7	226.2	80.0
HSD17B12	"KAR, SDR12C1"	ENSG00000149084	"Hydroxysteroid 17-beta dehydrogenase 12"	Q53GQ0	11	43680558-43856617	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016427	Approved					NA	NA		200000			"HPA016427: AB_1844347"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.16e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (2.10e-8)"	"unprognostic (6.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	27.2	32.6	33.5	16.6	31.9	10.5	30.4	12.8	33.1	26.3	30.7	31.4	29.3	32.0	22.3	25.3	24.3	20.1	28.0	36.9	30.9	31.1	42.9	59.8	25.8	19.9	38.5	21.4	22.4	26.4	66.6	29.4	19.4	45.7	26.4	29.4	26.6	25.3	22.9	16.1	18.2	30.8	23.3	44.9	23.5	25.6	17.6	24.4	15.2	32.4	32.5	17.5	19.4	18.6	12.8	18.7	9.8	12.7	13.5	15.0	9.6	9.0	14.8	16.5	16.7	55.3	52.6	10.8	23.4	23.1	16.3	17.8	17.9	19.1	22.7	16.6	21.0	27.0	35.7	11.5	29.5	20.2	4.2	21.3	10.5	8.3	15.6	28.1	32.5	30.1	32.3	22.7	16.4	46.8	20.8	22.5	14.3	9.9	37.9	14.0	5.2	8.6	14.5	30.2	11.4	10.8	14.6	24.5	25.6	31.1	22.4	6.0	13.6	31.3	26.4	22.8	16.2	18.9	26.2	21.5	17.6	6.9	45.7	27.3	19.5	24.5	13.6	19.1	5.8	13.2	6.1	12.2	5.5	11.0	12.7	11.7	11.0	8.8	9.2	18.7	12.8	15.0	12.9	9.8	13.5	6.5	15.1	5.0	9.6	33.5	31.9	12.8	30.8	30.9	31.1	38.5	21.4	45.7	24.4	59.6	94.5	60.7	41.7	28.2	71.5	81.5	76.5	89.7	64.8	48.8	72.6	50.4	23.2	87.7	47.4	65.0	71.5	23.3	72.4	37.6	41.7	54.4	152.4	109.0	55.3	114.4	132.6	70.0	43.0	14.4	31.7	49.6	37.1	32.5	68.5	118.3	65.6	45.6	53.4	39.7	63.0	77.6	48.4	11.4	11.5	40.0	62.6	27.4	93.1	38.3
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813017-48836678	"Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 44.3"	"Cell type enhanced"	"Detected in many"	19	"Distal tubular cells: 66.3;Hofbauer cells: 120.5;Proximal tubular cells: 271.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 23.0;HHSteC: 21.7;hTERT-RPE1: 16.3;Karpas-707: 24.6;RT4: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021467	Approved					NA	NA					"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	5.9	25.7	15.5	2.9	16.2	1.4	4.2	20.2	14.1	11.5	4.1	9.7	3.7	3.3	13.2	8.1	3.3	8.3	9.2	4.8	10.5	13.5	44.3	24.0	11.6	5.7	11.9	15.8	32.2	6.0	15.3	9.2	6.5	9.8	8.0	2.1	34.4	2.6	8.1	1.3	3.4	3.7	7.3	9.0	6.7	3.2	4.5	7.1	5.0	16.6	3.2	3.5	7.8	8.0	5.9	0.7	0.0	0.0	7.5	4.8	1.3	0.0	6.0	6.0	1.0	7.1	1.1	0.1	1.1	8.3	0.5	0.5	5.5	0.1	3.7	6.2	0.2	23.0	0.0	0.6	0.0	0.6	0.2	0.4	1.6	0.1	0.8	21.7	0.0	9.7	8.4	0.2	0.6	0.2	16.3	7.8	2.1	0.0	24.6	0.0	0.2	0.5	0.2	0.5	3.5	4.1	3.3	0.0	0.7	0.0	17.6	1.6	4.1	0.0	0.8	4.6	2.6	0.2	0.2	0.0	0.1	2.3	0.2	0.0	4.2	7.8	0.2	5.3	0.6	0.0	0.0	0.0	0.0	1.4	0.0	2.1	5.9	2.6	1.1	0.0	4.5	4.8	3.6	0.0	7.5	0.0	0.7	0.7	1.3	15.5	16.2	20.2	12.8	10.5	13.5	11.9	15.8	9.8	7.1	3.0	8.6	1.5	3.1	2.3	5.0	1.4	0.0	0.0	3.4	7.0	0.0	1.0	66.3	1.4	0.3	3.6	0.0	0.0	1.0	2.1	11.5	3.7	6.9	26.6	120.5	11.1	12.7	21.5	7.6	0.9	3.7	13.5	20.3	13.6	0.0	38.4	4.0	0.0	6.7	271.8	1.4	0.0	4.1	0.9	7.0	1.6	1.8	2.2	0.0	2.3
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.8	15.4	29.0	38.4	72.4	34.0	15.3	17.4	23.5	16.5	30.1	12.7	29.8	23.9	35.9	18.8	24.3	18.0	21.3	37.9	25.8	26.1	19.7	31.4	16.8	24.2	18.4	9.9	49.2	29.6	15.9	17.7	16.7	19.4	28.2	16.5	10.7	13.9	17.9	15.5	15.1	6.4	21.5	44.1	10.9	19.3	29.1	25.8	26.4	49.4	21.9	18.9	40.9	6.4	19.0	28.7	23.7	16.7	20.0	16.2	11.1	17.8	14.2	7.1	14.8	8.8	18.4	26.5	15.9	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5	68.5	94.4	20.8	34.3	13.3	18.5	62.9	81.5	24.1	47.8	34.9	13.7	57.8	71.3	28.8	7.4	26.4	50.3	0.0	31.4	21.8	24.2	32.2	65.9	203.2	70.1	14.3	31.7	31.3	50.9	9.3	31.9	35.3	8.5	103.6	42.6	44.1	23.2	24.6	48.1	50.5	15.4	6.5	20.0	15.9	22.2	15.1	54.3	13.1	51.1	31.4
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204642-33206831	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 106.1;Proximal tubular cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		52000			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	3.5	11.5	4.1	5.4	4.1	3.0	6.1	3.4	5.9	5.3	12.4	5.3	17.7	6.6	3.2	14.7	11.3	8.1	8.6	11.0	4.1	3.7	13.9	24.0	8.1	7.7	5.3	4.6	3.3	47.8	12.8	6.6	3.5	4.7	4.5	5.6	9.3	16.7	30.1	14.6	10.6	11.2	4.1	5.3	5.4	5.8	5.1	2.4	10.3	11.2	15.5	10.7	5.3	5.2	4.8	4.8	0.4	3.1	4.1	7.8	6.0	1.1	2.1	1.0	1.3	0.3	0.6	0.4	0.1	0.7	0.0	0.0	1.5	2.5	7.0	2.0	0.1	0.3	4.2	1.0	3.2	0.1	1.2	1.2	0.3	2.0	3.8	3.0	0.0	0.5	0.7	4.3	0.0	7.4	0.0	0.3	2.5	0.1	6.8	0.6	2.3	5.2	0.1	0.3	3.3	0.9	3.0	0.1	14.8	4.1	0.1	2.0	1.1	0.4	5.6	1.3	0.7	9.6	0.2	0.1	0.2	1.2	0.0	0.0	14.6	7.0	2.6	0.4	0.1	0.2	0.0	1.4	0.4	4.8	3.1	7.8	4.8	7.2	7.3	2.8	3.1	7.6	7.8	0.1	4.1	3.1	4.8	5.2	6.0	4.1	4.1	3.4	5.9	4.1	3.7	5.3	4.6	4.7	2.4	17.9	16.3	6.7	21.5	26.4	10.3	24.3	38.2	26.8	14.8	21.0	5.9	25.7	106.1	24.6	5.1	8.5	30.9	23.3	28.3	10.1	10.0	13.7	6.9	60.4	14.9	1.6	17.2	6.7	8.9	11.1	6.9	10.0	47.2	10.0	23.7	28.7	19.1	21.0	5.6	106.8	11.8	0.0	5.9	7.5	5.5	32.5	14.5	14.0	43.6	21.3
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 52.9;Hofbauer cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;Hep G2: 23.1;HMC-1: 35.9;U-2197: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	7.0	8.1	0.8	4.1	2.9	10.7	0.5	8.8	14.0	1.7	3.6	0.6	12.3	0.4	2.9	10.8	0.3	2.1	0.8	1.3	0.9	31.6	1.9	0.5	6.4	23.1	2.7	0.1	35.9	5.1	2.2	8.4	1.7	4.1	0.8	0.4	1.6	0.3	6.6	15.1	0.2	5.0	0.6	3.0	1.1	0.8	2.8	7.8	5.4	0.4	3.0	1.5	1.1	5.8	0.8	0.4	11.2	0.5	4.1	3.7	1.0	34.9	0.9	0.6	5.1	0.4	14.3	0.9	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7	3.0	6.2	2.7	2.2	7.0	0.7	1.6	25.5	1.4	0.0	14.0	0.0	1.7	13.3	34.6	37.8	6.5	20.6	0.0	26.8	2.6	9.0	2.5	9.2	52.9	55.1	1.6	7.5	6.7	7.9	1.1	6.1	14.8	13.5	21.6	7.2	1.9	19.4	11.2	4.9	33.2	0.4	12.9	9.0	0.6	1.1	11.0	1.1	1.0	15.7	2.4
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383783	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	16.3	28.1	8.5	11.9	16.3	6.3	26.3	3.2	10.6	9.4	50.4	16.2	10.8	52.2	6.8	13.0	23.1	5.7	17.6	9.5	10.8	9.9	21.5	41.8	19.5	16.2	24.3	8.0	6.8	11.9	17.9	27.4	22.9	12.4	13.9	32.2	3.3	16.5	9.2	19.4	14.8	74.6	12.1	15.0	19.6	29.4	10.6	14.6	6.6	23.9	17.2	12.1	17.8	26.7	16.4	17.4	69.4	30.6	13.5	30.6	23.8	23.1	38.5	0.8	0.0	11.8	9.0	8.6	10.1	10.0	7.8	9.4	22.2	20.4	5.3	20.8	12.6	30.4	32.6	0.0	6.1	7.6	60.3	4.7	6.5	38.0	0.0	28.5	2.4	31.1	12.9	43.5	6.3	9.9	0.0	22.3	0.0	16.0	7.0	14.5	21.7	0.0	1.5	12.5	40.7	19.2	4.9	0.0	19.0	10.6	12.9	10.5	0.1	32.8	13.0	15.4	4.2	27.2	12.2	27.1	5.6	12.3	11.3	0.2	7.5	9.2	0.1	0.0	16.5	24.1	43.7	30.6	37.3	15.5	27.5	17.5	14.9	18.0	16.5	17.4	16.4	15.8	15.5	69.4	13.5	28.3	5.1	30.6	23.8	8.5	16.3	3.2	10.6	10.8	9.9	24.3	8.0	12.4	14.6	23.8	8.1	24.1	49.8	32.3	0.3	9.7	117.2	8.1	10.3	45.4	0.0	50.0	26.6	84.2	36.1	22.9	185.2	0.0	63.6	102.1	14.2	53.7	23.0	69.2	75.1	3.2	23.2	28.8	55.0	45.4	18.4	40.5	42.2	143.3	93.7	9.4	88.6	161.4	8.9	60.3	1.7	12.9	29.5	27.3	17.2	36.8	51.5	35.8	83.1	52.5
LCLAT1	"AGPAT8, ALCAT1, FLJ37965, LYCAT"	ENSG00000172954	"Lysocardiolipin acyltransferase 1"	Q6UWP7	2	30447226-30644225	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031880, HPA049217"	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum"	Cytosol	"HPA031880: AB_10610002, HPA049217: AB_2680678"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.52e-3)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (9.67e-4)"	"prognostic unfavorable (8.72e-4)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.85e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.10e-1)"	7.7	9.7	7.0	13.7	8.7	12.3	7.1	10.2	10.1	11.6	10.7	5.2	12.6	15.7	18.7	15.0	13.0	9.9	12.6	21.7	7.5	9.2	15.2	13.8	10.0	12.5	6.1	6.0	15.4	16.7	10.8	21.8	5.7	7.0	10.7	10.6	9.7	9.5	16.3	10.9	9.4	25.0	11.3	5.5	8.0	8.4	12.1	4.2	20.7	17.9	11.9	11.7	9.1	10.4	9.6	2.8	10.5	3.9	4.1	12.6	2.8	11.0	14.6	7.9	13.3	1.8	4.2	11.3	8.0	8.0	8.5	7.2	14.7	13.0	7.1	7.4	12.4	10.6	12.5	26.1	10.8	8.5	9.0	8.9	13.1	9.2	14.1	8.4	18.5	10.0	3.2	8.5	9.0	12.6	5.6	5.9	4.1	12.0	6.8	6.5	8.6	10.5	10.9	8.6	9.0	8.4	10.3	15.8	14.5	6.8	16.2	9.2	14.2	17.9	11.9	10.3	5.7	8.6	6.4	6.7	15.5	12.9	8.3	12.5	4.9	10.3	16.0	15.8	13.6	11.8	10.5	2.5	4.8	5.6	3.9	6.6	7.5	8.7	7.1	2.8	9.6	12.6	12.1	7.4	4.1	3.5	2.2	4.0	2.8	7.0	8.7	10.2	10.1	7.5	9.2	6.1	6.0	7.0	4.2	8.9	5.8	4.5	4.6	6.4	12.5	15.1	22.9	13.4	7.9	14.0	25.5	4.3	0.0	7.2	3.1	6.7	11.5	0.0	14.3	4.3	5.5	7.7	3.5	19.0	4.9	14.3	12.6	11.1	5.4	1.2	5.2	2.7	5.0	0.0	15.3	7.3	10.3	7.0	8.5	12.2	16.7	6.5	16.2	8.9	20.5	5.8	1.6	8.7	14.3	4.4
LIPT1	"MGC12290, MGC13378"	ENSG00000144182	"Lipoyltransferase 1"	Q9Y234	2	99154955-99163157	"Disease related genes, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034802	Approved					NA	NA					"HPA034802: AB_10669851"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.32e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.49e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (9.60e-8)"	11.9	9.5	13.9	7.7	14.5	12.5	13.0	18.4	16.9	10.3	8.7	10.1	12.6	9.6	13.1	17.4	6.9	10.1	7.5	10.2	12.7	5.8	10.5	9.1	7.3	11.2	16.4	13.6	14.4	9.3	7.7	20.0	5.5	13.6	10.5	8.6	8.2	10.0	14.6	14.7	8.1	9.8	9.5	15.2	14.1	8.4	14.8	16.4	3.8	13.4	8.6	8.1	10.3	8.9	10.7	4.1	11.4	7.8	12.2	18.9	8.6	5.8	3.8	5.2	8.8	9.3	11.1	12.5	3.8	4.6	3.0	3.3	9.2	9.8	9.2	8.2	2.2	8.1	5.1	6.3	4.7	6.1	9.9	11.4	9.7	4.7	8.0	9.9	6.3	4.9	6.6	7.7	5.4	12.5	6.3	8.5	10.9	9.2	5.6	5.2	4.7	6.4	12.3	13.2	5.6	9.5	11.0	5.6	9.5	9.6	8.5	5.0	4.9	5.3	6.1	13.3	9.9	6.3	13.2	6.2	4.5	6.2	3.9	3.5	8.8	11.6	10.0	4.6	10.8	6.4	8.4	7.8	11.4	13.0	7.1	16.0	10.7	14.8	14.2	4.1	9.8	18.9	15.6	2.0	12.2	6.5	4.0	8.6	8.6	13.9	14.5	18.4	16.9	12.7	5.8	16.4	13.6	13.6	16.4	3.0	7.0	3.2	9.7	3.2	5.3	6.1	0.0	9.4	4.5	12.2	2.0	6.0	11.6	4.4	29.4	7.1	3.6	0.0	3.0	3.8	4.2	5.1	4.7	2.1	6.2	11.1	5.8	11.6	6.3	18.9	8.9	2.1	1.7	5.4	5.8	10.4	3.7	6.0	7.1	9.0	9.8	6.5	5.1	24.0	8.6	3.8	4.5	10.0	5.8	6.4
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523977	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 35.6"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 286.5;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;EFO-21: 33.5;PC-3: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	9.8	5.6	5.2	9.0	5.7	5.1	7.4	9.2	9.5	5.4	7.5	2.9	4.5	3.9	7.0	3.2	3.2	5.9	5.8	4.3	5.3	5.2	4.9	3.1	35.6	8.5	3.2	3.7	5.0	5.4	3.1	5.6	10.0	4.6	5.2	2.3	13.6	4.5	4.4	3.5	3.2	5.9	5.5	3.3	28.8	9.4	3.0	2.9	5.8	4.7	1.4	8.1	6.6	10.6	0.9	0.7	2.4	1.7	1.7	3.6	0.6	2.0	3.0	0.5	3.3	0.3	0.5	34.9	7.8	0.4	0.4	0.3	1.1	0.9	6.8	33.5	0.2	1.4	5.8	0.6	0.2	0.2	16.5	14.2	1.6	4.9	2.0	0.6	1.7	4.6	0.6	0.1	0.3	0.1	0.5	0.4	2.3	3.7	1.3	0.0	4.3	6.4	2.6	12.3	0.1	23.3	12.3	0.6	4.9	1.4	2.8	4.4	4.3	6.2	5.7	1.8	0.3	2.6	2.7	3.9	0.6	7.7	2.3	2.8	4.4	4.2	1.6	1.4	2.8	2.1	0.0	0.6	0.8	3.6	1.7	3.6	0.9	0.8	1.8	0.7	0.7	0.1	1.0	2.4	1.7	1.2	0.2	0.8	0.6	5.2	5.7	9.2	8.0	5.3	5.2	3.2	3.7	4.6	2.9	80.4	286.5	25.1	1.9	5.6	52.2	3.2	7.6	5.3	21.6	14.0	137.4	5.1	0.0	16.9	1.5	10.3	2.6	0.0	11.7	67.8	9.3	5.6	8.1	4.0	21.8	22.3	14.3	18.4	26.3	1.5	10.0	16.2	6.8	10.8	9.0	28.2	22.2	0.0	14.5	4.4	124.0	0.0	12.3	1.7	9.8	3.4	26.5	26.7	2.5	1.6
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 64.6;granulocytes: 165.5;Kupffer cells: 68.0;Macrophages: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.0;HaCaT: 24.5;HL-60: 27.3;HMC-1: 45.6;hTERT-RPE1: 45.8;WM-115: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	8.9	1.1	0.9	0.0	3.1	1.2	1.6	3.8	3.7	1.9	1.9	2.0	32.0	0.0	13.2	5.4	1.5	24.5	0.6	5.3	3.1	2.4	2.6	9.2	2.9	4.6	1.1	27.3	45.6	0.6	5.3	2.1	1.7	45.8	14.7	0.5	0.4	0.1	3.2	0.5	0.0	11.0	1.4	2.5	0.1	2.8	1.0	1.3	1.8	3.5	0.6	7.1	7.4	3.0	5.3	4.6	1.3	6.9	16.5	0.3	0.0	1.9	2.6	0.1	0.0	0.0	0.7	13.3	32.5	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9	6.0	31.3	1.7	29.9	13.7	1.6	1.6	5.1	2.7	23.9	64.6	9.8	0.7	1.7	7.2	1.3	22.7	4.1	0.0	8.5	6.9	13.8	6.0	165.5	1.7	33.6	0.0	1.2	4.3	68.0	1.7	15.3	64.1	16.9	7.2	11.9	26.1	20.5	31.6	12.0	4.4	5.2	0.0	2.4	11.6	3.8	13.4	1.6	1.3	9.8	15.9
LPCAT3	"C3F, MBOAT5, nessy, OACT5"	ENSG00000111684	"Lysophosphatidylcholine acyltransferase 3"	Q6P1A2	12	6976186-7018510	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.5;liver: 78.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.74e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.23e-1)"	16.4	24.4	4.2	8.8	5.0	8.1	15.1	15.7	5.4	7.9	37.5	6.1	8.1	43.4	8.2	7.8	13.6	9.1	11.3	20.2	4.1	2.7	37.3	78.2	20.3	17.9	5.2	5.3	13.9	38.7	4.6	9.4	29.0	4.8	13.7	17.2	8.3	22.2	8.2	19.4	13.3	85.5	12.4	4.9	11.3	22.8	7.6	4.0	14.1	14.6	10.3	13.7	15.7	8.5	5.3	13.9	32.3	33.7	11.5	10.8	12.4	6.2	11.6	5.0	14.1	35.4	16.7	10.8	3.6	15.5	10.0	17.1	24.7	32.7	6.8	2.1	5.8	21.4	15.8	6.0	13.4	7.8	16.7	7.3	13.7	10.3	22.1	7.6	7.0	14.7	26.3	7.8	9.6	4.8	6.4	9.3	10.5	7.3	4.9	6.5	9.5	8.6	8.7	16.8	22.4	6.8	9.1	7.1	7.0	12.3	48.9	4.4	4.2	21.9	33.9	2.4	16.5	3.4	9.9	3.8	6.2	9.3	10.9	2.6	6.2	4.4	10.0	7.7	7.4	5.4	13.9	20.8	32.3	8.6	30.0	10.0	5.0	9.0	9.7	13.9	5.3	8.5	8.7	20.0	11.5	33.7	7.9	10.8	12.4	4.2	5.0	15.7	5.4	4.1	2.7	5.2	5.3	4.8	4.0	65.5	29.7	4.5	32.1	20.9	5.2	0.4	15.3	13.4	23.9	19.2	0.0	71.1	10.0	25.0	1.5	9.8	66.7	0.0	29.4	45.9	18.4	22.1	13.9	52.5	36.0	11.1	41.5	14.1	18.0	1.2	17.0	13.7	6.8	16.2	22.8	12.3	18.9	24.6	6.0	34.4	3.9	19.4	9.4	14.6	30.6	19.4	55.5	13.8	32.4	25.1
LPCAT4	"AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2"	ENSG00000176454	"Lysophosphatidylcholine acyltransferase 4"	Q643R3	15	34358618-34367278	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 63.9;Paneth cells: 83.4;Undifferentiated cells: 62.1;Urothelial cells: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 41.5;OE19: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057321	Supported					NA	NA					"HPA057321: "	"unprognostic (2.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.15e-2)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.44e-3)"	9.7	5.3	20.1	9.6	35.1	5.0	11.0	38.6	32.2	11.9	30.5	4.3	3.5	25.3	8.0	8.6	17.7	16.4	19.0	17.1	14.2	21.0	4.9	1.8	7.8	7.2	13.2	18.2	9.6	6.8	6.4	6.1	4.6	28.9	5.7	30.0	2.9	6.4	8.3	6.1	15.2	23.8	14.4	7.1	8.5	33.1	2.6	13.1	4.5	4.4	4.5	9.3	15.4	14.2	2.6	6.2	4.7	1.8	2.1	9.4	1.0	5.1	12.2	6.1	4.8	16.6	16.9	2.9	7.2	12.2	6.9	9.4	4.4	13.8	4.6	15.0	10.0	16.2	41.5	5.3	13.6	3.0	9.4	3.0	4.6	5.1	4.2	3.4	4.9	4.8	12.5	6.2	6.5	8.5	16.0	11.2	8.5	3.0	9.0	12.8	4.9	4.3	9.7	6.1	42.9	9.7	5.4	6.9	9.3	15.0	12.3	4.8	3.7	4.3	5.8	2.7	7.4	4.5	6.7	13.8	12.8	7.8	20.1	6.8	11.1	8.7	1.6	9.5	13.8	2.9	0.1	1.1	4.5	3.9	1.4	9.4	2.3	4.6	6.0	1.8	2.6	2.8	2.5	4.7	2.1	1.8	6.2	7.3	1.0	20.1	35.1	38.6	32.2	14.2	21.0	13.2	18.2	28.9	13.1	23.8	5.1	11.9	7.6	4.2	10.4	10.4	30.6	13.4	7.9	8.7	3.9	3.4	1.7	9.9	0.0	22.7	63.9	0.0	8.6	14.1	6.6	8.4	11.5	0.8	6.9	9.5	24.3	13.5	6.5	0.6	14.4	6.1	8.5	4.6	52.9	0.8	28.2	83.4	6.3	3.3	6.1	12.9	8.5	0.7	4.9	5.4	2.1	15.2	62.1	107.8
LPGAT1	"FAM34A, FAM34A1, KIAA0205, NET8"	ENSG00000123684	"Lysophosphatidylglycerol acyltransferase 1"	Q92604	1	211743457-211830772	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 288.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.70e-2)"	15.9	17.4	11.8	10.7	20.3	14.9	16.5	12.3	22.7	10.5	13.3	25.9	9.9	19.5	7.9	9.4	6.7	7.5	10.4	9.7	15.1	13.6	8.6	75.6	9.6	13.8	19.0	11.9	6.1	13.1	15.1	9.0	7.7	15.5	9.5	9.0	21.8	9.0	15.6	8.3	5.2	39.8	10.3	16.0	13.3	6.4	17.5	18.9	5.1	22.1	3.9	8.0	9.2	6.9	1.6	2.7	13.4	2.3	4.5	1.2	0.7	14.7	16.3	5.4	12.8	9.7	13.7	7.7	10.6	16.9	9.9	9.2	4.8	12.4	6.0	6.2	16.4	11.1	8.1	18.0	9.5	12.6	11.8	6.1	6.3	13.7	11.0	11.7	15.6	10.9	8.0	11.7	9.1	12.0	18.3	11.9	8.8	7.2	0.1	13.1	4.6	5.9	5.8	5.9	6.4	2.7	14.3	21.3	1.8	11.0	12.3	31.2	16.2	17.4	18.5	18.1	8.7	9.4	10.2	11.4	18.1	8.0	16.6	17.2	8.9	10.9	16.3	9.0	13.3	12.4	9.5	2.3	13.4	1.2	1.9	1.0	1.6	0.8	0.9	2.7	1.0	0.2	0.7	10.4	4.5	1.3	2.1	0.2	0.7	11.8	20.3	12.3	22.7	15.1	13.6	19.0	11.9	15.5	18.9	26.8	18.9	11.0	47.5	10.9	140.9	25.4	73.9	37.5	18.2	12.2	58.9	1.6	1.7	53.5	288.3	27.4	28.8	0.0	50.8	3.5	14.7	35.8	12.7	49.1	18.6	33.4	13.2	21.5	35.6	39.3	43.7	26.7	28.7	19.8	12.2	31.9	50.2	16.9	52.3	18.6	121.2	19.4	20.6	61.8	32.6	6.6	0.9	16.6	19.1	57.7
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000828-96043520	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 215.6;Kupffer cells: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		85000000	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	27.9	33.2	11.2	21.5	16.7	55.7	19.0	24.1	15.6	27.2	29.1	13.1	16.7	27.6	27.6	14.1	53.4	22.7	14.5	19.2	10.6	12.2	27.2	19.4	68.0	33.4	12.3	11.3	49.9	28.2	21.2	31.8	11.3	13.3	29.6	17.8	20.7	21.1	16.1	20.6	23.6	41.2	21.5	13.3	44.3	22.1	13.7	11.5	29.2	38.8	22.3	43.1	30.1	25.2	20.6	35.3	6.1	84.2	14.2	9.0	54.6	21.0	22.6	31.8	18.9	27.6	30.9	13.9	8.8	26.1	17.4	20.3	16.5	18.2	47.1	11.1	13.1	13.7	27.7	26.0	35.9	23.8	16.1	25.2	17.3	14.5	20.0	16.3	9.1	10.5	29.4	30.3	24.0	29.5	79.5	34.5	27.6	10.5	8.3	25.1	14.4	23.9	28.0	37.0	25.1	30.7	22.4	23.7	27.1	32.0	26.8	16.5	19.5	17.8	20.8	19.1	25.5	25.9	11.2	12.3	7.4	12.5	10.5	9.5	11.2	19.4	21.8	5.2	16.5	5.8	0.4	76.0	2.2	4.5	84.2	8.4	15.1	6.3	5.8	35.3	20.6	9.0	6.7	6.1	14.2	73.2	8.7	6.3	54.6	11.2	16.7	24.1	15.6	10.6	12.2	12.3	11.3	13.3	11.5	35.7	107.1	87.8	57.2	46.0	19.4	23.4	17.8	48.2	91.0	36.6	31.4	27.0	63.0	34.2	44.9	33.1	22.4	0.0	24.3	24.3	27.5	27.6	7.0	18.1	215.6	11.1	20.7	47.3	278.8	8.1	33.9	139.0	20.3	38.7	40.9	32.1	23.4	24.6	38.5	53.1	58.0	6.5	18.5	45.1	12.5	65.5	17.4	34.8	53.6	42.1
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism"	"Lyase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell type enriched"	"Detected in many"	6	"granulocytes: 332.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 52.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.3	0.0	0.2	0.2	0.3	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9	0.0	5.6	2.2	7.5	8.9	0.2	0.0	12.7	4.0	3.4	14.0	0.0	6.9	1.7	4.1	0.3	11.3	0.4	0.0	2.1	1.5	4.7	3.1	332.3	0.8	33.8	0.0	2.9	53.4	8.9	0.0	15.3	23.5	1.7	1.0	1.6	0.0	2.1	0.0	44.6	40.2	0.3	0.0	0.9	0.0	0.7	6.0	2.5	5.0	2.6	5.0
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20102145-20212399	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 9.7;Melanocytes: 8.5;Paneth cells: 8.6;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 30.3;HEL: 24.9;T-47d: 22.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	9.9	3.3	1.4	16.5	2.1	6.2	16.5	1.5	1.8	22.5	17.3	6.4	7.1	9.7	18.8	9.9	9.6	18.1	18.8	8.4	1.7	1.7	4.4	4.0	14.0	7.6	6.5	0.7	10.5	4.4	4.7	2.7	3.2	6.2	9.3	15.4	7.2	6.5	9.4	2.2	4.3	21.1	17.2	10.0	4.6	10.6	2.6	3.2	3.9	6.6	6.5	11.1	10.4	12.8	0.3	2.8	6.4	6.8	0.5	4.1	0.9	3.3	3.5	6.6	4.5	0.7	2.2	0.3	5.3	1.5	3.7	4.1	1.9	12.9	0.0	11.1	5.1	2.7	30.3	6.4	2.7	5.2	8.3	3.1	24.9	5.7	0.0	4.1	7.9	8.7	0.9	2.4	1.6	6.7	1.8	2.0	5.2	4.0	4.7	0.8	3.0	4.4	4.7	1.4	2.8	1.8	1.6	7.6	17.5	3.7	6.6	0.2	4.1	1.1	5.3	5.7	12.2	22.9	2.7	1.9	4.4	3.0	2.5	2.2	6.9	15.4	0.0	0.3	5.5	5.3	6.4	4.4	6.0	0.7	4.7	4.1	0.2	1.2	1.7	2.6	0.3	0.3	0.3	5.7	0.5	6.8	2.8	1.3	0.9	1.4	2.1	1.5	1.8	1.7	1.7	6.5	0.7	6.2	3.2	3.0	0.3	0.0	0.6	9.7	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.1	1.7	1.9	0.0	0.2	3.6	0.0	1.0	0.1	0.8	0.6	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.3	2.1	8.5	0.0	0.9	2.0	1.3	8.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	13.6	0.2	0.0	2.0	1.3
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 133.5;Muller glia cells: 95.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.4	2.6	7.9	3.4	3.6	8.0	4.6	4.1	1.5	5.3	3.5	0.7	13.5	2.4	4.9	9.7	4.2	6.5	7.0	8.2	8.0	7.5	12.1	10.1	3.7	0.0	4.4	0.0	3.2	5.8	4.9	5.0	3.5	11.7	2.8	3.5	8.6	1.9	4.6	2.2	3.0	0.2	3.1	3.8	10.0	4.5	12.5	0.1	7.8	1.2	4.7	14.5	4.2	25.5	4.0	4.1	4.8	2.9	1.5	9.4	5.0	7.2	11.6	0.7	0.2	2.7	14.7	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8	17.9	10.1	4.5	2.9	3.0	18.3	10.6	5.1	16.0	19.4	38.4	7.9	2.5	5.0	4.5	7.3	8.8	10.3	46.7	1.4	1.3	9.8	21.0	8.1	0.0	1.7	133.5	36.0	4.3	2.1	7.8	4.9	4.3	13.5	44.1	49.8	95.3	52.2	20.4	7.1	8.4	7.2	6.5	12.0	10.7	23.7	4.4	1.6	2.1	11.9	29.8
MBOAT4	"FKSG89, GOAT, OACT4"	ENSG00000177669	"Membrane bound O-acyltransferase domain containing 4"	Q96T53	8	30131824-30144686	"Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 23.9;stomach 1: 7.7"	"Cell type enhanced"	"Detected in some"	22	"Cholangiocytes: 5.1;Ductal cells: 1.6;Early spermatids: 1.0;Intestinal endocrine cells: 3.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;Hep G2: 6.9;OE19: 7.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044509			Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044509: AB_2678966"	"unprognostic (4.35e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-6)"	"unprognostic (9.87e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.66e-2)"	0.4	1.8	0.3	0.5	0.6	1.0	0.3	0.3	0.3	0.3	0.5	0.3	0.3	0.8	0.9	0.3	0.3	3.9	2.1	0.4	0.3	0.1	0.4	1.5	0.9	0.8	0.3	0.3	0.5	23.9	0.0	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	1.3	0.3	0.3	1.4	7.7	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.8	0.7	2.6	1.5	2.8	4.1	0.6	0.4	1.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	1.9	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.3	0.3	0.1	6.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.6	0.0	0.1	0.5	0.3	0.0	7.7	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.2	1.3	0.0	0.2	0.1	0.0	0.0	1.1	0.8	0.4	0.6	0.6	2.1	0.5	1.5	2.4	0.0	1.6	2.0	0.7	1.8	2.4	4.1	2.6	2.8	0.2	0.4	0.5	0.6	0.3	0.6	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBOAT7	"BB1, hMBOA-7, LENG4, LPIAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	10.7	63.1	16.8	14.8	24.2	15.9	7.9	11.3	37.8	10.3	17.7	9.2	15.6	30.3	10.5	8.0	10.5	11.5	14.3	6.9	18.5	23.4	10.5	11.6	11.5	14.7	10.0	18.8	15.1	24.4	23.8	12.4	11.9	21.6	11.4	6.1	8.1	10.8	28.8	7.9	10.0	28.5	6.5	9.2	14.4	16.4	30.8	6.8	7.6	12.7	5.0	6.3	22.6	17.5	0.3	2.9	30.6	2.1	0.9	0.5	0.8	14.2	8.5	1.3	14.0	4.6	3.6	12.3	25.0	8.9	5.8	11.5	4.8	16.2	3.7	11.2	5.4	2.5	29.2	0.0	5.1	1.1	5.1	16.6	3.9	9.2	3.1	4.5	9.0	57.3	6.7	3.4	2.8	2.0	4.6	10.4	2.7	14.7	11.8	2.0	8.6	2.6	3.2	5.9	2.5	18.2	8.4	2.4	7.5	5.8	17.3	0.5	3.7	16.7	10.2	5.1	0.1	10.3	0.8	20.7	12.3	4.4	3.6	9.9	5.4	9.3	1.5	17.7	6.4	8.1	15.7	2.1	30.6	0.2	1.5	0.5	0.2	0.2	0.2	2.9	0.3	0.1	0.2	30.0	0.9	0.8	0.8	0.2	0.8	16.8	24.2	11.3	37.8	18.5	23.4	10.0	18.8	21.6	6.8	11.9	26.6	12.2	44.1	12.4	15.8	6.5	30.6	13.4	14.8	41.8	5.9	38.6	5.0	45.1	1.1	16.6	88.9	0.0	28.7	43.8	12.7	39.8	76.1	13.9	28.4	28.6	40.8	14.7	36.9	1.9	17.8	32.1	8.5	19.8	45.8	22.4	34.4	40.3	14.5	12.2	6.8	38.8	23.4	3.9	14.5	18.9	43.1	11.4	38.5	48.0
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765547	"Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.7;testis: 27.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 121.8;Early spermatids: 123.3;Spermatocytes: 50.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.2;SCLC-21H: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved					NA	NA					"HPA073761: AB_2732241"	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.9	2.3	3.1	0.7	9.0	0.6	1.9	1.5	5.7	2.0	1.1	5.0	3.6	0.5	2.5	6.6	1.1	26.7	1.5	1.9	3.4	4.2	4.2	0.6	3.6	0.8	2.4	3.5	4.5	1.1	6.3	15.1	0.5	9.5	1.3	1.1	2.8	1.7	2.2	0.9	1.0	0.6	1.5	1.6	0.6	1.1	27.6	1.8	0.1	5.2	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	2.4	1.8	4.9	0.4	2.3	0.7	0.0	0.9	1.0	0.7	0.2	1.6	1.1	1.1	0.2	2.2	1.1	0.1	1.4	1.0	0.1	0.1	0.5	0.4	1.5	1.1	0.8	2.5	1.4	0.5	0.1	0.3	1.1	1.4	2.3	0.1	1.4	0.7	2.9	1.5	0.6	3.2	0.3	2.9	3.1	1.8	0.1	7.2	0.3	6.9	1.5	2.2	1.1	0.6	1.1	2.2	0.0	0.1	1.2	1.2	0.3	0.6	0.7	2.9	0.4	2.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	3.1	9.0	1.5	5.7	3.4	4.2	2.4	3.5	9.5	1.8	6.0	1.0	0.0	1.2	0.7	3.0	1.2	2.5	121.8	6.8	0.0	0.0	0.1	11.6	0.7	123.3	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	3.2	1.2	0.0	0.0	17.1	1.7	0.2	1.7	0.0	0.0	7.7	0.1	0.0	2.8	5.1	9.9	0.0	1.0	50.4	4.0	0.3	0.0	0.0	0.0	0.4
MEIKIN		ENSG00000239642	"Meiotic kinetochore factor"	A0A087WXM9	5	131806993-131945698	"Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 16.3"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 16.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.7;non-classical monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SuSa: 2.3;U-2 OS: 5.9"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.21e-1)"				"unprognostic (2.30e-1)"			"unprognostic (2.64e-2)"		"unprognostic (5.27e-2)"	"unprognostic (4.31e-1)"		"unprognostic (4.64e-6)"	"unprognostic (2.38e-1)"		"unprognostic (3.81e-1)"		0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.5	0.0	3.2	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	2.7	0.4	0.5	0.1	0.1	1.5	0.5	1.0	0.0	0.0	0.0	3.2	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	4.1	0.0	0.0	0.0	0.0	0.0
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 382.8"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 3471.1;Proximal tubular cells: 978.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 46.1;myeloid DC: 34.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 34.1;monocytes: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 342.0;ASC TERT1: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	127.9	106.0	18.5	10.8	32.6	9.5	116.8	10.3	14.0	9.3	39.7	9.6	2.6	17.0	4.1	6.4	19.5	6.9	26.6	12.1	19.6	13.9	56.9	382.8	42.0	2.7	18.9	8.9	3.1	12.4	0.8	5.3	8.7	18.4	23.5	28.3	3.0	14.7	8.2	8.9	7.0	15.5	11.5	20.1	0.9	10.3	6.8	12.0	0.0	69.9	13.9	3.6	32.6	37.2	0.2	34.1	2.7	46.1	0.0	0.2	13.0	0.0	30.6	7.3	8.5	342.0	132.0	0.0	25.1	25.7	13.7	21.3	11.6	51.3	0.0	3.0	32.1	43.1	0.1	19.0	40.2	12.4	0.0	2.5	10.4	17.0	40.7	79.9	20.2	0.0	85.6	44.8	41.8	44.1	34.0	24.0	0.0	7.3	0.0	29.4	6.2	0.0	8.1	60.9	0.0	24.3	0.0	4.3	13.8	30.8	60.5	1.3	1.1	39.2	25.2	1.0	41.3	27.1	11.4	15.1	14.1	1.9	27.7	32.3	0.0	0.0	0.0	46.4	32.3	0.4	2.7	46.1	0.4	0.0	7.0	0.1	0.2	0.0	0.0	34.1	0.0	0.0	0.0	1.5	0.0	1.5	9.6	0.2	13.0	18.5	32.6	10.3	14.0	19.6	13.9	18.9	8.9	18.4	12.0	247.1	493.0	46.4	120.5	22.8	0.0	5.3	738.8	293.1	502.7	68.0	0.0	2.3	154.2	22.7	20.8	14.2	262.1	46.7	371.4	189.8	162.1	379.2	32.4	3471.1	168.6	0.0	43.8	78.5	223.7	10.9	30.8	51.0	37.1	187.6	224.9	0.0	374.3	135.3	106.4	978.0	1.0	0.0	12.2	0.5	2.2	15.4	6.6	37.4	362.2	564.6
MGST2	MGST-II	ENSG00000085871	"Microsomal glutathione S-transferase 2"	Q99735	4	139665768-139740745	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.9;monocytes: 25.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;OE19: 91.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA010707	Approved					NA	NA					"HPA010707: AB_1853922"	"unprognostic (9.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.33e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.41e-2)"	"prognostic favorable (3.22e-9)"	"unprognostic (4.10e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.01e-2)"	26.9	30.2	6.9	9.7	10.8	7.4	29.0	12.6	9.3	16.4	27.3	7.3	31.3	27.3	12.2	19.4	54.9	14.7	42.0	26.9	7.4	9.0	25.3	79.1	20.6	21.6	10.1	5.9	10.6	27.8	16.4	18.2	19.2	10.2	23.3	25.4	14.7	30.4	36.7	20.4	24.2	60.3	13.3	10.7	19.6	15.2	29.0	8.8	8.3	23.7	40.9	26.8	19.1	22.6	0.5	46.9	8.1	25.9	5.8	8.8	8.8	6.6	9.7	5.0	0.0	0.8	2.7	3.0	1.2	11.0	0.5	1.8	10.1	47.4	0.0	27.7	2.9	2.4	12.6	8.9	13.7	0.8	3.7	8.0	29.3	10.7	40.0	2.3	25.2	22.6	9.2	33.7	0.3	2.1	11.1	27.7	0.0	12.1	4.4	4.0	5.5	0.0	4.1	1.1	91.7	9.9	2.1	5.9	8.9	25.8	14.3	12.7	3.8	9.0	14.1	10.7	0.3	9.0	33.5	17.6	0.9	4.8	1.3	1.0	5.2	3.6	1.6	0.6	42.7	2.2	8.1	25.9	7.0	1.1	15.4	0.7	0.3	1.9	0.9	35.7	0.5	0.6	0.6	4.4	5.8	4.8	46.9	8.8	8.8	6.9	10.8	12.6	9.3	7.4	9.0	10.1	5.9	10.2	8.8	23.8	29.3	18.2	223.2	54.3	8.1	90.8	229.3	57.6	47.8	90.7	23.6	70.4	76.3	102.7	5.6	212.7	268.6	23.3	122.5	52.4	30.4	143.0	43.7	322.9	310.1	6.4	117.0	164.5	94.6	9.0	41.1	102.8	37.1	19.0	165.9	13.7	108.9	204.6	31.5	203.6	2.7	12.9	48.4	3.7	15.1	109.2	56.2	27.1	227.8	357.7
MGST3	GST-III	ENSG00000143198	"Microsomal glutathione S-transferase 3"	O14880	1	165630861-165661796	"Enzymes, Predicted membrane proteins"		"Lyase, Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 1846.4;Syncytiotrophoblasts: 1983.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 88.9;HDLM-2: 94.3;OE19: 97.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053311, HPA077929"	Enhanced		Approved	Nucleoplasm		NA	NA		40000	Nucleoplasm		"HPA053311: AB_2682108, HPA077929: "	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	42.8	30.8	52.5	9.7	30.5	19.0	51.2	17.9	56.0	18.4	39.7	18.4	19.1	65.2	19.5	101.8	19.7	20.6	26.5	133.6	38.1	33.9	45.2	29.5	20.8	11.0	44.2	37.6	22.7	17.7	11.1	18.3	30.9	39.6	21.2	40.4	20.3	29.8	20.6	87.2	15.6	53.4	24.7	38.7	12.4	29.8	19.4	23.3	2.7	25.7	41.8	8.2	19.9	17.3	21.3	35.1	20.7	47.0	15.7	38.0	40.7	22.2	16.3	17.7	13.9	62.1	37.3	88.9	18.6	30.0	14.5	25.3	17.0	29.0	1.4	14.7	22.7	14.3	27.2	4.3	18.2	14.7	94.3	11.1	3.4	12.8	7.7	17.5	5.3	7.5	31.8	14.7	20.0	7.7	28.6	23.6	6.1	8.3	8.5	27.1	4.9	5.9	12.3	38.7	97.4	21.0	5.6	7.6	2.8	76.5	20.9	13.7	16.8	18.7	24.3	37.0	37.1	18.5	26.2	21.4	18.0	10.7	12.4	13.4	6.3	4.3	0.7	33.4	14.1	11.6	10.4	45.7	20.7	30.1	37.0	30.3	21.3	38.0	33.5	35.1	19.9	24.4	26.7	9.8	15.7	47.0	15.1	32.3	40.7	52.5	30.5	17.9	56.0	38.1	33.9	44.2	37.6	39.6	23.3	95.3	125.6	83.1	202.5	202.9	129.1	591.8	331.2	242.2	134.2	528.7	251.3	1846.4	848.8	339.3	13.2	253.1	716.8	630.8	371.6	1154.8	298.4	174.8	89.0	248.3	760.5	123.9	146.8	184.8	114.8	21.3	359.3	238.2	492.6	405.8	197.9	162.7	335.4	599.7	375.8	841.2	122.6	498.0	374.9	15.6	33.3	203.4	1983.2	87.4	339.8	197.4
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 114.3;Pancreatic endocrine cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 21.0;HaCaT: 33.2;RH-30: 51.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	21.0	5.7	0.1	0.1	0.0	0.0	11.5	0.1	0.8	0.4	0.0	14.9	9.0	0.0	5.3	0.0	1.7	33.2	7.5	9.0	0.4	0.0	2.3	0.0	2.5	10.5	0.0	0.0	0.1	0.0	7.9	0.2	5.5	1.7	0.7	0.1	0.1	8.3	0.9	8.1	0.0	0.0	1.5	12.3	2.3	0.0	51.4	3.5	19.0	4.3	11.4	0.2	8.0	9.5	0.0	3.0	5.6	0.0	0.5	0.0	11.6	0.1	2.2	5.6	3.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3	50.6	12.0	0.8	8.3	0.3	8.2	1.9	15.3	24.1	19.4	7.0	9.8	3.2	5.0	40.6	14.7	0.6	114.3	0.0	41.1	1.1	0.5	42.9	0.0	15.3	0.7	0.0	6.4	0.0	0.3	1.5	0.9	0.9	3.3	3.6	33.5	29.9	76.1	53.7	0.7	13.0	29.0	0.0	0.2	9.5	3.8	5.6	3.9	0.0	38.0	58.3
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: AB_2673579"	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	32.1	33.9	6.4	20.8	9.1	9.6	18.1	11.3	6.6	15.5	13.6	22.0	10.2	24.5	37.7	9.3	20.1	15.4	13.4	13.6	6.0	10.2	62.5	8.8	23.7	22.1	12.5	17.1	19.5	7.3	15.3	14.4	15.0	7.8	17.5	9.6	17.6	10.4	10.2	42.2	27.3	25.5	10.7	30.4	47.1	21.7	16.5	26.8	11.3	14.8	13.7	16.5	4.4	17.9	26.7	6.3	9.6	14.2	10.1	6.5	22.3	22.5	34.3	22.0	24.5	46.0	8.8	22.1	18.9	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8	8.9	27.5	83.3	53.7	62.3	28.9	38.0	53.5	29.4	26.1	36.6	11.8	113.1	81.2	114.3	2.1	90.5	71.7	46.7	129.7	161.7	59.9	66.0	66.9	63.8	109.5	35.0	55.8	64.4	62.9	8.3	43.1	71.4	113.1	75.7	61.8	26.2	121.2	58.3	43.9	155.0	22.4	64.7	78.5	5.8	39.4	79.2	91.0	68.3	80.9	64.7
NAA20	"dJ1002M8.1, NAT3, NAT5"	ENSG00000173418	"N(alpha)-acetyltransferase 20, NatB catalytic subunit"	P61599	20	20017116-20033655	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063344			Supported	Cytosol		NA	NA			Cytosol		"HPA063344: AB_2684991"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.18e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	15.9	20.0	14.2	10.0	21.4	17.4	23.2	15.5	34.1	17.3	12.7	12.0	22.7	9.7	20.5	17.7	58.4	15.8	12.3	24.1	14.7	14.1	24.6	25.0	15.7	19.0	13.1	18.3	12.9	43.2	24.8	20.0	18.5	19.4	14.4	12.2	11.2	22.0	20.6	35.2	15.6	11.0	17.3	13.1	11.0	14.5	43.7	10.2	9.5	23.6	37.5	22.1	14.0	23.7	18.6	28.3	20.4	27.5	17.7	25.8	26.4	40.5	24.6	8.9	13.9	18.8	19.8	13.4	30.0	20.5	27.0	25.3	12.6	29.4	22.0	16.3	20.2	21.8	32.2	15.2	48.1	22.0	9.9	16.5	16.5	6.5	18.8	27.0	17.4	12.2	22.5	31.7	27.4	27.7	15.6	23.2	15.8	26.7	22.8	23.5	31.7	24.5	18.2	6.9	28.1	40.3	13.5	35.1	29.2	26.6	9.4	16.9	11.5	18.1	51.2	25.0	6.1	31.6	28.1	25.2	22.5	13.2	27.0	27.5	24.8	30.9	23.8	13.6	15.3	16.0	8.0	27.5	20.4	17.6	27.5	25.8	18.6	20.5	20.2	28.3	16.5	19.9	22.0	3.6	17.7	23.2	22.9	20.8	26.4	14.2	21.4	15.5	34.1	14.7	14.1	13.1	18.3	19.4	10.2	62.5	35.6	41.7	83.1	96.6	54.1	70.6	71.4	99.0	55.7	99.5	23.6	98.0	195.6	180.5	209.7	76.7	31.4	0.0	145.5	94.1	66.4	74.5	49.7	69.9	213.0	65.2	39.6	52.2	51.1	27.3	64.7	64.9	67.4	121.8	44.4	78.6	191.0	35.1	70.4	177.4	48.7	38.8	66.9	234.3	53.9	103.8	71.5	45.7	56.2	118.5
NAA40	"FLJ13848, NAT11"	ENSG00000110583	"N(alpha)-acetyltransferase 40, NatD catalytic subunit"	Q86UY6	11	63938959-63957328	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 96.9;Late spermatids: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037816, HPA056142"	Uncertain		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA037816: AB_10672289, HPA056142: "	"unprognostic (3.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.29e-3)"	"unprognostic (3.42e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.25e-2)"	4.9	12.4	9.8	10.0	11.6	4.1	7.6	16.7	13.5	7.1	7.3	12.2	10.8	9.2	5.0	7.7	9.2	11.2	7.6	13.8	9.8	10.0	10.0	5.1	6.1	10.7	8.3	8.6	4.2	8.9	28.0	22.7	10.5	8.9	6.0	7.9	12.2	9.7	11.3	7.5	4.5	9.8	5.4	7.6	12.5	6.3	19.2	8.9	10.1	10.1	4.1	11.7	8.1	4.9	4.1	5.0	3.5	0.8	6.7	10.1	2.8	10.7	12.6	15.7	8.4	4.4	4.3	10.0	8.0	8.6	19.9	14.0	10.4	13.7	6.6	10.0	7.2	13.9	9.7	13.1	5.8	14.8	8.7	8.1	9.1	8.0	11.7	5.9	14.3	7.8	4.5	5.3	12.3	3.4	7.8	12.8	11.6	15.3	5.0	9.2	8.1	15.2	11.3	14.6	10.0	8.5	15.1	14.2	8.4	13.3	8.3	20.9	11.1	12.5	11.0	6.5	11.9	18.0	6.4	8.2	11.1	13.5	6.4	6.5	6.0	3.8	11.7	6.6	6.2	8.5	3.3	0.8	3.5	10.1	0.6	3.6	4.1	2.7	4.8	3.6	3.9	1.7	4.1	0.3	6.7	0.3	5.0	0.8	2.8	9.8	11.6	16.7	13.5	9.8	10.0	8.3	8.6	8.9	8.9	3.0	3.7	5.1	1.9	2.5	27.2	12.8	7.6	22.7	12.5	17.4	31.4	8.4	0.0	5.2	38.5	7.1	10.5	0.0	4.7	10.2	4.6	1.9	1.1	4.5	7.8	96.9	16.8	10.4	9.4	100.4	4.4	8.4	1.7	3.6	6.5	9.4	4.8	3.5	6.7	3.0	24.2	0.0	3.1	19.1	16.8	2.5	3.4	8.2	6.8	1.0
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N(alpha)-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716460-113746300	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved					NA	NA					"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	23.4	23.6	15.9	18.0	19.8	19.7	25.6	17.1	16.5	14.7	16.2	9.3	12.9	12.7	18.4	13.3	32.6	14.7	13.6	17.0	14.1	10.8	17.6	31.8	17.3	20.7	13.8	13.7	17.8	20.7	18.4	14.1	14.9	15.6	14.5	14.7	10.7	21.6	13.8	86.5	17.7	14.0	16.1	15.7	17.7	16.9	19.0	12.9	22.5	18.3	37.0	23.2	19.9	19.8	32.3	24.7	28.7	22.6	17.4	27.3	26.2	90.0	39.4	21.7	25.2	29.5	24.0	45.3	48.5	27.3	30.0	34.6	56.5	32.5	62.4	30.1	25.7	23.7	37.3	37.7	33.2	55.1	13.0	19.3	67.2	29.7	34.0	27.1	70.0	21.9	20.4	26.3	33.5	48.5	19.8	26.7	26.4	42.2	25.2	30.9	42.7	46.2	15.2	48.5	35.3	58.0	47.6	33.3	49.3	22.8	68.8	33.4	19.3	35.2	26.2	35.3	19.6	36.3	23.3	24.6	41.5	41.2	17.5	36.5	28.0	46.4	115.8	32.5	39.5	25.4	8.5	22.5	11.9	27.3	22.6	24.3	32.3	20.6	25.5	24.7	20.5	18.2	24.0	28.7	17.4	19.8	14.4	21.9	26.2	15.9	19.8	17.1	16.5	14.1	10.8	13.8	13.7	15.6	12.9	44.7	29.9	65.7	72.5	149.5	21.5	41.9	22.9	25.4	42.1	34.9	7.9	37.5	66.3	50.5	52.7	36.5	37.5	0.0	47.8	76.9	38.8	84.6	46.2	63.8	57.0	38.1	19.1	26.4	50.8	39.9	28.4	52.5	59.1	42.3	31.3	30.1	51.1	34.9	29.4	56.1	16.9	19.4	85.8	52.4	57.5	155.5	52.3	62.5	39.8	140.8
NAA60	"FLJ14154, NAT15"	ENSG00000122390	"N(alpha)-acetyltransferase 60, NatF catalytic subunit"	Q9H7X0	16	3443611-3486963	"Enzymes, Predicted intracellular proteins"	"Chromosome partition"	"Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040916	Approved		Uncertain	"Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"		"HPA040916: AB_10794428"	"unprognostic (8.59e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.39e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.81e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.74e-3)"	18.5	28.7	24.2	17.9	30.8	26.6	16.2	38.1	40.2	17.1	29.4	29.1	34.0	36.8	24.3	18.6	21.3	21.7	23.7	26.2	25.6	21.3	35.8	40.3	23.6	19.4	21.6	17.7	21.2	41.8	46.4	29.0	27.0	24.4	23.7	21.4	29.1	20.7	31.6	38.9	16.9	42.2	19.9	25.7	28.1	34.8	25.3	19.0	22.8	21.8	21.8	24.1	21.7	22.1	8.5	11.2	34.8	13.2	11.6	13.4	10.0	8.2	32.5	23.0	24.2	18.4	12.6	20.6	15.8	16.9	16.4	14.8	22.2	17.8	17.2	16.1	18.0	11.7	19.3	22.7	18.4	16.0	25.8	15.3	20.9	20.5	26.0	19.9	26.7	27.7	15.4	14.3	11.2	21.7	20.2	26.2	15.4	22.0	24.5	11.5	37.8	16.8	19.7	28.0	21.9	9.5	21.1	17.4	26.0	16.9	17.4	12.2	26.4	23.5	26.2	12.5	23.0	23.4	18.9	19.3	21.1	18.1	6.8	14.6	20.5	19.0	16.7	6.7	16.6	16.1	19.8	10.5	34.8	11.8	12.3	12.5	8.0	10.8	11.5	11.2	8.5	9.3	10.8	13.2	11.6	13.2	7.8	13.4	10.0	24.2	30.8	38.1	40.2	25.6	21.3	21.6	17.7	24.4	19.0	8.9	16.5	13.7	11.2	0.1	21.2	12.6	35.7	6.7	10.3	12.2	5.9	22.8	36.5	27.5	41.1	18.6	61.4	0.0	36.4	33.1	15.4	16.7	30.0	42.3	27.8	11.1	25.9	27.6	28.5	44.0	10.6	14.5	0.0	26.2	34.4	20.8	29.9	45.6	14.9	32.7	14.2	25.8	11.2	14.9	20.2	0.3	27.6	21.0	31.9	22.0
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.4	17.6	9.4	20.0	11.4	10.1	10.9	12.4	9.1	15.8	12.6	19.7	7.2	40.0	9.2	10.4	13.6	18.9	35.4	18.9	20.2	11.1	22.7	18.1	14.4	18.4	10.3	45.3	13.2	10.3	13.0	10.3	29.0	7.4	12.0	19.3	39.5	14.0	13.1	23.6	36.9	20.6	13.5	21.6	21.2	27.8	31.9	16.7	9.1	21.8	14.0	10.6	16.7	17.7	7.4	9.5	17.7	12.5	9.6	14.1	11.2	20.6	22.9	15.3	18.3	38.1	14.2	18.8	13.9	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9	6.0	16.5	12.0	9.6	10.9	11.2	9.8	10.2	14.7	22.7	14.0	11.8	15.4	5.0	6.8	3.8	7.8	3.5	23.3	8.3	9.9	7.4	6.4	4.7	7.2	10.5	11.1	6.9	6.7	4.0	2.1	8.6	6.0	1.7	11.8	8.5	7.7	6.9	2.9	12.4	5.0	10.1	12.9	8.1	17.9	25.4	12.0	12.0	10.2	12.4	6.3
NAT14	KLP1	ENSG00000090971	"N-acetyltransferase 14 (putative)"	Q8WUY8	19	55485004-55487568	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 42.2"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 60.2;Horizontal cells: 139.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047187			Approved	Mitochondria		NA	NA			Mitochondria		"HPA047187: AB_2679974"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (7.00e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.58e-1)"	3.6	10.1	15.8	5.7	19.6	4.5	5.5	25.8	25.8	8.2	7.0	8.9	3.1	3.5	12.6	10.1	2.9	24.1	6.5	5.9	15.4	16.7	9.2	2.5	7.8	4.6	10.8	15.5	14.1	5.6	11.2	19.2	8.5	10.6	6.8	3.1	7.8	5.0	10.5	2.9	4.1	3.4	11.1	6.5	3.7	5.6	4.9	9.5	42.2	9.8	1.3	3.8	6.0	4.3	1.8	1.8	2.3	0.3	0.3	1.0	0.6	2.4	8.9	9.8	18.1	4.1	5.1	6.2	9.2	10.7	10.1	14.4	3.1	7.9	1.0	3.2	5.9	5.0	3.3	6.4	5.6	6.2	9.9	55.3	8.0	11.9	6.7	7.4	5.9	8.1	7.3	2.1	7.4	1.9	19.9	7.3	14.5	9.9	2.8	5.8	3.0	9.9	9.0	14.0	4.7	4.9	9.8	6.3	3.6	23.0	4.6	30.3	20.6	3.7	5.4	8.1	3.8	4.4	5.7	8.8	3.7	10.2	0.5	7.3	5.7	2.3	4.2	8.2	1.0	9.2	0.0	0.3	0.2	0.5	0.3	1.0	0.6	0.4	0.3	0.0	1.8	0.7	0.7	2.3	0.3	0.3	1.8	0.0	0.6	15.8	19.6	25.8	25.8	15.4	16.7	10.8	15.5	10.6	9.5	6.0	2.7	7.3	6.1	2.6	60.2	4.5	2.5	14.7	2.3	27.9	33.4	10.6	13.3	14.0	1.4	4.3	0.7	0.0	1.0	6.9	8.2	4.4	0.0	2.9	2.6	139.8	12.2	4.9	0.8	1.7	10.9	0.7	5.0	3.6	1.8	34.9	4.7	0.0	9.9	3.5	34.0	0.0	9.2	4.1	2.9	0.5	5.0	1.3	0.9	1.4
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell type enriched"	"Detected in some"	45	"Horizontal cells: 276.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4"									HPA021918	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.0	0.6	0.2	0.1	4.6	0.1	0.5	0.1	6.9	0.0	0.3	5.2	0.5	0.3	0.0	0.0	0.4	6.1	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2	0.0	0.0	0.0	0.0	0.0	1.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NAT6	FUS2	ENSG00000243477	"N-acetyltransferase 6"	Q93015	3	50296402-50299421	"Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.3"	"Group enriched"	"Detected in many"	21	"Early spermatids: 179.7;Late spermatids: 391.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 29.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.0"	"Cell line enhanced"	"Detected in all"		"HMC-1: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039576	Approved					NA	NA					"HPA039576: AB_10794750"	"prognostic favorable (3.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.55e-1)"	7.9	6.9	9.3	7.7	17.5	30.6	8.6	15.4	24.8	9.6	7.0	8.8	12.9	6.8	10.7	11.1	9.7	10.6	11.6	10.9	11.5	9.9	8.9	8.8	9.8	10.1	8.8	12.1	13.4	8.8	14.5	8.8	6.3	22.3	10.6	8.7	8.5	13.2	12.6	12.0	15.5	7.9	7.6	8.9	9.9	10.0	59.3	6.7	7.2	8.8	11.1	10.4	8.0	9.3	6.1	2.8	29.0	2.3	5.3	6.1	2.8	4.0	3.1	4.8	5.0	5.8	6.8	3.1	3.9	7.8	6.2	5.3	2.7	7.8	12.6	2.9	6.7	5.0	5.2	2.9	12.7	2.6	8.0	5.0	25.2	18.0	6.3	5.2	4.2	32.3	8.1	9.0	10.3	7.2	9.4	7.4	7.0	2.3	12.0	5.5	4.3	4.9	19.3	2.6	1.8	10.6	3.2	1.7	15.1	10.5	2.1	3.4	4.8	4.4	9.2	1.8	3.2	4.0	12.3	6.0	5.0	5.0	6.0	3.7	8.2	4.3	3.1	8.6	7.9	4.6	6.7	1.6	29.0	4.2	2.3	6.1	6.1	5.7	5.0	2.8	4.3	4.6	3.7	0.5	5.3	1.4	1.4	5.1	2.8	9.3	17.5	15.4	24.8	11.5	9.9	8.8	12.1	22.3	6.7	6.0	5.1	2.2	7.5	3.0	5.0	0.0	0.0	5.3	3.4	0.0	3.9	4.7	0.0	0.0	179.7	7.1	3.0	0.0	0.0	4.3	4.1	5.5	12.7	4.7	4.1	0.0	8.7	8.6	4.0	391.0	7.8	2.6	5.0	0.0	2.4	3.7	0.0	3.5	8.5	0.0	2.7	12.9	5.7	13.6	10.2	3.4	4.2	7.2	3.3	8.1
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640832-73642393	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 140.4"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 1951.9"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 16.9"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	1.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.0	0.0	159.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	22.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	1951.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAT9	DKFZP564C103	ENSG00000109065	"N-acetyltransferase 9 (putative)"	Q9BTE0	17	74770547-74776367	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021820, HPA057149"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021820: AB_1847958, HPA057149: AB_2683350"	"unprognostic (7.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.26e-6)"	"prognostic favorable (7.80e-4)"	"unprognostic (8.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.03e-3)"	9.4	31.6	20.1	11.3	17.8	11.8	13.5	20.0	20.6	13.6	11.2	9.9	21.7	8.0	11.6	24.5	9.1	16.8	12.9	11.3	18.4	12.1	12.9	16.6	10.5	12.0	18.1	17.8	21.5	14.5	18.5	25.1	13.8	23.1	15.8	9.9	11.6	18.1	13.2	9.5	10.9	8.5	11.2	17.0	12.1	11.2	12.2	20.7	7.9	14.9	7.0	10.8	11.3	10.3	19.6	13.7	9.7	16.7	10.9	21.5	8.4	9.5	13.9	8.9	8.1	14.6	18.3	10.7	18.1	16.2	19.4	16.8	24.0	10.6	26.1	7.0	14.5	12.5	10.5	12.0	20.1	12.5	5.4	18.0	16.7	10.3	21.3	17.0	8.6	10.8	16.7	15.0	19.3	29.5	16.2	21.1	16.9	20.8	8.3	14.1	9.1	17.2	7.0	6.9	18.6	20.4	11.5	26.2	15.1	14.0	15.6	12.8	17.1	7.6	22.5	35.1	12.8	20.9	11.6	12.1	22.4	18.2	9.7	17.1	11.5	4.1	14.6	9.3	5.9	14.2	9.7	11.5	4.6	6.9	16.7	13.7	14.0	12.3	10.1	13.7	19.6	21.5	15.5	2.9	10.9	9.4	10.3	6.5	8.4	20.1	17.8	20.0	20.6	18.4	12.1	18.1	17.8	23.1	20.7	6.0	12.6	22.2	30.8	31.1	35.9	5.0	5.1	5.3	6.8	17.4	45.2	18.9	6.6	13.9	4.5	17.4	10.0	0.0	17.0	16.5	18.5	26.9	1.1	8.5	15.7	42.9	25.3	7.4	8.3	2.9	27.3	15.2	10.1	19.0	12.9	12.4	16.5	16.9	15.9	9.8	39.2	6.5	18.6	17.9	24.3	26.0	18.5	12.9	16.4	31.4
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261062	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 96.5;Syncytiotrophoblasts: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	23.8	9.1	9.6	6.6	9.4	5.6	19.7	16.4	16.1	5.4	6.2	10.0	4.7	5.0	7.7	11.2	5.7	7.2	8.5	31.3	7.9	8.6	24.1	11.8	15.9	23.1	7.5	9.2	7.4	6.4	11.3	9.2	24.4	7.7	6.2	5.7	8.5	7.6	5.8	39.9	10.0	5.3	8.2	6.8	16.2	6.2	9.3	6.2	11.3	10.4	6.8	4.9	9.1	5.0	3.7	8.8	9.4	18.2	1.3	4.5	7.7	4.6	5.0	4.0	12.6	19.0	13.9	9.2	11.6	15.5	17.6	14.8	11.6	8.7	8.5	14.6	16.5	13.7	7.3	4.2	5.0	8.1	2.4	6.4	2.4	4.9	9.2	10.2	2.3	12.6	9.5	5.7	17.6	2.8	22.4	10.7	4.2	3.5	4.5	11.3	10.1	3.2	7.0	2.5	4.4	5.7	4.7	5.7	26.3	8.8	4.3	1.3	2.6	15.5	4.7	9.5	3.5	12.1	11.4	8.7	15.4	7.5	19.8	7.2	17.0	14.4	10.3	14.0	6.6	5.9	9.4	14.4	9.3	3.1	16.8	3.2	3.3	3.4	4.5	8.8	3.7	4.5	3.7	0.6	1.3	18.2	7.8	3.2	7.7	9.6	9.4	16.4	16.1	7.9	8.6	7.5	9.2	7.7	6.2	6.0	3.5	0.0	2.1	4.2	12.2	19.7	2.5	1.4	4.5	8.7	7.9	17.6	5.0	8.5	1.7	6.3	4.0	0.0	6.2	7.0	6.9	2.5	15.0	10.9	96.5	36.5	0.0	11.1	32.7	4.5	2.0	16.4	11.8	6.4	6.1	4.3	5.7	4.5	1.4	18.1	5.5	0.0	4.1	3.9	2.2	3.0	42.4	4.3	3.3	1.7
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.3;LHCN-M2: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA049215: , HPA058413: AB_2683711"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	4.6	31.4	9.1	4.4	14.1	3.6	4.4	20.0	15.4	12.6	4.6	7.2	12.2	3.4	10.1	3.2	13.9	7.0	6.2	13.4	10.9	9.2	3.3	1.7	5.0	6.6	7.1	8.8	4.9	4.6	6.9	4.1	4.0	8.4	5.0	2.5	7.6	5.8	16.4	5.9	6.8	2.9	6.3	5.5	4.8	5.4	5.4	5.9	2.6	8.5	4.7	5.9	6.5	5.4	4.1	7.2	13.7	5.8	7.8	12.0	4.7	4.4	5.3	1.3	9.3	5.7	3.4	0.5	1.3	2.7	2.0	1.4	0.6	6.8	0.3	5.6	2.8	2.3	6.0	1.9	61.3	0.6	2.8	0.6	0.7	3.2	1.3	8.5	0.7	8.0	4.4	7.2	5.9	12.8	4.8	1.8	2.2	0.3	4.2	21.3	1.2	0.7	0.9	1.7	1.3	3.6	1.3	1.6	6.9	3.4	1.7	1.5	2.3	10.7	2.0	2.0	0.9	2.3	0.3	1.1	5.3	2.8	12.8	2.3	3.7	2.0	0.5	15.3	1.6	3.0	13.7	5.8	7.1	12.0	5.2	9.4	3.7	8.0	10.0	7.2	4.1	5.4	8.1	1.2	7.8	4.2	3.9	5.2	4.7	9.1	14.1	20.0	14.4	10.9	9.2	7.1	8.8	8.4	5.9	6.0	3.2	3.0	4.4	3.5	12.7	2.7	2.5	4.0	4.5	15.7	17.7	0.0	1.7	5.2	0.2	3.5	0.0	0.0	8.6	1.1	4.1	2.3	5.7	1.0	3.1	7.9	5.8	4.9	2.8	0.0	5.2	2.9	3.3	2.8	2.0	9.3	22.6	1.5	3.9	0.7	15.7	6.5	4.7	1.0	3.4	3.3	6.9	6.5	1.2	5.6
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	18.7	0.0	8.9	30.0	10.4	31.9	1.4	12.3	0.2	0.3	0.9	13.7	0.0	0.5	3.4	57.8	41.7	0.1	1.4	0.1	0.0	0.1	0.0	13.3	0.0	0.7	0.0	0.0	6.1	9.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	8.9	1.6	0.0	0.0	0.0	1.0	19.9	0.1	0.7	16.7	30.6	0.1	1.3	16.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.0	15.7	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6	0.0	0.0	0.0	8.2	15.9	0.0	0.0	0.0	0.0	4.5	3.5	0.0	118.4	1.7	10.6	0.4	0.3	0.0	0.0	1.0	226.1	92.9	6.9	1.1	0.0	15.4	0.0	7.0	0.0	0.0	0.0	0.3	3.8	13.5	12.6	6.4	0.0	5.7	0.0	0.0	0.5	0.0	0.0	11.2	0.3	0.0	37.6	231.0	0.0	0.3	38.2
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599855	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 117.6;liver: 113.8"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 377.0;Hepatocytes: 710.5;Proximal tubular cells: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"OE19: 135.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		940000			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	9.9	23.7	6.7	3.4	8.1	0.4	8.0	9.7	10.0	8.0	116.3	2.2	3.0	45.2	8.0	7.8	27.4	14.3	15.2	7.7	7.0	4.2	47.3	113.8	5.2	2.6	3.3	6.6	5.9	4.3	6.2	9.0	3.2	6.4	12.3	6.7	6.8	11.4	6.4	3.3	6.7	117.6	8.7	2.5	2.2	21.2	3.3	3.4	1.1	9.0	36.4	12.5	21.9	23.6	0.3	8.9	0.2	0.9	0.0	0.2	0.5	7.7	32.9	9.6	0.1	35.3	35.7	7.5	12.6	19.2	12.0	12.6	8.9	10.6	0.0	3.6	12.0	23.8	9.5	7.7	13.3	14.9	0.0	2.3	1.9	20.4	43.3	8.1	1.1	4.0	25.4	20.1	16.5	8.4	14.2	30.4	0.0	1.3	0.0	23.3	2.3	0.0	0.2	3.9	135.6	8.1	0.0	2.7	0.2	14.1	25.3	10.8	0.5	15.5	4.7	4.6	10.1	14.5	5.2	24.5	2.3	4.9	26.9	2.2	0.0	0.0	0.0	11.5	0.0	2.9	0.0	0.9	0.0	0.0	0.1	0.2	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	8.9	0.0	0.5	6.7	8.1	9.7	10.0	7.0	4.2	3.3	6.6	6.4	3.4	17.9	24.1	7.4	46.4	34.3	15.0	31.9	377.0	41.5	26.1	134.3	23.6	41.2	127.6	59.9	2.6	22.5	52.9	0.0	153.0	26.9	30.9	61.7	1.1	710.5	45.6	0.0	25.5	47.3	25.0	2.2	30.8	19.7	33.7	37.9	29.6	37.3	177.9	43.2	37.1	445.1	42.8	12.9	54.5	8.7	4.5	26.7	17.2	5.1	43.5	89.4
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294612-73325281	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 134.3"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 193.7;Muller glia cells: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.8;BJ: 33.5;CACO-2: 29.9;HDLM-2: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA049199: AB_2680673"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	18.3	3.2	2.7	9.5	3.3	0.7	11.8	1.7	2.8	8.2	18.7	2.9	10.0	13.6	5.9	5.8	9.4	4.4	21.9	9.6	2.3	2.4	19.6	37.5	8.7	4.8	4.1	1.7	4.9	14.8	3.7	17.9	20.9	8.7	12.4	6.4	134.3	22.6	5.7	3.4	4.4	34.1	14.0	6.9	5.6	15.3	8.0	2.1	2.0	3.5	7.3	6.5	12.8	6.5	0.6	0.7	4.4	0.6	0.2	2.3	0.5	4.2	12.2	1.3	5.6	46.8	3.4	12.4	33.5	5.4	1.3	2.2	29.9	12.1	2.9	4.4	18.7	2.0	11.1	6.1	4.8	2.7	33.6	15.4	5.2	12.0	9.2	1.8	2.4	5.7	2.0	6.2	5.2	4.9	5.9	4.9	2.9	5.9	4.3	2.2	1.8	2.5	1.0	1.6	25.8	6.0	2.2	1.4	1.7	9.1	6.0	0.8	1.0	2.8	20.9	1.7	1.8	4.1	1.3	7.4	2.0	3.4	9.2	2.5	2.8	2.9	2.4	1.6	2.2	4.6	4.4	0.6	1.1	1.2	0.3	0.7	0.6	1.3	1.4	0.7	0.1	2.3	1.2	0.8	0.2	0.5	0.2	0.7	0.5	2.7	3.3	1.7	1.8	2.3	2.4	4.1	1.7	8.7	2.1	11.9	28.0	0.0	8.6	11.9	3.0	8.1	30.6	20.1	18.2	193.7	21.6	15.7	3.3	12.8	53.9	10.3	25.7	0.0	15.2	16.8	18.4	19.0	2.3	35.0	16.7	3.2	4.1	1.8	4.0	5.2	2.6	6.0	16.9	0.0	13.1	296.7	39.0	25.9	3.5	18.6	10.4	0.0	8.2	9.3	5.3	12.2	35.1	2.2	14.1	16.0
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)"	Q96NR8	14	67701886-67734452	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase	"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.3"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 371.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.7;K-562: 1.9;SK-MEL-30: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.0	1.9	0.0	0.0	0.5	0.0	1.2	0.3	0.5	4.9	0.0			0.0	0.0	5.3	9.9	0.1	10.6	0.0	0.1	0.3	7.7	1.9	0.0	0.0	1.3		0.0	1.7	0.0	0.1	0.0		0.0	0.0		0.6	0.0	0.0	29.3	0.0	0.0	0.0	0.0	6.9	0.0			0.4		0.6	0.0	9.7	0.2	0.6	0.0	0.9	0.5	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.3	1.5	0.0	2.7	0.7	0.2	0.6	0.0	0.0	0.6	0.4	0.0	0.9	0.1	0.0	0.2	0.0	1.0	0.1	0.2	0.0	0.7	0.2	1.9	0.7	0.1	0.7	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.3	1.2	0.0	0.0	1.0	2.3	0.1	0.7	0.1	0.0	0.3	1.3	0.4	0.0	1.6	0.7	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.6	0.6	0.1											0.0	0.0	0.0	0.2	4.1	37.5	0.0	20.4	0.0	0.0	1.8	137.4	0.0	0.0	0.7	0.1	0.1	0.0	0.0	1.6	0.0	0.9	0.4	0.0	4.2	0.2	19.1	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	29.8	1.0	0.2	0.0	6.5	371.5	0.0	0.1	0.0	0.0	33.8	0.0	0.0	0.0	0.3
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.4	6.8	4.0	6.0	6.6	5.5	4.2	8.7	9.4	7.5	8.3	3.5	9.0	5.1	5.0	5.0	17.6	4.2	7.1	11.4	3.0	5.4	8.8	7.5	5.6	5.1	4.7	5.2	3.8	10.7	8.8	6.1	34.0	10.0	5.7	4.0	6.4	11.6	13.1	9.4	18.0	6.9	5.2	2.2	6.8	9.5	4.4	3.0	2.1	7.2	8.6	8.9	8.5	10.2	7.4	6.0	5.4	6.7	6.1	8.5	3.5	3.1	3.6	0.6	1.9	0.4	0.4	5.8	2.9	0.3	2.1	1.5	5.4	3.6	1.8	2.4	0.7	0.4	3.2	3.8	2.3	0.2	1.6	10.1	2.0	4.7	3.7	0.9	4.8	1.4	1.3	0.9	1.9	1.4	0.7	2.8	1.6	4.0	1.0	0.7	5.2	0.8	3.1	0.8	6.9	4.7	2.5	1.0	10.0	1.3	5.5	2.2	2.7	2.8	8.0	3.6	0.6	3.9	4.7	2.9	0.3	1.1	0.2	3.9	2.0	3.6	2.2	1.5	3.4	2.0	4.1	4.1	5.4	8.5	6.7	7.7	6.1	7.0	7.7	4.5	7.4	8.4	6.8	2.6	6.1	5.9	6.0	5.7	3.5	4.0	6.6	8.7	9.4	3.0	5.4	4.7	5.2	10.0	3.0	14.9	16.2	5.1	19.9	9.5	17.3	22.2	28.1	6.7	11.4	14.0	39.3	30.2	10.0	12.3	18.5	6.5	27.1	0.0	5.7	26.9	6.0	23.1	8.1	6.0	9.9	23.8	11.5	16.5	4.1	11.2	3.4	5.0	6.8	1.8	19.8	10.0	11.4	26.2	3.2	3.4	27.0	6.5	5.1	1.4	9.6	15.3	175.4	8.7	21.9	72.9
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560680	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	13.8	16.2	10.7	8.7	14.3	5.1	14.0	14.2	15.4	11.3	14.1	11.0	9.6	12.7	16.2	14.3	16.0	12.7	11.0	29.0	12.2	10.4	23.0	22.1	12.5	14.6	11.7	9.0	11.7	21.0	23.5	13.5	14.2	13.2	20.7	12.0	10.6	13.8	13.1	27.8	9.9	16.3	22.9	10.3	15.4	15.9	11.1	8.8	17.4	18.1	13.6	10.7	18.1	17.9	9.9	7.6	7.2	2.0	3.7	7.6	1.6	18.6	5.9	5.0	4.1	15.1	16.1	16.8	11.4	11.7	10.3	10.3	4.6	9.7	18.4	6.8	6.8	13.4	10.2	7.2	13.3	12.1	10.2	19.8	7.2	6.5	13.8	12.9	8.7	9.8	12.2	13.6	10.0	15.7	14.5	9.5	7.5	12.8	6.3	16.9	6.0	7.5	15.4	13.5	14.3	16.9	11.0	13.6	7.9	20.2	12.2	7.7	13.4	6.2	13.7	16.2	10.9	6.8	5.0	9.5	14.7	9.1	11.6	13.5	17.9	14.7	13.7	10.5	6.0	11.5	1.7	1.8	7.2	4.4	2.0	7.6	7.4	5.1	6.3	2.3	9.9	7.3	6.0	0.8	3.7	1.9	7.6	5.8	1.6	10.7	14.3	14.2	15.4	12.2	10.4	11.7	9.0	13.2	8.8	14.9	10.9	21.4	26.0	21.8	22.4	43.0	22.9	2.7	6.8	15.7	5.9	40.0	26.6	32.8	16.1	17.9	14.0	0.0	30.8	42.8	33.7	31.0	12.7	26.8	21.0	14.3	12.7	17.2	15.1	9.4	61.9	14.8	21.9	22.6	27.1	25.0	23.9	32.3	42.1	30.5	18.0	32.3	30.7	71.9	28.2	16.3	38.2	17.5	29.8	23.7
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		6600000	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.1	20.9	12.5	18.7	20.4	19.2	31.4	14.8	28.8	18.6	21.0	15.0	24.6	4.2	19.1	26.1	11.5	34.9	15.9	29.0	13.0	11.4	20.5	10.5	10.0	14.0	17.4	26.7	37.1	17.5	30.0	16.6	19.1	23.1	33.4	10.4	23.8	6.2	18.8	17.5	3.6	11.4	17.6	30.6	10.4	14.0	17.6	29.6	38.6	17.5	14.4	12.2	36.7	45.8	14.8	25.3	34.8	15.2	23.8	8.7	11.8	8.5	18.0	13.9	11.2	3.8	8.7	22.7	17.4	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0	8.9	19.2	23.6	35.3	25.5	11.5	9.0	43.3	13.4	15.9	24.4	9.8	99.1	16.6	59.5	4.4	20.4	152.6	0.0	44.9	74.5	19.0	29.0	15.0	46.6	92.1	11.1	43.1	27.0	67.5	3.8	23.6	48.7	23.6	85.6	66.6	10.8	41.4	81.6	21.5	50.1	7.7	25.8	18.6	15.7	8.2	18.9	73.2	17.5	73.0	31.8
SATL1		ENSG00000184788	"Spermidine/spermine N1-acetyl transferase like 1"	Q86VE3	X	85092287-85243961	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 11.7;Ciliated cells: 17.4;Club cells: 12.5;Late spermatids: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HAP1: 3.5;HEL: 1.2;RH-30: 1.5;SH-SY5Y: 1.4;SuSa: 1.0"									HPA060369	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060369: AB_2684265"					"unprognostic (1.77e-1)"	"unprognostic (2.06e-1)"				"unprognostic (4.69e-3)"			"unprognostic (7.88e-2)"					0.3	2.7	2.9	0.4	2.6	0.4	0.4	5.4	4.6	0.4	0.4	0.2	0.0	0.3	0.4	0.3	0.3	0.4	0.3	0.5	2.2	2.0	1.1	0.4	0.3	0.3	1.1	2.7	0.4	0.3	0.3	7.2	0.4	2.2	0.5	0.4	0.0	0.4	0.3	0.7	0.6	0.3	0.3	1.4	0.4	0.3	4.8	0.4	0.0	0.4	0.2	0.3	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	3.5	0.0	0.0	0.0	0.6	1.2	0.1	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.0	0.1	0.5	1.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.6	5.4	4.6	2.2	2.0	1.1	2.7	2.2	0.4	11.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	17.4	12.5	0.0	0.0	0.0	3.3	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced					NA	NA					"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favorable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	9.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	21.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2	44.7	125.1	0.0	5.5	45.3	0.2	0.1	10.2	48.2	36.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.0	1.2	0.0	1.5	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.3	1.0	7.1	9.9	58.7	3.2	0.0	0.0	1.4	0.0	0.3	0.2	4.1	63.1	0.0	0.0	4.5	19.5
SDR42E1	HSPC105	ENSG00000184860	"Short chain dehydrogenase/reductase family 42E, member 1"	Q8WUS8	16	81988855-82011488	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 8.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;NK-cells: 3.6;T-cells: 4.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.5;hTCEpi: 10.8;MCF7: 7.1;RT4: 17.4;SCLC-21H: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014388	Uncertain					NA	NA					"HPA014388: AB_1851226"	"unprognostic (2.09e-1)"	"unprognostic (4.90e-1)"	"unprognostic (9.52e-3)"	"unprognostic (3.81e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.93e-4)"	"unprognostic (4.90e-7)"	"unprognostic (2.18e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.27e-2)"	1.3	0.3	0.2	6.5	0.5	0.3	5.8	0.2	0.2	3.5	12.2	0.0	4.1	7.9	4.6	3.9	11.5	2.1	2.6	2.2	0.2	0.4	7.4	8.3	4.1	3.6	0.2	0.1	0.6	14.3	3.8	14.9	0.3	0.2	3.1	2.2	1.4	18.8	3.4	0.7	16.7	21.3	1.5	0.3	3.8	3.6	7.3	0.1	8.2	6.1	7.3	13.7	4.3	4.7	4.0	0.4	0.8	0.0	3.6	4.6	2.0	3.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.5	0.0	1.5	0.0	0.3	7.5	0.0	5.8	0.0	0.0	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.3	10.8	1.4	5.5	0.0	0.0	0.0	1.2	0.0	0.8	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.3	17.4	7.5	0.0	0.2	3.6	0.0	0.2	0.1	0.0	0.2	0.0	4.0	0.0	0.0	3.7	5.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	1.8	0.0	2.4	4.0	1.5	2.5	0.3	2.1	4.6	3.6	0.1	3.6	0.0	0.4	3.0	2.0	0.2	0.5	0.2	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.6	1.7	3.5	5.3	0.0	2.4	2.5	4.0	2.3	1.8	0.0	0.4	3.3	8.0	0.9	0.3	3.1	0.0	6.5	0.1	0.5	3.2	0.0	3.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.7	0.0	4.9	0.0	4.9	3.5	0.0	2.1	0.0	0.0	0.3	8.2	3.4	8.0	0.2	1.0	3.3	4.1
SDR42E2		ENSG00000183921	"Short chain dehydrogenase/reductase family 42E, member 2"	A6NKP2	16	22165583-22191754	"Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.0;fallopian tube: 5.0;testis: 3.3"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 22.2;Erythroid cells: 23.3;Muller glia cells: 18.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.03e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.72e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.32e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.61e-2)"	0.1	0.1	1.0	0.2	2.1	0.1	0.0	0.0	1.1	0.5	0.0			0.6	0.1	0.1	0.0	5.0	0.2	0.0	1.7	2.4	0.2	0.0	0.4	0.3	0.0		0.3	0.5	0.1	2.2	0.2		0.2	0.1		0.2	0.0	1.5	0.6	0.2	0.0	0.3	0.5	0.1	3.3			0.1		0.0	0.1	0.0	0.8	0.3	6.0	0.8	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.3	0.4	0.5	0.3	0.4	0.1	0.8	0.3	0.4	6.0	0.3	0.1	0.3	0.3	0.2											0.0	3.7	11.9	0.2	0.7	7.7	1.6	5.1	2.7	0.0	0.0	0.0	0.7	0.0	0.6	1.6	2.1	22.2	23.3	0.4	0.2	1.1	0.9	2.3	3.2	2.1	4.8	2.4	3.7	11.0	1.1	5.5	3.1	1.7	8.2	9.0	18.4	0.2	3.5	1.4	0.2	3.6	0.0	1.0	0.6	0.1	1.5	1.1	8.6	4.7	0.3
SDR9C7	"RDHS, SDR-O"	ENSG00000170426	"Short chain dehydrogenase/reductase family 9C member 7"	Q8NEX9	12	56923154-56934405	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 31.4;tongue: 27.8"	"Cell type enhanced"	"Detected in single"	38	"Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 1.1;SK-BR-3: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.90e-5)"	"unprognostic (7.93e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"		"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.74e-3)"	0.1	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.1	9.6	0.1	0.1	0.1	0.0	0.7	0.1	8.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.1	2.0	0.1	0.5	31.4	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	0.1	27.8	9.9	0.1	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 468.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 69.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		18000	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	42.3	19.9	15.0	22.1	18.8	23.7	50.5	13.7	16.9	20.1	24.1	17.8	25.7	20.0	19.9	25.6	42.4	15.2	20.0	48.1	15.4	12.6	22.4	24.0	27.6	40.2	18.2	14.8	18.0	28.5	18.2	18.4	23.7	20.3	19.7	24.8	11.7	30.2	24.5	89.7	19.4	24.4	26.6	24.5	33.6	16.1	45.4	16.2	19.0	20.0	29.7	20.8	28.5	35.6	8.9	10.4	69.7	16.3	13.9	14.5	10.0	19.3	7.1	11.4	10.4	47.9	41.6	18.8	29.3	29.4	27.9	29.6	20.5	16.2	9.9	18.9	36.3	34.8	11.3	10.1	19.1	26.6	21.4	7.2	23.6	10.9	21.7	29.0	12.7	24.1	29.7	22.2	30.7	33.8	30.0	43.9	10.6	8.8	28.0	37.3	5.7	11.4	8.1	11.1	14.2	12.2	13.2	48.0	7.3	24.0	33.4	12.5	9.1	16.5	21.3	34.9	17.8	8.4	13.0	38.4	26.9	16.3	33.5	24.1	14.8	13.6	14.6	13.3	13.1	16.2	29.4	13.7	14.7	10.6	14.5	10.4	8.9	9.9	10.6	10.4	8.1	4.8	8.5	69.7	13.9	16.3	10.2	14.5	10.0	15.0	18.8	13.7	16.9	15.4	12.6	18.2	14.8	20.3	16.2	77.4	64.0	67.1	96.1	79.6	31.2	138.8	43.3	80.3	58.0	52.4	49.1	72.5	72.9	127.2	468.5	101.4	103.4	46.7	149.1	181.7	92.1	83.8	111.9	70.0	131.7	15.9	83.1	143.6	150.6	144.3	65.0	116.4	77.6	140.7	120.2	67.6	162.6	110.1	79.9	93.5	53.0	77.6	110.4	217.9	73.1	103.3	85.2	73.9	68.5	158.5
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236395	"Enzymes, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 168.1"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	27	"basophil: 27.3"	"Lineage enriched"	"Detected in many"	27	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 2.5"	HPA026089	Enhanced					NA	NA					"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	1.1	8.1	0.7	4.1	0.8	1.2	3.4	1.5	1.0	0.5	4.2	0.4	1.3	2.5	0.2	17.5	1.2	2.6	1.3	0.2	1.1	1.1	39.4	168.1	1.7	0.8	0.3	1.0	0.7	6.3	2.0	10.4	7.4	3.0	1.2	4.0	3.2	0.6	0.3	0.2	0.6	5.3	0.1	0.3	0.4	0.4	0.7	0.1	0.1	1.0	0.2	1.3	1.4	0.8	0.1	0.0	27.3	0.0	1.0	0.5	0.2	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.5	9.3	2.5	0.0	0.2	0.4	0.2	32.2	8.2	0.2	0.8	12.6	10.1	13.2	16.6	8.3	0.1	23.1	9.5	0.0	0.7	0.0	0.0	0.0	0.0	6.1	4.0	0.0	0.0	2.9	0.6	15.6	0.6	36.0	0.6	0.0	0.0	0.6	1.7	16.3	14.9	0.9	3.1	0.4	0.0	0.4	1.7	8.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	27.3	0.0	0.4	0.4	0.0	0.4	0.1	0.4	0.4	0.0	0.1	0.1	0.1	0.2	1.0	0.0	0.0	0.5	0.2	0.7	0.8	1.5	1.0	1.1	1.1	0.3	1.0	3.0	0.1	0.0	0.6	0.9	0.8	0.9	0.7	0.3	0.0	54.9	6.8	8.7	0.0	236.8	10.0	0.3	0.4	0.1	20.6	0.0	1.7	2.6	0.0	1.8	5.8	188.9	14.3	1.6	4.1	3.7	2.5	0.0	0.3	0.1	0.0	0.0	18.6	0.5	1.6	28.1	0.0	112.0	1.5	0.0	0.1	1.8	2.5	0.3	45.9	4.3	21.1	4.4
TECRL	"DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL"	ENSG00000205678	"Trans-2,3-enoyl-CoA reductase like"	Q5HYJ1	4	64275257-64409468	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 131.5"	"Cell type enriched"	"Detected in single"	16229	"Cardiomyocytes: 1622.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"OE19: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA																							0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	131.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.3	0.0	0.9	0.9	0.6	1.1	0.5	0.2	0.3	1.1	0.0	0.1	0.2	1.1	0.7	0.5	0.3	0.3	0.6	0.5	0.3	0.1	0.4	0.5	0.0	0.7	1.4	1.4	0.2	1.2	0.6	0.1	0.5	0.2	0.3	1.0	0.2	0.3	0.7	1.1	0.2	0.2	0.5	0.8	0.7	2.8	0.2	0.5	0.8	0.4	2.5	0.5	0.2	0.6	0.5	0.1	0.1	1.4	0.4	0.5	0.7	1.1	0.8	0.7	0.8	1.0	0.2	0.7	0.5	0.8	0.6	0.6	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1622.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099413-79212667	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease mutation, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA050992: AB_2681299"	"prognostic unfavorable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favorable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	13.2	7.4	19.2	10.5	17.9	5.3	11.9	21.5	14.6	8.9	5.9	20.5	14.8	8.9	12.6	17.1	11.6	13.4	10.0	6.1	17.0	17.7	19.2	17.8	7.1	6.5	19.7	12.5	9.4	10.5	22.3	11.5	7.6	16.1	10.9	5.3	11.4	10.6	15.4	4.9	9.6	7.2	11.9	20.9	5.4	7.6	15.8	17.9	10.3	29.4	4.9	8.9	8.7	8.6	8.5	13.8	5.4	8.8	7.8	12.3	5.4	5.0	4.5	5.0	3.2	5.3	2.4	5.3	0.7	1.5	1.7	1.5	3.5	4.3	9.5	3.8	0.7	2.4	4.4	2.5	0.6	1.3	5.0	12.8	3.1	0.8	7.2	4.0	7.8	1.5	2.9	1.8	1.1	1.0	0.4	2.2	13.4	4.2	1.9	1.2	40.0	13.4	10.6	4.3	3.1	2.6	14.2	1.9	9.6	2.4	1.7	8.1	5.2	3.1	5.8	1.7	5.0	5.7	5.4	0.5	1.3	4.5	1.0	2.9	0.0	8.9	19.4	5.1	4.0	2.2	5.4	8.8	1.9	10.5	7.2	12.3	8.5	8.5	9.2	6.8	6.4	8.4	8.9	0.8	7.8	5.0	13.8	12.3	5.4	19.2	17.9	21.5	14.2	17.0	17.7	19.7	12.5	16.1	17.9	6.0	5.8	8.5	14.2	8.1	6.9	6.9	17.8	24.1	17.0	14.0	3.9	21.1	28.2	10.9	34.6	9.0	5.1	0.0	9.1	10.9	9.9	12.1	12.7	16.6	7.7	4.8	9.2	8.6	5.4	34.4	13.0	6.5	5.0	2.8	4.5	36.6	4.6	5.8	16.6	15.7	11.6	6.5	8.3	14.4	12.4	5.9	14.5	6.4	6.3	11.1
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200968-44214294	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol		No	No			Cytosol	Mitochondria	"HPA030817: AB_10599828, HPA030818: AB_10602102"	"unprognostic (1.25e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.30e-3)"	"unprognostic (7.80e-3)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.66e-3)"	26.5	21.9	35.1	21.4	30.6	31.1	23.1	19.0	32.2	21.8	27.6	26.5	27.9	21.1	21.0	32.6	31.1	16.0	16.8	22.3	34.9	33.5	24.4	17.3	19.6	25.7	36.1	24.0	14.3	51.2	29.7	21.6	25.7	26.8	21.3	26.7	18.3	39.1	24.6	29.1	21.8	21.7	27.1	31.4	20.5	24.9	27.3	25.1	22.2	21.0	23.4	26.3	17.5	15.5	7.7	11.1	15.7	12.8	7.2	12.4	6.3	22.6	23.9	20.1	28.1	25.3	22.2	16.6	45.7	35.1	25.6	26.0	25.1	18.8	21.6	20.6	44.8	49.3	28.0	24.6	30.2	32.7	26.0	23.5	12.6	17.7	15.7	31.7	26.7	23.1	20.7	29.6	31.2	33.4	22.7	30.8	19.9	29.2	16.0	33.9	23.4	19.9	29.7	49.2	30.4	40.0	21.9	18.2	18.6	21.1	19.1	23.6	46.4	21.7	34.7	24.7	29.8	27.3	27.6	35.2	27.5	34.1	27.2	50.2	42.7	47.1	32.1	37.4	23.7	53.8	5.9	11.2	15.7	7.8	12.8	11.0	6.9	9.2	12.4	10.3	7.7	8.8	8.6	9.5	7.2	12.1	11.1	9.4	6.3	35.1	30.6	19.0	32.2	34.9	33.5	36.1	24.0	26.8	25.1	11.9	10.3	13.7	14.7	23.1	6.4	17.3	7.6	1.4	6.8	19.2	9.8	21.7	21.6	42.1	21.1	14.0	30.8	0.0	71.4	49.0	21.6	29.1	1.1	14.3	36.6	12.7	13.3	11.1	19.6	5.9	9.2	17.2	25.3	55.1	24.1	9.8	58.9	17.5	12.7	18.2	7.7	0.0	18.4	15.6	18.8	22.6	41.2	8.5	18.3	28.6
ZDHHC1	"C16orf1, HSU90653, ZNF377"	ENSG00000159714	"Zinc finger DHHC-type containing 1"	Q8WTX9	16	67394419-67416833	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 24.6;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 2.6;intermediate monocyte: 3.6;myeloid DC: 2.4;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.6;ASC TERT1: 15.1;U-138 MG: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042531, HPA048659"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA042531: AB_2678041, HPA048659: AB_2680483"	"unprognostic (8.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.05e-3)"	"prognostic favorable (1.25e-6)"	"unprognostic (1.68e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.55e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.63e-3)"	9.6	6.3	4.3	3.9	6.6	0.5	10.2	5.3	10.5	16.9	7.4	5.5	7.9	3.8	13.5	16.4	6.3	22.6	14.0	6.2	4.5	3.7	11.2	3.8	7.8	4.9	5.3	3.5	17.1	16.2	11.5	14.0	15.1	6.5	11.6	3.2	11.2	14.7	12.1	8.0	10.8	3.9	9.3	3.3	10.1	6.2	25.7	2.6	0.6	31.3	9.3	4.9	6.9	9.7	0.0	2.4	0.3	3.6	0.0	0.0	0.8	5.1	6.2	1.5	8.2	13.6	15.1	0.0	2.9	11.1	2.9	3.5	0.0	3.2	0.0	1.3	5.2	3.0	3.3	0.5	0.5	0.6	1.6	4.7	0.4	0.1	0.4	6.9	0.3	4.3	7.2	6.4	3.2	0.9	6.9	3.8	0.0	0.0	0.0	2.0	0.5	0.0	0.0	3.0	2.0	0.1	0.0	0.1	0.0	4.2	3.1	2.2	7.5	0.5	0.2	6.7	0.6	2.1	1.2	5.0	13.1	2.1	6.3	3.5	1.5	0.3	0.0	8.0	0.1	5.4	0.0	2.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.8	4.3	6.6	5.3	10.5	4.5	3.7	5.3	3.5	6.5	2.6	0.0	0.0	0.0	5.5	6.4	2.4	0.8	15.3	1.4	1.2	7.0	3.9	1.4	8.3	2.9	24.6	4.5	2.1	0.0	3.4	0.1	6.6	6.0	0.0	1.6	2.0	3.2	8.6	7.4	15.2	44.2	13.6	1.3	5.0	0.0	12.5	8.3	2.2	3.5	10.3	5.1	0.3	0.0	6.4	8.7	5.1	6.1	4.8	0.0	6.2	4.4
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.8	1.4	3.4	1.0	4.2	0.7	2.7	11.0	3.8	1.6	1.5	6.3	1.0	9.5	1.7	2.9	3.2	10.3	1.2	6.4	4.2	3.8	2.0	2.6	7.5	1.0	15.2	1.9	1.5	1.9	1.8	7.8	1.2	10.9	2.7	1.2	1.0	1.4	3.4	2.1	2.7	1.7	1.0	5.0	2.4	5.9	6.3	6.1	1.0	1.1	2.3	1.8	1.0	1.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	7.4	4.1	0.8	1.3	0.3	5.5	0.3	0.1	0.2	0.1	1.0	0.3	3.0	0.8	0.1	0.9	6.9	2.2	0.0	0.1	9.0	4.8	0.3	2.6	3.7	0.3	4.3	0.3	0.4	0.3	0.9	1.0	0.3	0.0	1.2	0.7	1.7	0.2	3.3	0.4	2.6	7.3	0.0	2.9	4.5	2.8	4.1	0.2	1.5	4.1	0.7	0.2	0.1	3.1	8.4	11.5	0.7	0.4	0.2	6.9	3.9	0.1	5.5	7.7	0.9	0.3	8.9	0.2	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	11.0	3.8	4.2	3.8	15.2	1.9	10.9	6.1	17.9	9.6	0.0	0.3	1.6	2.0	6.7	0.0	42.8	23.9	0.0	0.0	0.2	0.0	0.4	6.6	0.8	1.7	0.0	0.0	0.1	1.7	0.4	3.5	1.7	0.3	6.4	1.7	1.3	0.0	6.8	0.6	0.0	0.0	0.0	2.0	0.3	0.2	1.1	0.0	0.8	1.7	6.5	1.0	9.3	3.8	1.4	0.2	0.0	1.1	0.3
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710360-766952	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.5;Ciliated cells: 36.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;RPMI-8226: 4.5;SCLC-21H: 6.6;THP-1: 7.2"									"HPA057886, HPA069008"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA057886: AB_2683548, HPA069008: AB_2686068"	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.3	1.8	2.9	0.0	3.7	0.0	0.6	11.7	5.3	0.0	1.1			3.8	0.5	0.4	2.8	3.4	0.5	3.8	3.9	2.9	0.4	0.6	5.3	0.0	2.8		0.8	2.4	1.5	3.7	0.1		0.6	1.9		1.0	0.4	3.3	4.8	5.9	0.0	2.5	3.3	3.8	0.8			0.7		0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.9	0.8	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.2	1.0	0.3	0.0	0.8	2.4	5.1	0.2	0.0	3.1	2.3	0.1	1.9	0.9	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	0.3	0.0	0.0	4.5	0.1	1.5	6.6	1.9	0.1	0.0	0.6	0.6	0.1	7.2	0.1	0.0	2.6	0.0	0.0	2.5	0.8	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1											17.9	16.5	0.0	1.0	2.4	6.1	7.3	2.5	36.1	10.3	3.5	0.0	0.0	0.0	0.6	1.1	1.1	2.4	0.0	0.7	0.0	1.1	0.4	1.1	1.6	1.3	9.5	2.9	0.6	0.0	0.0	0.9	0.0	0.0	0.0	2.3	0.5	0.1	0.6	0.0	0.3	0.2	6.5	2.1	1.0	0.8	2.8	0.0	0.0	1.7	0.8
ZDHHC12	"FLJ14524, ZNF400"	ENSG00000160446	"Zinc finger DHHC-type containing 12"	Q96GR4	9	128720869-128724127	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 77.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 54.8"	"Low region specificity"	"Detected in all"							HPA059339	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		No	No			Nucleoplasm	"Intermediate filaments"	"HPA059339: AB_2683985"	"unprognostic (2.05e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.34e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-2)"	"unprognostic (9.97e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.82e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.23e-1)"	7.3	10.9	3.9	15.3	4.5	21.8	11.2	2.5	6.5	7.5	21.2	6.8	19.3	16.2	5.9	8.3	27.2	6.9	21.5	9.2	3.5	3.1	20.6	23.6	14.2	28.0	3.8	3.8	5.0	40.5	4.3	5.0	24.7	4.8	11.1	8.4	7.7	26.3	13.3	7.5	16.8	33.0	5.4	5.8	14.9	18.7	9.2	2.7	23.6	10.3	16.4	24.4	10.1	11.7	22.2	50.6	77.4	28.7	17.4	26.1	18.8	14.2	39.0	1.6	8.4	5.1	3.5	16.4	9.2	8.2	10.1	6.8	31.9	16.5	9.9	8.6	6.9	17.6	37.7	3.5	18.2	1.0	18.2	9.4	5.2	29.7	14.0	10.4	8.7	24.2	5.6	12.6	8.2	3.1	4.8	7.4	18.8	5.2	25.3	1.9	54.8	11.9	17.5	7.2	31.7	32.3	5.4	5.9	28.5	7.7	13.4	11.6	8.4	12.5	17.3	4.9	2.7	26.7	9.3	7.4	0.0	10.5	7.1	12.3	16.4	28.9	4.4	16.8	10.1	11.1	39.2	26.5	77.4	23.5	24.7	20.3	20.3	21.8	22.5	21.0	22.2	22.7	20.6	56.8	17.4	28.7	50.6	26.1	18.8	3.9	4.5	2.5	6.5	3.5	3.1	3.8	3.8	4.8	2.7	14.9	8.1	54.1	42.0	14.3	0.9	9.6	79.0	4.0	11.4	43.6	0.0	147.4	11.6	94.7	58.6	14.7	157.1	70.0	176.4	191.0	11.1	49.6	18.4	48.9	121.4	0.0	49.2	28.3	52.9	22.4	8.9	39.8	40.5	159.7	93.7	14.5	109.4	171.9	6.7	32.7	1.7	6.5	9.5	23.1	17.5	24.6	112.1	48.4	94.2	52.6
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type containing 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.7	5.2	6.3	9.3	8.0	6.8	7.3	13.2	9.7	8.8	13.2	5.8	7.1	8.7	6.4	5.6	36.4	10.5	6.9	7.7	6.2	7.1	10.8	2.3	4.7	6.9	5.4	5.2	5.8	14.0	10.9	20.1	9.4	9.4	7.1	14.7	6.4	11.2	5.9	2.1	14.9	12.3	4.9	4.7	6.3	14.4	11.2	4.8	15.0	7.7	18.2	27.5	15.3	14.5	6.3	4.3	23.4	5.8	4.3	7.5	3.5	15.9	7.6	7.3	6.2	2.6	3.0	7.0	7.7	7.1	8.6	10.0	4.6	3.8	8.2	5.3	6.4	19.4	24.4	10.4	5.0	9.5	10.1	9.1	4.3	4.8	3.7	6.0	5.8	7.4	3.4	6.0	3.6	5.1	8.1	54.4	11.5	4.1	4.1	8.8	5.2	7.4	4.7	6.0	15.1	7.0	8.2	10.1	1.9	8.9	10.6	12.7	9.3	9.2	11.2	4.1	7.3	5.3	6.7	15.6	7.7	5.4	11.7	6.1	3.5	10.8	7.5	9.2	6.0	13.4	7.4	3.5	23.4	6.8	5.8	6.1	6.3	5.3	7.5	4.3	4.2	5.1	6.5	4.4	4.3	4.6	4.2	6.8	3.5	6.3	8.0	13.2	9.7	6.2	7.1	5.4	5.2	9.4	4.8	8.9	12.5	4.9	19.3	21.5	10.4	32.9	10.2	33.5	21.6	15.7	9.8	7.5	5.0	17.2	73.0	9.3	13.5	0.0	17.0	15.7	10.6	33.7	11.5	0.8	5.5	15.9	15.0	9.2	5.9	36.4	7.2	7.4	3.3	29.7	21.1	61.2	17.7	14.0	2.1	2.2	8.5	0.0	5.6	38.7	22.6	31.7	5.3	8.7	18.7	44.2
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria		NA	NA			Nucleoli	Mitochondria	"HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1.0	1.9	1.1	1.9	0.7	1.6	2.0	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4.0	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4.0	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1.0	3.0	3.2	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3.0	0.0	2.7	2.3	11.4	14.5	14.4	15.3	0.0	1.2	7.0	5.9	8.9	10.0	5.2	7.8	10.5	6.6	0.0	2.8	1.8	7.9	14.3	0.0	21.2	9.2	116.0	2.4	24.5	12.1	4.0	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0.0	7.2	2.4	4.1	7.3	17.6	5.0	9.7	2.4
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 6.0;Cardiomyocytes: 6.9;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 5.7;K-562: 3.6;LHCN-M2: 4.0;MOLT-4: 4.2;NTERA-2: 3.7;RH-30: 5.8;RPTEC TERT1: 3.2;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	3.6	0.1	4.0	0.0	4.2	0.1	3.7	0.0	0.0	0.0	5.8	0.0	3.2	0.0	1.6	4.8	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.9	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1	6.0	1.9	0.0	1.4	3.5	3.7	6.9	2.5	0.0	2.3	5.2	3.9	0.0	0.0	0.7	0.0	2.1	0.0	0.0	0.6	0.0	0.9	1.0	1.1	0.0	0.1	0.0	1.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.3	0.3	0.0	3.5	1.0	2.1	6.5	1.4	0.1	0.4	3.1	0.0	0.0	0.0	0.3
ZDHHC16	APH2	ENSG00000171307	"Zinc finger DHHC-type containing 16"	Q969W1	10	97446131-97457370	"Enzymes, Predicted membrane proteins"	"Apoptosis, DNA damage"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039893, HPA040214"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039893: AB_10794757, HPA040214: AB_2676886"	"unprognostic (4.44e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-1)"	12.0	13.7	15.9	10.8	17.3	6.4	17.9	17.6	24.6	17.1	17.9	15.6	18.1	15.1	15.5	21.2	17.6	11.5	14.4	18.1	13.2	11.0	23.3	37.4	20.8	11.1	10.9	13.0	15.1	22.5	21.8	15.4	30.7	10.5	16.0	18.9	18.1	28.5	14.1	20.7	14.0	15.7	17.6	8.5	13.2	19.4	16.4	10.8	14.7	19.6	15.4	16.1	15.1	20.0	9.3	14.2	9.4	10.4	13.0	12.0	5.8	21.7	25.5	17.0	21.0	27.3	18.7	17.8	23.9	31.9	27.6	26.5	19.8	19.5	19.2	27.6	34.9	24.2	25.6	21.4	33.8	24.7	19.0	24.8	12.2	17.9	18.8	21.9	14.4	17.9	20.9	22.4	32.3	23.3	30.0	28.3	17.8	9.7	14.6	35.0	20.7	21.8	19.8	13.9	19.8	22.2	15.0	17.3	17.6	23.4	10.1	8.3	11.8	14.6	15.1	12.9	17.7	19.9	14.2	17.3	17.4	16.2	11.2	27.9	14.0	22.6	11.8	20.1	22.5	9.1	0.3	9.8	9.4	7.0	10.4	8.0	8.2	12.0	11.1	14.2	9.3	9.9	9.8	0.5	13.0	10.4	10.9	9.4	5.8	15.9	17.3	17.6	24.6	13.2	11.0	10.9	13.0	10.5	10.8	17.9	17.2	14.5	15.7	4.6	15.1	9.7	15.3	6.7	27.3	12.2	3.9	35.3	21.6	31.3	20.3	9.2	12.9	0.0	28.4	55.1	10.0	16.3	6.9	15.8	21.8	12.7	6.9	8.0	7.3	5.7	8.1	7.5	3.3	24.4	16.7	10.4	30.7	10.5	3.5	17.8	10.6	6.5	4.9	16.1	12.7	3.8	31.7	7.5	17.9	14.1
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type containing 17"	Q8IUH5	12	76763588-76853696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 16.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	7.9	7.8	10.0	5.8	14.0	11.3	8.8	18.1	18.1	8.0	5.9	9.2	3.8	3.6	12.0	6.8	6.4	7.0	5.5	6.4	8.7	6.5	9.1	13.1	5.4	7.1	11.3	10.7	11.5	5.2	9.5	10.3	8.7	13.2	7.9	5.4	5.9	5.7	7.3	5.4	5.9	6.4	8.0	10.0	7.1	6.1	6.4	11.6	7.5	6.2	4.1	5.7	5.6	6.3	3.8	16.3	5.8	2.2	1.7	3.6	1.4	5.2	6.4	20.1	10.2	12.1	12.8	9.8	10.6	8.8	7.1	6.2	5.0	3.8	7.3	6.4	10.3	7.0	4.9	7.9	6.6	11.0	6.0	8.4	10.5	7.9	7.7	8.2	10.5	9.4	12.0	6.9	6.6	9.9	23.8	8.1	10.0	11.3	3.4	9.2	4.9	7.5	14.1	14.9	2.3	7.4	10.2	7.1	7.8	8.1	8.0	7.9	13.6	11.6	4.3	6.8	18.1	9.5	10.6	11.1	9.7	7.3	5.9	6.0	5.4	5.3	7.9	3.6	5.0	10.0	5.7	2.1	5.2	3.6	2.2	2.9	2.6	2.9	2.7	2.6	3.8	3.1	2.6	5.8	1.7	2.1	16.3	1.2	1.4	10.0	14.0	18.1	13.8	8.7	6.5	11.3	10.7	13.2	11.6	29.8	16.5	7.3	9.8	6.4	45.0	18.5	10.2	18.7	19.4	12.2	37.3	14.4	0.0	7.7	7.3	19.6	4.1	23.3	4.0	8.2	15.1	9.9	40.4	9.8	7.6	27.0	18.4	18.4	13.2	10.6	18.7	14.9	5.0	7.2	5.9	26.4	6.4	5.5	19.8	4.4	32.3	0.0	16.0	17.4	22.1	4.8	4.7	10.9	5.2	4.5
ZDHHC18	DKFZp667O2416	ENSG00000204160	"Zinc finger DHHC-type containing 18"	Q9NUE0	1	26826710-26857602	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 86.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 27.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040234	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA040234: AB_10805709"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.42e-7)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (1.36e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	20.5	8.2	13.3	22.7	18.9	86.2	39.0	21.4	18.4	10.2	13.0	11.9	7.5	11.7	12.4	6.4	19.3	9.9	13.5	9.8	13.5	20.0	7.8	14.5	16.2	23.5	16.3	12.8	9.6	10.8	7.1	10.5	20.3	15.2	10.7	13.9	11.2	14.1	9.8	8.7	16.3	12.2	16.6	10.4	27.1	10.8	7.0	9.5	11.7	14.6	10.1	23.3	16.5	24.7	0.2	0.4	27.0	0.6	0.5	1.3	0.2	18.5	8.3	13.5	9.3	11.3	7.9	13.3	11.2	13.3	19.7	14.7	7.6	11.9	8.6	7.2	14.8	10.3	13.1	14.3	6.7	17.0	54.3	12.2	8.3	6.1	10.5	9.7	7.3	7.3	6.8	9.1	18.1	12.0	7.1	11.0	13.3	8.6	17.9	7.8	9.0	13.9	5.9	12.9	11.6	8.0	11.6	11.6	9.1	8.3	4.7	6.3	7.6	7.5	5.7	8.1	10.8	5.1	7.3	9.3	13.7	10.5	22.3	12.8	21.3	15.3	7.4	7.7	13.4	9.3	0.0	0.2	5.1	0.9	0.6	0.7	0.2	0.6	0.6	0.4	0.1	0.4	0.4	27.0	0.5	0.4	0.2	1.3	0.2	13.3	18.9	21.4	18.4	13.5	20.0	16.3	12.8	15.2	9.5	8.9	9.3	9.8	7.5	22.8	39.0	4.8	12.7	0.0	6.8	1.8	25.5	8.9	0.0	3.2	2.9	8.0	12.3	23.3	2.5	6.3	7.1	12.5	1.1	10.4	6.6	17.5	2.9	6.7	6.9	1.4	5.8	8.9	10.1	36.9	4.3	4.8	6.7	9.5	3.5	2.2	33.0	0.0	5.5	2.2	11.1	31.7	5.1	8.7	5.2	13.2
ZDHHC19	MGC33345	ENSG00000163958	"Zinc finger DHHC-type containing 19"	Q8WVZ1	3	196197449-196211437	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 53.4"	"Group enriched"	"Detected in some"	15	"Early spermatids: 298.7;Late spermatids: 632.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"eosinophil: 2.4;memory B-cell: 3.9;naive B-cell: 5.2;neutrophil: 3.4"	"Group enriched"	"Detected in many"	24	"B-cells: 5.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;K-562: 1.2;NTERA-2: 1.1;SH-SY5Y: 1.9;THP-1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (2.87e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.63e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.46e-7)"	"unprognostic (8.05e-4)"	"unprognostic (4.71e-1)"	"unprognostic (7.08e-3)"	"unprognostic (4.28e-2)"	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	5.2	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	298.7	0.7	0.0	0.0	0.0	0.4	0.3	0.1	0.0	3.4	1.3	0.0	0.0	0.0	1.5	632.3	15.3	1.4	0.0	0.0	0.0	0.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	4.9	3.0	0.0	2.1	0.0	0.0	0.0
ZDHHC2	"DHHC2, ZNF372"	ENSG00000104219	"Zinc finger DHHC-type containing 2"	Q9UIJ5	8	17156029-17224799	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 72.6;Rod photoreceptor cells: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023331, HPA023334"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023331: AB_2671165, HPA023334: "	"unprognostic (8.92e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (5.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.10e-2)"	10.1	22.5	14.8	9.4	14.5	24.4	14.8	22.8	12.2	12.9	13.4	17.5	17.4	9.3	7.0	10.5	5.3	12.8	6.4	10.1	13.0	14.0	24.2	7.5	12.7	10.3	13.6	10.9	13.0	27.0	19.2	20.2	6.1	14.7	12.0	10.3	21.2	15.9	13.7	15.9	3.4	9.1	8.8	25.9	11.2	14.1	14.2	14.5	13.8	32.3	10.4	10.2	17.3	8.7	5.3	4.6	4.9	2.7	4.4	7.0	1.5	0.9	5.2	10.2	2.1	9.0	16.1	6.0	17.6	21.4	10.0	11.9	1.6	14.7	10.6	6.9	15.3	25.2	0.6	13.7	8.7	18.6	6.9	6.9	9.6	7.6	2.1	9.0	10.1	1.1	6.7	1.4	12.5	11.4	23.1	16.4	12.7	1.1	28.6	12.0	0.2	7.4	6.1	6.5	7.8	8.1	7.4	10.2	3.9	18.1	11.3	5.5	3.6	7.5	0.0	1.6	15.9	0.4	4.6	13.5	5.1	15.6	11.2	17.5	5.7	21.3	12.5	14.1	9.3	2.3	2.6	2.6	4.9	4.1	2.7	7.0	5.3	5.1	4.9	2.2	4.6	4.7	5.0	1.8	4.4	1.6	4.6	2.6	1.5	14.8	14.5	22.8	12.2	13.0	14.0	13.6	10.9	14.7	14.5	41.7	20.1	11.5	11.9	2.7	37.3	11.3	10.2	6.7	14.8	48.8	72.6	0.5	18.3	19.5	6.7	9.0	6.3	0.0	29.1	0.9	7.4	32.3	8.1	7.3	11.7	11.1	18.9	5.5	21.8	8.2	4.6	15.5	21.9	4.6	15.0	23.4	34.3	10.5	2.8	19.8	80.1	12.9	7.6	5.5	2.5	2.4	0.3	13.4	13.7	23.7
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type containing 20"	Q5W0Z9	13	21372573-21459370	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 77.2;Kupffer cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	7.5	7.0	8.3	9.4	33.6	14.9	11.3	6.4	15.3	10.3	10.9	21.0	7.6	10.8	9.3	5.6	18.4	7.1	10.0	5.4	12.7	11.8	3.8	7.6	10.6	12.3	47.4	4.9	6.5	6.1	4.0	5.3	10.8	26.1	9.2	9.6	3.1	10.4	9.9	5.5	12.2	15.4	8.9	45.0	8.6	23.1	22.0	35.8	10.4	10.0	5.1	10.9	16.2	9.6	4.6	7.8	8.8	15.2	10.1	10.2	11.1	13.2	7.7	11.2	7.1	10.5	11.1	27.5	14.6	14.7	9.8	8.7	13.9	40.9	14.2	7.9	17.8	10.3	21.7	12.9	11.2	18.5	15.4	8.2	24.9	4.8	7.7	5.9	16.8	10.8	10.0	7.9	9.6	6.8	12.4	15.1	18.4	6.9	6.0	14.4	11.2	23.5	6.4	9.1	35.2	7.6	18.9	20.2	4.9	11.6	24.9	10.7	4.9	19.1	12.0	7.8	12.0	11.0	8.6	26.2	10.3	9.9	17.3	10.8	6.2	7.6	14.7	7.4	9.7	29.1	8.8	15.2	3.4	10.2	14.2	9.4	4.6	8.8	8.7	7.8	3.7	8.3	8.5	2.7	10.1	12.0	3.9	9.3	11.1	8.3	33.6	6.4	15.3	12.7	11.8	47.4	4.9	26.1	35.8	47.6	26.9	15.8	6.9	0.9	8.3	6.4	17.8	20.1	36.4	10.4	7.9	18.2	0.0	8.6	77.2	15.0	29.0	0.0	10.5	16.6	10.3	19.1	13.9	17.4	19.9	17.5	23.1	19.6	86.8	67.8	14.4	35.8	1.7	7.2	29.0	4.4	18.7	23.0	10.3	6.2	9.6	19.4	6.9	9.7	12.3	1.4	37.3	20.8	23.4	16.9
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type containing 21"	Q8IVQ6	9	14611071-14693471	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	6.5	10.8	15.9	7.9	16.8	4.2	11.6	29.0	22.6	7.8	8.5	9.3	3.8	12.2	9.8	11.7	14.4	7.5	6.7	9.0	13.8	10.4	9.4	4.8	9.2	11.1	9.4	16.5	10.0	8.4	11.5	22.2	7.8	14.8	10.0	9.9	6.6	8.3	7.4	7.7	15.7	12.6	7.7	9.9	9.5	7.9	7.3	9.7	4.7	11.3	9.9	10.7	7.7	11.3	5.2	1.4	0.5	0.8	2.8	1.7	0.6	5.4	2.8	5.6	3.6	0.9	1.0	4.3	7.0	2.2	2.5	2.9	1.4	2.6	5.4	1.7	4.9	3.1	3.6	3.8	2.3	3.6	10.8	2.9	23.0	6.1	2.7	3.0	4.0	7.7	1.9	5.3	2.9	1.9	4.6	14.6	2.2	1.9	0.6	4.4	3.0	0.9	3.9	3.9	2.3	5.3	0.0	2.6	2.7	7.7	6.1	3.4	9.1	3.2	4.0	2.1	4.4	5.0	6.6	10.3	1.8	2.7	1.8	6.4	2.3	4.2	0.0	3.8	0.2	1.8	0.5	0.4	0.1	1.2	0.8	1.3	5.2	1.2	1.1	0.2	3.5	0.8	1.2	0.0	2.8	0.6	1.4	1.7	0.6	15.9	16.8	29.0	22.6	13.8	10.4	9.4	16.5	14.8	9.7	20.8	17.9	23.9	7.6	8.5	42.8	16.2	20.4	10.7	22.7	41.8	41.2	7.1	5.0	13.7	4.0	14.8	33.7	0.0	15.6	5.4	9.4	16.4	10.4	6.8	9.6	35.0	15.0	30.7	15.1	4.5	17.8	11.7	1.7	12.6	13.4	75.7	25.7	10.5	29.4	7.9	50.3	6.5	11.3	14.6	16.1	17.6	6.4	10.2	10.2	13.2
ZDHHC22	C14orf59	ENSG00000177108	"Zinc finger DHHC-type containing 22"	Q8N966	14	77131270-77142734	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 52.3"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 9.9;Cone photoreceptor cells: 3.9;Late spermatids: 3.3"	"Cancer enriched"	"Detected in single"	40	"glioma: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.3;NTERA-2: 5.6;RH-30: 9.4;SCLC-21H: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049471, HPA072213"			Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA049471: AB_2732553, HPA072213: AB_2686496"	"unprognostic (1.02e-1)"	"unprognostic (3.42e-1)"		"unprognostic (1.22e-4)"	"unprognostic (1.66e-1)"	"unprognostic (8.86e-2)"		"unprognostic (2.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.79e-1)"	1.1	1.5	11.2	1.1	12.6	1.1	1.1	8.4	52.3	1.1	1.2	6.7	0.0	1.1	1.1	1.4	1.3	1.2	1.1	1.2	14.5	18.4	1.1	1.1	1.1	1.1	10.7	19.5	1.1	1.1	1.1	3.1	1.1	9.2	1.1	1.3	0.5	1.1	1.1	1.3	1.1	1.1	1.2	3.6	1.1	1.3	1.4	5.1	0.0	1.3	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	5.6	0.0	0.7	0.0	9.4	0.0	0.0	0.0	10.4	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	11.2	12.6	8.4	29.5	14.5	18.4	10.7	19.5	9.2	5.1	0.0	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ZDHHC23	MGC42530	ENSG00000184307	"Zinc finger DHHC-type containing 23"	Q8IYP9	3	113947901-113965401	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.8"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.4;Late spermatids: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016808	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016808: AB_1859002"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.48e-7)"	"unprognostic (2.58e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (3.29e-3)"	1.0	0.8	6.3	2.1	5.9	0.4	1.9	2.7	10.4	1.4	7.7	0.9	2.2	6.0	1.5	1.6	1.7	2.1	1.8	1.3	8.9	1.9	4.7	3.2	2.4	2.7	0.9	4.7	1.1	4.4	8.2	3.5	0.4	1.4	1.8	9.9	1.2	4.9	1.4	1.2	2.9	5.4	0.7	0.9	1.9	5.0	25.8	0.6	0.8	5.5	0.9	2.8	1.7	1.5	2.7	1.1	0.5	0.0	0.0	0.5	0.1	13.1	3.3	0.4	7.8	1.2	0.2	11.5	5.2	1.6	1.0	1.6	5.4	8.9	6.1	4.6	3.0	8.6	8.7	10.0	1.4	1.7	3.6	4.6	5.6	4.8	3.3	0.4	6.2	5.2	0.2	1.7	0.2	0.6	1.2	0.8	6.5	0.0	3.6	0.1	7.6	5.1	0.4	2.4	13.6	3.7	0.9	4.5	5.0	5.6	6.5	13.7	3.5	4.0	13.5	2.6	3.2	8.1	2.1	0.2	3.8	7.6	0.8	2.3	4.0	5.2	9.8	3.2	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.1	0.0	1.7	0.1	0.0	0.5	0.0	0.0	1.1	0.1	0.1	6.3	5.9	2.7	10.4	8.9	1.9	0.9	4.7	1.4	0.6	0.0	1.0	5.9	1.6	2.7	1.8	1.2	10.2	5.3	2.3	15.7	7.9	0.6	0.0	2.1	20.4	1.4	15.7	0.0	1.6	1.2	0.6	3.5	0.0	5.4	0.4	0.0	13.3	1.8	0.3	26.8	1.1	1.2	3.3	1.0	12.2	3.8	0.7	9.5	0.0	3.4	0.7	0.0	0.3	11.6	1.9	2.4	0.2	0.0	11.4	1.7
ZDHHC24		ENSG00000174165	"Zinc finger DHHC-type containing 24"	Q6UX98	11	66520637-66546238	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016619	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA016619: AB_2288672"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.55e-3)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (8.76e-2)"	"unprognostic (7.74e-3)"	"unprognostic (7.11e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.10e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.35e-1)"	11.7	17.4	10.5	10.3	12.8	14.1	12.3	5.7	15.5	7.7	8.3	13.8	10.8	9.1	9.4	17.0	12.2	9.0	11.3	9.9	10.7	11.8	17.3	13.4	11.1	20.4	12.8	10.3	6.5	19.4	22.6	9.6	13.7	9.3	11.4	7.7	10.0	12.4	13.1	7.9	13.2	9.4	7.1	10.0	16.0	12.4	9.9	10.5	11.7	17.7	7.9	13.4	10.0	7.8	5.8	17.2	2.4	5.5	6.6	7.2	4.6	4.7	7.6	2.5	6.5	6.2	5.1	6.3	4.0	3.4	3.2	2.2	6.6	7.7	1.4	10.9	3.4	8.5	11.6	1.9	3.5	2.3	6.8	4.8	2.9	3.7	4.1	5.8	3.0	7.2	6.1	6.3	2.7	3.8	3.8	5.3	11.0	4.2	4.2	4.0	10.3	5.7	8.3	5.0	12.0	6.5	7.3	5.3	8.9	3.9	3.8	3.5	5.5	6.4	6.7	11.0	2.9	9.3	2.4	8.3	7.4	2.3	8.6	2.9	6.3	2.0	2.0	6.5	1.4	8.0	2.4	5.5	1.0	6.2	4.8	5.7	5.4	5.0	7.2	6.3	5.8	3.0	5.4	2.4	6.6	4.4	17.2	5.1	4.6	10.5	12.8	5.7	15.5	10.7	11.8	12.8	10.3	9.3	10.5	11.9	8.8	14.9	12.3	7.1	8.8	3.8	12.7	5.3	2.3	22.7	9.8	28.2	8.3	42.7	10.7	17.0	37.0	0.0	42.7	30.1	14.0	21.3	9.2	14.3	58.2	22.3	13.8	20.3	38.9	10.2	6.9	18.7	16.9	38.7	17.0	17.5	34.3	31.6	9.2	24.8	10.3	19.4	12.2	31.9	2.7	7.0	20.1	28.7	19.6	19.7
ZDHHC3	"DHHC3, GODZ, ZNF373"	ENSG00000163812	"Zinc finger DHHC-type containing 3"	Q9NYG2	3	44915257-44976185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 493.4;Late spermatids: 1185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012465, HPA016616"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB012465: , HPA016616: AB_1859004"	"unprognostic (2.80e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.81e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-2)"	23.1	25.8	11.7	17.5	14.0	29.5	39.8	12.5	20.8	17.2	27.9	13.7	17.8	18.4	19.2	17.9	29.1	13.0	22.7	34.6	11.2	9.1	21.7	19.0	20.2	16.1	12.1	7.7	16.5	15.0	16.9	8.8	19.5	19.4	16.1	28.9	14.7	17.4	22.5	20.0	43.0	33.2	15.4	13.6	15.4	20.9	48.0	10.1	14.1	20.4	22.1	20.6	21.4	20.7	5.4	11.4	17.1	10.0	6.0	7.1	5.2	12.0	9.7	8.8	12.1	37.5	19.0	9.8	10.6	13.3	13.6	12.3	11.6	15.9	11.0	5.8	18.8	8.2	15.5	13.5	18.8	14.5	10.8	5.7	9.7	13.4	8.5	8.5	25.1	7.9	16.3	23.3	13.0	12.9	10.7	14.3	11.0	14.2	9.8	12.5	7.8	7.6	18.3	11.7	27.2	19.4	5.7	7.4	8.3	13.5	37.8	2.7	10.6	12.8	13.2	5.8	13.9	10.0	17.4	15.2	11.8	10.9	13.8	13.9	6.7	12.5	10.8	10.8	38.5	8.8	17.1	10.0	13.8	6.5	5.5	6.1	4.7	4.7	7.1	11.4	5.4	4.9	6.3	11.4	6.0	7.2	6.7	6.9	5.2	11.7	14.0	12.5	20.8	11.2	9.1	12.1	7.7	19.4	10.1	38.7	75.1	15.7	29.8	42.7	9.4	24.0	25.5	16.0	18.2	50.6	5.9	40.9	61.3	37.0	493.4	30.7	99.2	23.3	69.9	48.5	26.6	52.0	18.5	25.9	43.7	14.3	34.4	38.1	31.1	1185.8	48.1	27.2	23.6	30.7	65.3	25.6	78.0	59.6	42.1	23.7	8.6	19.4	23.7	52.6	40.9	52.7	85.0	20.8	60.2	82.9
ZDHHC4	"FLJ10479, ZNF374"	ENSG00000136247	"Zinc finger DHHC-type containing 4"	Q9NPG8	7	6577434-6589374	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032124	Approved					NA	NA					"HPA032124: AB_10610699"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (6.82e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (1.18e-7)"	"unprognostic (8.75e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.94e-4)"	17.7	24.3	20.7	13.5	22.0	11.4	23.6	8.2	29.9	20.7	24.9	22.5	18.2	14.0	21.6	26.9	16.1	25.5	18.8	21.9	17.3	19.7	25.7	34.5	17.0	19.7	19.8	17.7	22.7	46.5	27.2	18.7	14.1	20.4	20.0	16.3	28.0	29.8	22.4	34.9	9.5	16.3	22.7	17.1	13.6	23.5	27.0	12.3	18.1	30.5	17.4	16.5	23.3	13.7	17.6	50.6	20.9	14.9	11.9	15.4	12.6	21.7	13.9	5.2	31.0	28.5	21.5	23.7	12.3	3.1	15.1	18.8	17.3	31.3	12.9	19.6	22.7	32.4	20.0	18.2	12.2	15.7	7.7	10.6	14.3	16.6	18.5	25.3	17.0	15.7	22.5	18.0	11.8	0.0	19.2	13.4	25.7	29.3	19.3	20.9	22.8	9.1	16.7	27.1	20.1	12.1	12.6	26.4	19.2	12.0	17.3	12.5	32.0	16.3	6.0	21.4	28.7	20.7	22.4	9.0	17.8	25.9	17.0	17.8	28.6	22.8	29.9	10.7	21.4	24.9	20.9	11.7	18.0	11.5	14.9	12.5	17.6	11.6	12.7	13.2	16.1	15.4	14.7	1.3	11.9	10.8	50.6	10.3	12.6	20.7	22.0	8.2	29.9	17.3	19.7	19.8	17.7	20.4	12.3	35.7	15.3	25.1	40.1	10.1	30.0	3.6	56.0	26.8	31.8	33.2	9.8	58.4	72.9	53.9	2.0	10.8	10.2	0.0	58.4	56.0	26.7	32.7	10.3	38.4	48.4	20.6	31.2	20.9	26.0	2.2	16.7	18.1	20.3	38.7	19.1	45.6	49.0	17.5	30.8	58.5	19.8	12.9	30.9	76.1	50.3	8.2	40.8	22.4	29.3	26.5
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type containing 5"	Q9C0B5	11	57667747-57701187	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	19.6	18.2	6.9	14.2	16.1	13.0	17.3	12.4	19.2	20.0	18.7	14.1	20.9	14.6	19.8	15.9	45.8	16.0	19.1	18.2	8.2	8.1	27.8	24.8	18.7	18.0	8.5	8.2	16.2	21.3	31.4	13.9	31.4	12.8	15.5	18.2	19.1	29.3	18.4	31.3	33.2	25.9	15.2	8.7	21.5	16.3	35.7	7.8	26.4	25.5	23.9	39.1	23.3	26.0	9.4	13.4	15.5	11.3	6.9	13.1	9.0	28.4	31.6	12.4	12.6	27.5	21.2	23.4	26.8	32.1	22.4	16.8	19.1	35.1	19.2	34.8	31.6	19.3	40.3	19.3	31.7	20.0	23.6	8.7	16.3	14.5	17.0	30.8	30.5	27.7	29.8	28.7	33.1	33.7	18.6	25.2	16.2	21.4	24.3	28.3	17.1	17.1	8.5	15.0	21.1	19.0	17.1	25.1	23.7	25.6	42.2	9.0	11.5	24.9	28.2	26.1	17.5	30.2	17.5	29.5	29.1	15.1	30.5	18.6	17.7	21.9	16.5	21.6	15.8	25.2	15.5	8.1	9.8	11.1	10.1	13.1	9.0	10.9	9.4	8.0	9.4	11.0	11.1	10.2	6.9	11.3	13.4	9.8	9.0	6.9	16.1	12.4	19.2	8.2	8.1	8.5	8.2	12.8	7.8	14.9	10.9	5.3	10.2	14.3	17.5	18.1	12.7	14.7	20.5	12.2	35.3	8.5	3.3	13.1	15.8	11.7	31.9	0.0	15.7	8.4	8.5	14.0	19.6	13.2	11.0	12.7	11.1	13.5	16.1	6.8	10.9	12.0	1.7	9.0	16.2	9.6	19.0	19.3	7.1	10.2	45.0	0.0	9.2	6.5	6.6	17.3	15.6	8.7	15.8	15.9
ZDHHC6	"FLJ21952, ZNF376"	ENSG00000023041	"Zinc finger DHHC-type containing 6"	Q9H6R6	10	112424428-112446917	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014357	Approved					NA	NA					"HPA014357: AB_2304658"	"unprognostic (1.21e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.21e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.87e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.22e-2)"	17.6	17.7	14.4	21.6	17.2	13.9	17.7	17.5	19.1	16.6	21.3	15.4	25.6	32.2	21.6	25.7	21.1	16.5	17.1	15.1	15.4	13.2	41.7	21.3	17.6	20.3	20.1	15.2	24.5	19.0	15.6	17.6	19.3	19.8	18.6	22.6	18.2	21.4	23.5	13.8	14.8	43.8	16.7	15.5	22.3	18.8	10.7	15.0	20.2	20.5	12.9	21.6	16.7	17.9	16.8	16.4	20.2	17.2	15.5	23.0	15.0	20.6	16.2	16.9	20.9	16.4	12.5	12.0	20.3	19.3	16.1	19.3	15.3	37.1	11.5	9.3	12.3	18.1	24.7	14.0	12.9	18.8	26.8	17.2	11.8	18.6	18.9	10.6	27.0	20.9	9.4	8.7	17.6	20.8	24.9	20.1	17.3	12.8	19.2	17.3	17.3	15.0	30.3	9.9	23.1	13.3	12.6	21.4	10.7	19.0	11.5	6.3	8.8	10.5	16.7	19.1	13.8	9.3	19.9	14.3	18.5	11.7	12.3	19.1	10.8	12.4	15.2	16.4	47.9	12.0	9.3	17.2	20.2	15.5	15.8	20.1	16.8	17.9	19.5	16.4	13.3	15.2	17.1	11.4	15.5	12.4	13.6	23.0	15.0	14.4	17.2	17.5	19.1	15.4	13.2	20.1	15.2	19.8	15.0	20.8	19.0	24.4	27.9	18.0	10.0	11.3	38.2	12.0	28.4	33.2	7.9	29.6	51.4	30.8	61.9	18.0	37.6	0.0	26.1	38.6	18.6	25.9	23.1	19.0	30.0	14.3	10.9	19.0	19.4	13.2	15.0	28.1	11.8	15.4	20.6	16.6	24.8	21.0	18.4	33.5	12.4	6.5	16.0	8.6	12.0	19.4	30.6	33.0	20.7	40.4
ZDHHC7	"DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370"	ENSG00000153786	"Zinc finger DHHC-type containing 7"	Q9NXF8	16	84974181-85011535	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019215, HPA059054, HPA059642"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019215: AB_2670102, HPA059054: AB_2683892, HPA059642: AB_2684093"	"unprognostic (9.77e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.41e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.42e-2)"	23.4	20.9	17.7	25.4	14.7	40.3	45.8	17.8	20.0	23.7	26.8	15.5	15.6	19.7	27.7	18.6	20.4	19.2	29.1	24.9	13.0	11.6	23.4	21.3	31.3	36.3	15.5	14.5	21.8	30.0	31.1	15.2	25.1	14.8	24.1	24.3	18.1	18.7	18.4	36.5	23.1	25.5	31.1	14.9	27.1	32.3	18.6	13.9	16.1	19.9	25.8	18.8	27.7	28.9	2.0	6.9	8.5	10.6	1.5	3.0	3.5	20.4	18.0	9.5	11.4	42.3	32.0	13.1	18.9	36.7	29.8	14.8	18.9	24.0	9.4	11.1	30.5	9.8	21.6	12.2	25.0	37.7	5.4	9.8	7.3	7.7	21.4	17.7	12.7	7.1	26.4	28.7	24.3	14.0	19.0	15.3	8.9	21.8	3.2	18.8	24.4	8.7	12.2	14.7	17.2	13.1	10.8	8.7	5.1	29.3	26.9	8.1	10.3	24.4	13.7	11.8	15.1	25.9	7.8	22.2	18.0	13.7	16.9	11.0	11.3	15.6	21.2	17.1	9.5	14.2	6.7	10.6	8.5	2.5	8.8	3.0	1.6	2.4	2.0	6.9	2.0	1.8	2.6	7.1	1.5	7.2	4.7	0.6	3.5	17.7	14.7	17.8	20.0	13.0	11.6	15.5	14.5	14.8	13.9	29.8	25.1	8.2	20.6	11.7	8.2	18.5	15.3	20.1	9.1	15.7	5.9	15.1	1.7	12.1	6.5	8.9	21.7	0.0	13.5	21.1	17.0	18.9	3.5	9.4	25.9	14.3	12.1	12.9	49.0	7.1	16.1	22.8	15.1	16.2	31.0	5.6	22.2	28.1	19.8	7.4	5.7	12.9	13.0	8.4	11.4	11.2	13.5	13.8	29.1	28.5
ZDHHC8	"KIAA1292, ZNF378"	ENSG00000099904	"Zinc finger DHHC-type containing 8"	Q9ULC8	22	20129456-20148007	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003422	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003422: AB_1080640"	"unprognostic (1.00e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.34e-3)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.57e-2)"	20.7	19.2	25.7	16.9	23.0	9.2	23.4	24.4	35.3	14.3	9.9	14.0	17.3	11.6	16.0	10.9	13.9	13.6	14.4	16.0	18.7	10.6	15.2	16.5	14.6	15.4	17.7	17.6	18.0	23.9	17.4	21.0	16.4	19.0	13.4	7.0	17.5	20.4	16.6	20.5	22.2	11.2	13.0	10.4	19.8	15.9	8.4	18.6	8.9	18.5	7.9	11.1	12.9	14.5	2.0	4.1	4.0	1.5	1.3	2.5	0.5	11.5	7.4	11.8	15.5	17.3	10.4	10.6	21.8	14.9	14.8	13.3	3.8	6.0	0.0	9.0	18.1	8.0	15.9	6.2	16.7	7.3	16.6	23.7	5.6	19.4	8.8	14.3	0.0	7.9	18.1	11.3	11.4	9.6	9.1	16.5	8.3	38.6	9.1	13.1	5.6	6.8	15.1	6.0	5.1	11.7	14.6	10.3	4.1	6.4	14.1	19.0	9.6	8.8	4.3	10.4	5.6	0.3	7.9	18.9	33.7	24.7	18.9	9.7	13.2	4.3	4.4	9.9	7.3	9.9	4.0	1.2	0.3	2.5	1.5	1.3	0.8	0.7	1.2	0.4	2.0	1.3	1.8	0.0	1.3	0.8	4.1	2.0	0.5	25.7	23.0	24.4	35.3	18.7	10.6	17.7	17.6	19.0	18.6	3.0	1.9	2.7	3.4	8.0	11.5	6.8	5.1	0.0	3.4	10.4	13.7	3.1	1.7	4.5	0.5	9.0	2.4	0.0	3.8	6.1	8.0	4.0	5.7	7.8	4.2	12.7	4.1	11.6	4.9	1.3	10.0	5.0	5.0	2.8	5.5	8.3	6.2	4.3	13.8	1.9	11.0	6.5	5.5	0.3	2.3	8.5	2.9	2.5	4.8	2.7
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.0	7.9	11.4	23.0	39.4	31.1	9.3	14.9	17.1	7.2	9.0	12.5	19.7	0.5	25.5	15.9	18.6	10.2	12.8	15.0	10.4	0.8	8.0	3.0	8.3	16.4	15.6	2.0	5.4	33.7	24.4	11.7	17.4	12.6	13.5	5.0	3.2	6.1	11.5	13.1	2.8	3.7	6.1	33.8	13.7	2.7	7.3	8.8	10.4	8.4	9.0	7.6	4.2	22.1	6.9	14.0	9.4	3.3	10.9	7.3	2.5	17.1	12.0	5.7	4.0	1.8	13.1	8.3	3.6	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3	20.8	28.7	3.0	9.8	16.6	9.1	3.5	28.1	5.3	17.0	43.6	2.0	5.0	3.3	16.9	1.1	10.3	26.8	0.0	17.0	17.3	20.5	23.0	2.3	41.5	4.4	1.6	17.3	6.7	2.1	1.3	11.2	4.6	10.1	0.0	24.9	1.2	26.6	10.5	7.1	24.6	2.4	0.0	13.7	6.1	6.0	16.8	8.6	2.5	25.5	13.6
